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ABSTRACT
The aim o f the presen t s tu d y  was to characterize  the phenomenon o f 
resistance in pu ta tive  preneoplastic hepatocyte nodules. These 
hyp e rp las tic  nodules are generated d u rin g  the development o f liv e r 
cancer in response to chemical carcinogens, and comprise a population o f 
cells from which hepatocellu lar carcinoma can develop. As hepatocyte 
nodules grow in an environm ent th a t is otherw ise tox ic  they possess a 
re s is tan t phenotype.
To understand th is  resistance phenomenon a t the biochemical leve l, 
several phase I and I I  d rug-m etabo liz ing  enzymes in the nodules were 
examined. In it ia l experim ents were ca rried  out in ra ts  w ith  nodules 
produced by in itia tio n  w ith  d ie thy ln itrosam ine , followed by selection w ith  
2-acetylam inofluorene and carbon te tra ch lo rid e . These nodules showed a 
large decrease in phase I enzymes and enzymic a c tiv it ie s , such as the 
cytochromes P-450, cytochrome b 5, to ta l microsomal haem, am inopyrine 
N-demethylase and e th oxyreso ru fin  O-deethylase, bu t g lu ta th ione  and the 
phase II  enzymes, namely, g lu ta th ione  S -trans fe ra se , U D P -g lucuronyl 
trans fe rase , DT-diaphorase and y -g lu tam yltrans fe rase  were s ig n ific a n tly  
increased. The pa tte rn  o f changes o f these d rug-m etabo liz ing  enzymes 
o f the nodules was sim ilar when the nodules were produced by d if fe re n t 
in itia tion -p rom o tion  trea tm ents, inc lud ing  d ie thy ln itrosam ine  p lus a 
cho line /m eth ion ine -de fic ien t d ie t, 2-acetam idofluorene plus phenoba rb i- 
tone, o r d ie thy ln itrosam ine  plus o ro tic  acid . In  a d d itio n , the resistance 
phenotype was maintained when these nodules were tra n s fe rre d  in to  the  
spleen o f a ra t not exposed to chemical carcinogens, and allowed to grow
fo r several m onths, thus ind ica ting  th a t the newly acquired  biochemical 
pa tte rn  in the nodules had become co n s titu tive .
Unlike the hepatic nodules generated by previous in it ia t io n -p ro -  
motion trea tm ents, nodules generated by the hypolip idem ic agent, 
c ip ro fib ra te , exh ib ited  on ly  a decrease in phase I components o f the 
d rug-m etabo liz ing  enzymes, w ith  no increase in the phase I I  components. 
S im ila rly , hyperp las tic  nodules in live r mouse showed a decrease in 
phase I components, b u t no increase in phase II components.
In addition  to cytochrome P-450 and cytochrome b5, the to ta l haem 
and two o ther haem conta in ing p ro te in s , namely, catalase and tryp to p h a n  
2 ,3-d ioxygenase were also decreased in the nodules. A de fic iency in 
hepatic iro n , and a decrease in the a c tiv ity  o f de lta -A L A -syn th e ta se , the 
f i r s t  ra te  lim iting  enzyme in haem syn thes is , were also apparen t.
C haracterization o f the phase I I  components revealed the presence 
o f a new g lu ta th ione -S -trans fe rase  po lypep tide , which has been shown to 
be identica l to a placental form o f the transfe rase . Th is po lypep tide , 
a lthough present to a minimal e x te n t, o r absent, in normal ra t liv e r ,  is 
presen t in normal male mouse liv e r .
A dm in is tra tion  o f lead n itra te  to ra ts  induces a biochemical p a tte rn  
in the liv e r sim ilar to th a t seen in the hepatocyte nodules, inc lu d in g  a 
decrease o f phase I components and an increase in phase I I  components 
o f the d rug-m etabo liz ing  enzymes, and the induction  o f the novel 
g lu ta th ione S -transfe rase . F u rth e r studies w ith  lead n itra te  may y ie ld  
new ins igh ts  into the mechanisms o f p roduction  o f the biochemical 
changes induced in the nodules, as th is  agent generates the same 
changes w ith in  30 hours. Furtherm ore , the  lead n itra te -in d u ce d  changes
in phase I and phase II  enzymes are re ve rs ib le , while the changes seen 
in the hype rp las tic  nodules are not.
Thus th is  s tudy  has characterized one pa tte rn  o f biochemical 
changes exh ib ited  by the res is tan t phenotype o f hype rp las tic  hepatic
nodules, and a model system has been developed which induces the same 
changes, more ra p id ly  and in a reve rs ib le  fashion. One o f the im portant 
questions ye t to be answered however is the biological s ign ificance o f the 
res is ta n t phenotype in cancer development. Is the acqu is ition  o f
resistance on ly  im portant in expanding the in itia ted  cell population to 
generate nodules or does it also have a more d ire c t role in the
progression o f nodules to cancer? This is h ig h ly  re levan t to the
c la rifica tio n  o f the carcinogenic process in the liv e r and perhaps in o the r 
organs as w ell.
CHAPTER 1 
INTRODUCTION
1CHAPTER 1 
INTRODUCTION
Cancer is p robab ly  the most dreaded diseases a ffec ting  man. I t  is 
the second major cause o f death in the Western w o rld . Many human 
cancers are considered to be environm ent re la ted . The term  environm ent 
is here b road ly  defined to include occupation, d ie t and social hab its . 
A lthough cancer is a ub iqu itous disease, the types o f cancer v a ry  v e ry  
much in d if fe re n t geographic reg ions. These regional d iffe rences are 
probab ly  environm ental in o r ig in , ra th e r than gene tic , since they  change 
a fte r  the ind iv idua ls  move to another c o u n try . A lso , some cancers are 
c lea rly  related to hab it pa tte rns inc lud ing  d ie t and occupation. These 
include sm oking, u ra n ^ m , asbestos and some in d u s tr ia l chemicals.
A lthough the etio logic agents v a ry  w ide ly in th e ir  n a tu re , the 
processes th a t they induce show some remarkable s im ila ritie s . Almost all 
human and experim ental cancers are m ultis tep  in th e ir  developm ent, 
in vo lv ing  often 1/3 to 1/2 o f the lifespan o f the species.
These considerations favour the view th a t cancer p reven tion  may be 
possible o r feasible as we learn more about the e tio logy b u t especia lly as 
we understand more about its  pathogenesis. The s tu d y  o f carcinogenesis 
has th is  overall o rien ta tion  to add to our a b ility  to in te r ru p t the process 
o f carcinogenesis and the reby  p reven t cancer from even deve lop ing .
The na ture  o f cancer
Cancer is a p rogress ive  process by which cells in a m u ltice llu la r 
organism re v e rt to a un ice llu la r b io logy and economy, i.e . p rog ress ive ly
2escape in te rce llu la r and hormonal reg u la tio n , lose specialized fu n c tio n , 
and adopt the biochemical economy o f a s ing le -ce ll organism .
The pathological c r ite r ia  o f m alignant tumors include the fo llow ing :
1. Hyperplasia (increased number o f ce lls , increased d iv is io n ) , 
dysplasia (changes in organ isa tion) and cyto logica l abnorm alities (see 
be low ).
2. Invasion o f adjacent tissue (penetra tion  o f basement membranes)
3. Metastasis -  loss o f ce llu la r adhesion, ce llu la r m igra tion  and 
a b ility  to th r iv e  a t d is ta n t s ites.
A dd itiona l cha rac te ris tics  observed are increased frequency  o f 
cyto logica l abnorm alities o f both nucleus and cytoplasm such as 
pleomorphism and enlargement o f nuc le i, hyperchromasia and abnormal 
clum ping o f chrom atin , at times m u ltinuc lea tion , abnormal mitoses, 
prom inent nuc leo li, aniscytosis and enlargement o f ce lls , cannibalism  and 
cytoplasm ic inc lus ions, and changes in phenotyp ic expression.
In most cases, the cancer cell o rig ina tes by changes in normal ce lls 
and tumor development occurs over several years ra th e r than q u ic k ly  
from p re -e x is tin g  s ilen t neoplastic ce lls . Cancer ce lls , however, do not 
arise  d ire c tly  from normal ce lls , b u t from one or more cell populations 
w hich , a lthough derived  from normal ce lls , have developed a lte red  
p ro pe rtie s . M alignant neoplasia is thus the fina l re su lt o f a process o f 
ce llu la r evo lu tion in which the aforementioned cha rac te ris tic  p ro pe rtie s  
fo r  cancer iden tifica tion  are re la tive ly  late manifestations (Fou lds , 1969; 
Farber, 1980).
3Etio logy o f Cancer
Radiation, v iruses and chemicals have been implicated as causative 
fac to rs  fo r cancer in many species o f animals and in man. A lthough  
there  is g rea t d iv e rs ity  in the nature  o f these causative agents, the end 
p o in t o f the ce llu la r response is always the same -  the p roduction  o f a 
neoplastic ce ll. I t  is not known w hether o r not these agents operate 
th ro u g h  the same molecular mechanisms, bu t it  has been postu lated th a t 
there  may be m ultip le  mechanisms by which the e ffe c t o f va rious 
carcinogenic agents are mediated.
R adiation: Various forms o f rad ia tion  inc lud ing  u ltra v io le t, ion iz ing
and corpuscu la r types have been implicated as being carcinogenic in both 
animal and in man (U pton , 1975). C arc inogen ic ity  has been shown fo r  
p ra c tica lly  all types o f p a rticu la te  rad ia tion  investiga ted  (a ra y s , $ rays , 
p ro tons , n e u tro n s ). However in the electrom agnetic range on ly  those in 
the  h igh energy end o f the spectrum have been shown to be carcinogenic 
(UV lig h t, X -ra y s , gamma ra y s ). O f most widespread importance is the  
prevalence o f sk in  cancer in certa in  geographic areas, p a r tic u la r ly  in 
fa ir  skinned or Celtic race exposed to UV rad ia tion  o f  s u n lig h t (F itzp a ­
t r ic k  et a L , 1971 , 1974; Kopf et a L , 1977).
The early  use o f X -ra ys  in diagnosis was associated w ith  a h igh  
incidence o f skin  cancer among rad io log ists (F ru th  and Lorenz, 1954). 
In a sim ilar fash ion , ea rly  users o f the rapeu tic  rad ia tion  fo r  cond itions 
such as ankylosing sp o n d y lit is , m astitis and thym ic enlargem ent led to 
the eventual development o f cancer o f the bone, b reast and sa liva ry  
glands respective ly  in some exposed patien ts (U p ton , 1975). a -R ad ia tion  
was demonstrated as an occupational hazard fo r  uranium  miners exposed 
to radon (Lund in  et a l. ,  1971). Exposure to both neutron and gamma
4radiation from atomic bombs led to a h igh incidence o f leukemias in the 
Japanese population (Ish im aru et a L , 1971).
Another im portan t example o f a h igh r is k  population fo r  the 
development o f sk in  cancer fo llow ing the exposure to  UV rad ia tion  are 
ind iv idua ls  w ith  the gene tica lly  acquired cond ition , xeroderma 
pigmentosum ( X .P . ) ,  who have a reduced a b ility  to repa ir U V-induced 
DNA damage (Robbins e t a L , 1974). In d iv idu a ls  w ith  X .P . serve as an 
im portan t model fo r the s tu d y  on the re la tionsh ip  o f U V-induced DNA 
damage to carcinogenesis in the sk in  (C leaver, 1968, 1970; Epste in , 
1970; Robbins e t a [ . , 1974).
V iru s e s : Both DNA and RNA v iruses have been shown to be
cancer causing agents in many groups o f ve rteb ra tes  inc lud ing  b ird s , 
bats, roden ts , fe lin ids  inc lud ing  primates (Tooze, 1973; E pste in , 1976). 
Some o f the im portant ea rly  d iscoveries in v ira l oncogenesis were those 
o f Ellerman and Bag in 1908, who showed the cell free  transm ission o f 
fow l-leukem ia; o f Rous in 1911, dem onstrating v ira lly  induced sarcoma 
in fow l; o f Shope in 1932 showing v ira lly  induced papillomas in ra b b its ; 
and o f B ittn e r in the 1930s, dem onstrating th a t the h igh incidence o f 
mouse mammary cancer in certa in  s tra ins  was related to the transm ission 
o f v iru s  (m ilk  fac to r) in the m other's m ilk (see Gross, 1970 fo r  fu r th e r  
re fe rences). A lthough  an im portant role o f  v iruses in the causation o f 
many human cancers has been postu lated (G reen, 1970; Gross, 1970), 
so fa r  the most single convincing candidate is the E p s te in -B a rr (E .B ) 
v iru s  which has been implicated in the causation o f B u rk it t 's  lymphoma 
and nasopharyngeal carcinoma (E pste in , 1976; Henle and Henle, 1978).
DNA tum or v iruses  are a more heterogeneous set o f v iru s e s , which 
according to th e ir  DNA size and biological behaviour have been c lass ified
5as papova, adeno, herpes- and icron v iru s  (Essex et a\ . ,  1980).
Papova- and adeno-viruses are not carcinogenic fo r  th e ir  na tu ra l host, 
b u t they can easily transfo rm  xenogenic cells ]n  v it ro  as well as induce 
tumors in o ther hosts. For instance, SV40 monkey v iru s  does not induce 
cancer in monkeys, b u t read ily  produces u n d iffe re n tia te d  sarcomas and 
fibrosarcomas in newborn hamsters when innoculated subcutaneously and 
ependymonas when in jected in travenous ly  (Diamondopoulos and McLane, 
1974). Unlike the papova- and adeno-v iruses, several herpes v iruses  
are known to be oncogenic fo r  th e ir  hosts under na tu ra l cond itions. 
Classical examples are the induction  o f lymphomas in chickens by Marek's 
disease v iru s  (B igg s , 1968), and o f summer tumors in leopard frog  by 
Lucke's frog  v iru s . Two herpes v iruses have been associated w ith  
human cancer. One o f them, herpes simplex v iru s  type  2, which in fects 
the genita l area and is regarded as a causative agent fo r  some human 
cerv ica l carcinomas (Rawls et a l. ,  1980). The o th e r, E p s te in -B a rr v iru s  
(E B V ), is in tim ate ly  associated w ith  B u rk it t 's  lymphoma and w ith
nasopharyngeal carcinoma (K le in , 1975, 1979).
With respect to human liv e r cancer and v iru se s , ep idem io log ica lly ,
there  is a good corre la tion  between the presence o f one o r more o f the  
hepa titis  B antigens in the liv e r a n d /o r b lood, and liv e r  c irrh o s is  and 
cancer th roughou t the w orld . Especially in parts  o f A s ia , A fr ica  and 
Europe (A n th o n y , 1976; R ub in , 1976; B lum berg, 1977), a t least one 
additional fa c to r, exposure to m ycotoxins may p lay an im portan t role in 
the etio logy a n d /o r pathogenesis o f  liv e r cancer. In  the woodchuck, a 
close association between in fection w ith  a DNA v iru s  s im ilar to HBV and 
liv e r  cell cancer is also apparen t. In  the d u ck , liv e r cell cancer occurs
6in areas o f h igh live r cell cancer incidence in human, and an H B V -like  
v iru s  has been found in th a t species.
RNA tumor v iruses  (re tro v iru se s ) in general share ce rta in  
s tru c tu ra l fea tu res , v iz  a large s ing le -s tranded  RNA genome, and an 
envelope p ro te in  component. In fec tion  w ith  re tro v iru se s  is associated 
w ith  both neoplastic and non-neoplastic diseases in many species o f 
ve rte b ra te s , most s tr ik in g ly  so w ith  leukemias and lymphomas in ch icken , 
mouse, ca t, cow and Gibbon apes (Todaro , 1980). The most exc itin g  
phenomenon th a t has occurred in recent times is the ide n tifica tion  o f 
several oncogenes present in these re tro v iru se s  and th is  aspect w ill be 
discussed la te r.
Chemicals: Chemicals form the la rgest g roup  o f causative agents o f
human cancer. Epidemiologic stud ies continue to relate human cancer 
incidence to in d u s tr ia l (occupa tiona l), medical and social exposure to  
chemicals (H igginson and M u ir, 1973; D oll, 1977). The h is to ry  o f 
chemical carcinogenesis o rig ina ted  two centuries ago w ith  the e a rly  
observation o f John Hill in 1761 o f nasopharyngeal cancer in man from 
the excessive use o f tobaccoe s n u ff (c f. Redmond, 1970). La te r, S ir 
Percival Pott (1775) found th a t the increased incidence o f the scrota l 
cancer in form er chimney sweep boys could re su lt from fre q u e n t expo­
sure  o f the sk in  to soot.
Many physicians noted th a t occupational cancers were re lated to  the  
exposure o f w orkers to coal ta r ,  p a ra ffin  and mineral oil (H e n ry , 1947) 
and the reby  stim ulated the search fo r carcinogens in such complex 
in d u s tr ia l m ix tu res . I t  was not u n til 1915 th a t two Japanese w o rke rs , 
Yamagiwa and Ichikawa showed th a t sk in  cancer can be induced 
experim enta lly  by repeated application o f coal ta r  on the skin  o f  ra b b it
7by repeated topical application o f coal ta r  to th e ir  ears over long 
periods. T su tsu i in 1918, a pupil o f Yamagiwa, showed th a t ra ts and 
mice were also susceptib le to the carcinogenic e ffects  o f repeated 
application  o f coal ta r .  Subsequently, coal ta r  was fractionated  and the 
carcinogenic potentia l o f several po lycyc lic  aromatic hydrocarbons was 
discovered (Kennaway and H ieger, 1930) (F ig . 1 .1 ).
The find ing  was q u ick ly  taken up by leading organ ic chemists o f 
th a t tim e, notab ly by Cook et aL (1933) in Scotland and Fieser in the 
USA who synthesized numerous compounds related to dibenzanthracene 
which were tested fo r th e ir  ca rc inogen ic ity . Typ ica l compounds are 
listed in F ig. 1 .1 . I t  was hoped th a t the s tudy  o f these s tru c tu re s  
would p rov ide  a v ita l clue as to the chemical s tru c tu re s  which caused 
cancer b u t no easy reso lution appeared.
Since chimney sweeping had become b e tte r organized and forms o f 
heating o ther than coal fire s  came in to  vogue, the stud ies on ca rc ino ­
genic e ffec t o f po lycyc lic  hydrocarbons, tended to be regarded as on ly 
o f academic in te res t fo r  several years subsequent to  th e ir  d isco ve ry . 
However, in 1953 Doll fo llow ing in tensive  epidemiological and s ta tis tica l 
ana lys is, proved c lea rly  th a t c iga re tte  smoking was a prime cause o f 
lung cancer in man (F ig .1 .2 ). Careful analysis o f the  smoke and ta r 
obtained from cigare ttes demonstrated th a t it  contained more than 4000 
compounds many o f which are carcinogenic hyd roca rbons, the most 
im portant one being benzo(a)pyrene. Thus fo r  the f i r s t  time a close 
lin k  was established between academic research on cancer in animals and 
a v e ry  common environm ental hazard.
Another c lin ica l observation o f  an occupational cancer led to  the 
d iscovery  o f carcinogenic aromatic amines. Increased incidence o f
Dibenz[a,h]anthracene Benzo[a]pyrene
H3C
H2C — -CH2 
3-Methylcholanthrene
NH;N
2'I3-Dimethyl-4-amino-azobenzene
o
2-Naphthylamine
CH3
7,12-Dimethylbenz[a]anthracene
■ CH3
N*
N
/
J
\
N
CH3
A/,A/-Dimethyl-4-amino
azobenzene
HO
Estrone
Fig. 1.1 Structures of chemical carcinogens i.
The structures of the principal chemical 
carcinogens discovered prior to 1940.
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Fig.1.2 Relationships between cigarette smoking and 
lung cancer deaths in the UK, Canada and USA.
( ♦ — ♦ )  British doctors; ( □ — □) Canadian 
ex-servicemen; (■ — ■) US ex-servicemen;
( A  A ) survey of men in 25 states in USA.
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bladder cancer among dye fa c to ry  w orkers was f i r s t  described by Rehn 
(1895) in Germany. A large series o f aromatic-amines inc lud ing  an iline , 
8-naphthylam ine (F ig . 1 .1 ) , benzidine and d ipheny l amines were la te r 
associated w ith  the development o f human malignancy (Case et a L , 
1954). The experim ental evidence th a t such components could be 
carcinogenic was reported  by Hueper and his associate (1938) who found 
tha t b ladder cancer could be induced in dogs by 8 -naphthylam ine.
The azo dyes are the th ird  g roup  o f carcinogens th a t aroused 
increasing in te res t fo r  many years. Yoshida (1933) was the f i r s t  to 
show th a t ra ts  fed a d ie t conta in ing O-aminoazotoluene developed 
hepatomas. Soon a fte r , K inosita (1936) showed th a t N -N -d im e th y l-4 - 
aminoazobenzene is also a hepatocarcinogen (F ig . 1 .1 ).
In the in te rven ing  years , a large number o f chemicals th a t can 
induce cancer in mammalian tissues have been iden tified  and synthesized 
(F igs 1.3 and 1 .4 ). These chemical carcinogens consist o f  a large and 
s tru c tu ra lly  d iverse  g roup  o f compounds w ith  various species and tissue 
spec ific ities  (C layson, 1962; Hueper and Conway, 1964; Arcos e t a l . , 
1968; M ille r, 1970; W eisburger, 1973).
Recent data obtained from the Chemical A b s tra c t Service show th a t 
approxim ate ly 3.9 m illion known organ ic chemical compounds, are 
syn the tized  annua lly . Out o f these, about 1000 chemicals are a lready 
known o r are s tro n g ly  suspected to be carc inogenic, the rem aining large 
number o f chemicals s t il l have not been p ro pe rly  tested fo r  th e ir  
oncogenic po ten tia l. Basica lly , they may be c lassified in to  th ree  broad 
g roups:
i) the syn the tic  organic chemical carcinogens which include many 
new d e riva tive s  o f the po lycyc lic  aromatic hydrocarbons (P A H ), aromatic
11
amines and azo dyes, n itroqu ino line  oxides, a lky ln itrosam ines and 
amides, po lych lorina ted  a lipha tic  compounds such as v in y l ch lo ride  and 
a licyc lic  hydrocarbons, u re thane , eth ion ine and th iourea (F ig . 1 .3 ) .
ii)  N a tu ra lly  generated or n a tu ra lly  o ccu rrin g  carcinogens, 
inc lud ing  the a fla tox ins (de rived  from some s tra ins  o f A sp e rg illu s  
f la v u s ) , re lated compounds such as ste rigm atocystin  and its  d e r iv a tiv e s , 
p y rro liz id in e  alkalo ids such as lasiocarpine (Senecio c ro to la ria , e tc ) ,  
cycasin in the cycad nu ts o f p rim itive  palm tre es , and safro le in the  oil 
o f sassafras and o ther na tu ra l p roducts  (F ig .1.4) (Wogan, 1976). 
A fla to x in  B x, one o f the most potent hepatocarcinogens know n, induces 
hepatomas when adm inistered in a d ie t conta in ing on ly  15 ppb o f th is  
funga l tox in  (Wogan and Newberne, 1967). The in fection  o f some crops 
like peanuts, w ith  fung i conta in ing potent carcinogens such as a fla to x in  
B 1# may co n tribu te  to the s tr ik in g  incidence o f human liv e r cancer in 
A frica  and China (O ettle , 1964; Wogan, 1968).
ii i)  The known inorgan ic chemical carcinogens are a small g roup  o f 
metals e .g . be ry lliu m , cadmium, chrom ium, coba lt, lead, n icke l, selenium 
and certa in  complex s ilica tes.
Chemical Aspects o f Carcinogesis: Procarcinogens and Ultimate C arc ino­
gens -  A U n ify in g  Hypothesis
Chemical carcinogens are v e ry  d iverse  g roup  o f compounds lacking  
any common s tru c tu ra l s im ila rity  to exp la in  th e ir  ca rc in ogen ic ity . Due to 
th e ir  molecular s tru c tu re s  o f chemical carcinogens, a u n ify in g  hypothesis  
has been proposed over the past decade (Boyland and Lev i, 1935; 
W eisburger and W eisburger, 1973; M ille r, 1970; M ille r and M ille r, 1974, 
1977). Some o f the chemical carcinogens in te ra c t w ith  ce llu la r
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C—CH3
2-Acetylaminofluorene
(A/-2-fluorenylacetamide)
ecu
Carbon
tetrachloride
/ / O
CH3—CH2—O—C
\
n h 2
Ethyl carbamate
BeO 
Beryllium oxide
CH3- N
/
CH2—CH2—Cl
\CH2—CH2—Cl
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chloroethyl)-amine
CH3
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/
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N—NO
Dimethylnitrosamine
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I
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Ethionine
Fig.1.3Structures of chemical carcinogens II.
The structures of some chemical 
carcinogens identified between 1940 and 
1960.
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CH2—c h = c h 2
Safrole
[Sassafras]
O -C H
Aflatoxin Bi 
[Aspergillus flavus]
CH2—O—C—NH
OCH
NH
O
Mitomycin C
[Streptomyces
caespitosus]
HOHsC
/ ^ - O  o - CH2- N= N -C H 3
h o N — r  o
OH
Cycasin
(Cycad tree ferns)
R—O CH2—O—C—R
Pyrrolizidine alkaloids 
(Senecio, Crotolaria and 
Heliotropium  genera)
c h 3o  O o c h 3
Cl
Griseofulvin
(Penicillium
griseofulvum)
Fig.i.4Structures of chemical carcinogens III.
The structures of some chemical 
carcinogens that are products of plants and 
micro-organisms.
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components d ire c tly  and are called d ire c t acting  agents. Most, however 
are nonpolar compounds and as such do not read ily  in te ra c t w ith  ce llu la r 
components. In  o rde r to e xe rt th e ir  biological e ffe c t, these 
"procarcinogens have to be converted jn  v ivo  to ultim ate ca rc inogens." 
The ultim ate carcinogens, are h ig h ly  reactive  e le c troph ilic  components 
which in te rac t w ith  nucelophilic  sites p resent in ce llu la r components such 
as DNA, RNA, p ro te in  e tc . o r undergo deactivation h y d ro ly tic a lly . 
Examples o f these agents are predom inantly b io log ica lly  a lk y la tin g  agents 
e .g . S- o r N -m ustards, epoxides, a lky la lkane , su lphonates, lactones 
e tc . , inorgan ic chemicals and some radiochemicals.
The m ajority  o f the carcinogenic chemicals fa ll in to  the in d ire c t 
acting  class, which requ ire  metabolic conversion o f the pa ren t compounds 
to u ltim ate e lec troph ilic  reactants fo r th e ir  action (M ille r, 1970; M ille r 
and M ille r, 1971; W eisburger and William, 1975). Usually on ly  a small 
frac tion  o f procarcinogen is metabolically activated v ia  enzymatic means, 
whereas the bu lk  under most circum stances is subjected to d e to x ifica tio n . 
The pa ren t lypoph ilic  compound is o ften converted to a h yd ro p h ilic  one 
by conjugation and is then elim inated. The overall ca rc inogen ic ity  w ill 
the re fo re  be determ ined by the balance o f the activa tion  and deactiva tion  
processes. Such balance can be influenced by many fac to rs  inc lud ing  
age, hormonal and n u tr itio n a l s ta tu s , genetic d ispo s ition , c ircad ian  
rh y th m ic ity  and d rug  induced changes in metabolism.
Metabolism o f Chemical Carcinogens
Four major types o f enzymatic reactions have been recognized in the 
metabolism o f xenobiotics v iz  ox ida tion , reduc tion , h yd ro lys is  and 
conjugation (William, 1959).
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O xida tion ; Almost a ll o f the n a tu ra lly  occuring  and a vas t m a jo rity  
o f the syn the tic  chemical carcinogens requ ire  metabolic activa tion  in 
o rde r to e xe rt th e ir  biological e ffec ts . The p rin c ip a l enzymes 
responsib le fo r  the b io transform ation o f these xenobiotics fa ll in to  the 
general g roup  o f enzymes known as the cytochromes P-450 o r the  
m ixed-form ation mono-oxygenase systems. Th is  is a a membrane bound 
enzyme system in which NADP-cytochrome c reductase, phospholip id  and 
cytochromes P-450 (and related hemoprotein) are im portant components. 
These enzymes are located predom inantly on the endoplasmic re ticu lum  
and possib ly the nuclear membrane o f the cell (K asper, 1971; Khandwala 
and Kasper, 1973; Rogan and C ava lie ri, 1974; V aught and B re sn ick , 
1976; Rogan et a [ . , 1976; B resn ick et a L , 1977; Thomas et a L , 
1979). These membrane bound m ulti-com ponent enzyme systems o f an 
e lectron tra n sp o rtin g  u n it operate w ith  NADPH/NADH as co facto rs , 
molecular oxygen as substra te  and a term inal cytochromes P-450 (A tlas  
and N ebert, 1978). The enzymology o f the mono-oxygenase system is 
being characterized and appears to e x is t in m ultip le  forms (Thomas e t 
a L , 1976). The mono-oxygenase a c tiv ity  and associated cytochromes
P-450 can be induced by a number o f po lycyc lic  aromatic hydrocarbons 
( A lvares et a L , 1967; Conney, 1967) and these inducib le  mono-oxygenase 
"a c tiv itie s " (20 d iffe re n t form s) appear to be contro lled  by the Ah 
re g u la to ry  locus (N ebe rt, 1972; T h o rge irrson  e t a L , 1975; A tlas and 
N ebert, 1976; Felton e t a L , 1976; B urke  e t a l . , 1977; T h o rg e irrso n  
e t a L , 1977). An im portant p roduct o f the reg u la to ry  Ah gene is a 
cytosolic receptor p ro te in  capable o f b ind ing  to ce rta in  p o lycyc lic  
aromatic induce rs , and the reby  ac tiva ting  s tru c tu ra l gene(s) and
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resu lting  in an increase in enzyme ac tiv itie s  (N ebert e t a L , 1975;
Poland et a L , 1976).
The mixed function  oxidase cytochromes P-450 e x is t as several 
isozym es/form s, o f which at least two major groups the cytochromes 
P-448 and P-450 (Parke and Ioannides, 1984) are two d is t in c t ly  d if fe re n t 
enzymes w ith  d if fe re n t active sites and d if fe re n t substra te  a ffin it ie s  and 
specific ities  (Philipson e t a L , 1982). Th is is in agreement w ith  the 
s tud ies o f Dus (1982) who showed th a t the haemopeptide active  sites o f 
several isozymes o f cytochromes P-450 showed marked homology w ith  each 
o th e r, b u t l it t le  o r no homology w ith  the haemopeptide o f  P-448. O ther 
marked d iffe rences between the isoenzymes o f cytochrome P-450 and 
cytochrome P-448 shown in Table 1.1 ind icate th a t they  are p roduc ts  o f 
d if fe re n t genes and should be regarded as two d is t in c t g roups o f 
d if fe re n t enzymes.
Recent studies have also revealed th a t two groups o f enzymes show 
m arkedly d if fe re n t e ffec t in the metabolism o f xenobiotics (Ioannides et 
a h , 1984) whereas cytochromes P-450 genera lly  re su lt in the de toxica tion  
o f carcinogens and tox ic  chemicals, cytochrome P-448 leads to th e ir  
activa tion  (F ig . 1 .5 ). Th is is because the p ro duc t o f cytochrome P-448 
oxygenation are not read ily  acceptable substra tes fo r subsequent 
conjugation and detoxication by epoxide hydrolase or g lu ta th io n e -S - 
transfe rase  (G la tt et al_., 1983). Not on ly  are the carcinogenic
po lycyclic  hydrocarbons activa ted to th e ir  proxim ate carcinogen b u t 
aromatic amines, aromatic amides p ro te in  pyro lysa te  mutagens and 
mycotoxins are all s im ila rly  activated as are the d rugs  paracetamol and 
phenacetin (Ioannides et a l. ,  1984).
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Table 1.1
D ifferences between the cytochromes P-450 
and cytochromes P-448
Properties Cytochromes P-450 Cytochromes P-448
Reduced CO d iffe rence  
spectrum  absorption 
maximum
450 nm 448 nm
Enzymic site Cannot accommodate large 
molecules
Accommodates large 
p lanar molecules like  
subs titu ted  phenanthrenes
Enzymic a c tiv ity Oxygenation a t unhindered 
C atoms
O xygenation at C atoms 
in h indered positions and 
a t N atoms
Specific substra te 7-P en toxyreso ru fin 7 -E th o xy reso ru fin
Specific in h ib ito rs Metyrapone 9 -H yd ro xye llip tic in e
Physiological substra tes Xenobiotics, lip ids Steroids
Tissue d is tr ib u tio n P rinc ipa lly  liv e r , 
absent from placenta
P rinc ip a lly  e x tra h e p a tic , 
p resen t in placenta
Perinatal development Develop in neonate a fte r 
P-448; p robab ly  induced 
by xenobiotics in d ie t
Develop in fe tus  before 
P-450, poss ib ly  fo r 
ste ro id  metabolism
Enzyme induction Induced by d rugs  and 
xenobiotics which are 
small molecules (eg. 
p h en o b a rb ita l). Simul­
taneous induction  o f 
cytochrome P-450 reduc­
tase
Induced by carcinogens 
which are la rge , p lanar 
molecules (eg. 3 -m e th y l- 
ch o la n th re ne ). No 
simultaneous induc tion  o f 
reductase.
S tru c tu re Amino acid and nucleotide 
sequences show h igh homo­
logy , b u t d if fe r  from those 
fo r  P-448s
Amino acid and nucleo­
tide  sequences show h igh  
homology b u t d if fe r  from  
fo r P-450s.
A fte r  Parke and Ioannides (1984).
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C om putergraphic stud ies o f the dimensions o f the active  sites o f  the 
two d if fe re n t groups o f cytochromes show sim ilar marked d iffe rences 
(Lewis e t a l . , 1986). The active site o f cytochrome P-450 is su itab le  
fo r  in te rac tion  w ith  g lobu la r molecule (e .g . phenobarb ita l) whereas the 
active site o f cytochrome P-448 e x h ib it a sp e c ific ity  fo r  la rg e r p lanar 
molecule (e .g . d ib e n z (a ,h ) an th racene).
E thoxyreso ru fin  o-deethylase (EROD) a c tiv ity  has been shown to be 
a specific  enzymic assay fo r cytochrome P-448 (B u rke  and M ayer, 1974) 
and i f  th is  is used in con junction w ith  the in h ib ito r  9 -h yd ro xye llip tice n e , 
i t  p rovides g rea te r than 99% sp e c ific ity  fo r cytochrome P-448, the 
a c tiva ting  monooxygenase (Ph illipson e t a L , 1982).
Th is  g roup  o f enzymes is known to metabolize many d ive rse  carc ino­
gens e .g . po lycyc lic  hydrocarbons such as benzpyrenes, m ethylcho lan- 
th re n e , po lych lorina ted  b iphe ny ls , n itrosam ines, aminoazo dyes and azo 
compounds, aromatic amines, N -acetylacyl amines, n itro fu ra n s , epoxides, 
carbomates, a lky lha lides (C onney, 1967; Jerina and D a ly , 1974; 
H eide lberger, 1975; Nebert and Felton, 1976).
Among the most im portant microsomally mediated oxida tions in the 
metabolism o f carcinogens are :
E xpox ida tion : Catalyzed by the cytochrome P-450 mono-oxygenases,
th is  is a common reaction in the metabolism o f po lycyc lic  aromatic 
hydrocarbons and o ther unsatura ted compounds. Epoxides, as reactive  
in term ediates, were o r ig in a lly  proposed by Boyland (1950). A fla to x in  
B 1#- po lycyc lic  aromatic hydrocarbons are ju s t an example o f  a large 
number o f carcinogens th a t can undergo oxygen inse rtion  reactions a t a 
number o f double bonds to expoxides. The enzyme responsib le has been 
called a ry l hydrocarbon hydroxy lase  (Gelboin e t a l . ,  1974). Such
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epoxides may be hyd roxy la ted  by epoxide hydro lase , o r attacked by 
g lu ta th ione  S -trans fe rase , reduced non-enzym atically to phenol or 
subjected to a new round o f epoxidation (Sim e t a l . , 1974; Campbell and 
Hayes, 1976; Swenson et a L , 1977; Buening et a L , 1978).
C -H yd ro xy la tio n : H ydroxy la tion  at the carbon atoms o f some
chemical carcinogens have been implicated to y ie ld  proxim ate carcinogens. 
For example, in the metabolic activa tion  o f carcinogenic nitrosam ines and 
re lated compounds C -hyd ro xy la tio n  and subsequent N -dem ethylation are 
invo lved in the form ation o f u ltim ate carcinogenic in term ediates, the a lk y l 
carbonium ion (H eath, 1962; Magee and Barnes, 1967; Magee et a iL , 
1976). With more complex a lky ln itrosam ines, h yd roxy la tio n  can occur a t 
e ith e r the 6 or a& position proxim ate to the n itrogen  (D ru c k re y  et 
at. ,1964; Okada and S uzuk i, 1972; K ruge r and B ertram , 1973). 
Recently it  has been shown th a t sa fro le , the weak hepatocarcinogen, is 
also activated by C -h yd ro xy la tio n  to 1-h y d ro x y -s a fro le  which can be 
e ith e r es te rified  w ith  sulphate (W islocki et a [ . , 1976) o r expoxidated on 
the 2, ,3 '-bond  o f the safro le (S tillw e ll e t a j . , 1974) to form active
metabolites.
N -H yd ro xy la tio n : N -H yd roxy la tio n  o f aromatic amines is shown to
be the f i r s t  step in the formation o f proxim ate carcinogen (F ig . 1 .6 ) , 
p a rtic u la r ly  in the activa tion  o f 2-acetylam inofluorene (2 -A A F ). Th is  is 
followed by a second transform ation  to active  metabolites (M ille r, 1970; 
W eisburger and W eisburger, 1973). Present evidence indicates th a t the  
carcinogenic a ry lhyd roxam ic  ac id , N -hyd roxy-2 -ace ty lam ino fluo rene  
(N -O H -2-A A F) can e ithe r be es te rified  by su lphate , phosphate o r acetate 
to produce esters o f N -O H -2-AAF (M ille r and M ille r, 1971; Gutman et 
a l. ,  1972; Jackson and Irv in g ,  1972; L o tlika r e t a L , 1972) o r ac tiva ted
Fig. 1.6 
Pathways 
of 2-AAF 
activation 
and 
inactivation.
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by enzymatic N, O -acety ltransferase to y ie ld  an N -acety l-a ry lam ide (K ing  
and P h illip , 1968, 1969; K ing , 1974) both o f which are capable o f
reacting w ith  nucleic acids and p ro te ins . An a lte rna te  pathway has been 
proposed (B artsch  et a L , 1971) in which N -O H -2-AAF is converted by a 
peroxidase into free n itro y l radicals which undergo d ism utation to form  
N-acetoxy 2-AAF and 2 -n itro flu o re ne  (F loyd e t a l . , 1976).
R eduction: Reduction may lead to activa tion  o f some carcinogens.
For instance, the activa tion  o f 4 -n itro q u in o lin e -1 -ox id e  is believed to  
invo lve  reduction  o f the n itro  g roup  to the corresponding n itroso  and 
N -h yd ro xyd e riva tive s . Such reduction may be affected by a number o f 
enzymes (Wang et al_., 1974). The h yd ro xyd e riva tive  in tu rn  can be 
converted to more active compounds by aminoacyl t-R N A -syn the tase  
(Nagao and Sugim ura, 1976).
H yd ro lys is : Esters and amides are especially susceptib le  to
h y d ro lys is . For example cycasin , a methylazomethanol (g lycos ide , is 
hydro lyzed in the in testine  by a glycosidase releasing the m ethy lazoxy- 
methanol, the active moiety (M ille r, 1964).
C onjugation: Several k inds o f conjugation reactions operate in the
metabolism o f carcinogens and these are mediated by cytoso lic  enzymes. 
Im portan t examples are the formation o f g lucuron ides and the form ation 
o f g lu ta th ione  adducts. Aromatic amines, carbamates and amides can 
undergo conjugation reactions to y ie ld  N -g lucu ron ides. A lthough  in most 
cases such compounds are less active than the previous metabolic 
in term ediate, in a few cases, fo r  instance, the sulphate ester o f 2 -A A F , 
may be able to form covalent adducts w ith  macromolecules (M ille r and 
M ille r, 1976).
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The conjugation w ith  CSH is mediated by g lu ta th ione S -transfe rases 
(Jakoby, 1978). The nucleophilic  th io l g roup  in g lu ta th ione  reacts w ith  
e lec troph ilic  centre  o f active metabolites. Sulphates and acetyl g roups 
are good leaving groups and activa te  carcinogens while g lucuron ides and 
g lu ta th iones genera lly  detoxica te.
In te rac tion  o f Chemical Carcinogen w ith  C ellu lar C onstituents  o r 
Macromolecules
V ir tu a lly  all chemical carcinogens w ith  the possible exception o f 
hypolip idem ic agents and phthalates in te rac t e ithe r cova len tly  or 
non-cova len tly  w ith  DNA, RNA and p ro te in  and p robab ly  w ith  polysac­
charides (M ille r, 1970; Terayama, 1970; Tso and DiPaolo, 1973; Lawley, 
1976). In  DNA and RNA, the major site  o f reaction w ith  many
carcinogens (e .g . n itrosam ines, n itrosam ides, aromatic amines) is 
guanine, especially n itrogen  7 o r carbon 8. Some o f the reasons fo r  the 
enhanced re a c tiv ity  o f the N-7 position have been its  position
pe rip h e ra lly  in the wide groove o f the double he lix  and its increased 
nucleophilic  a c tiv ity  (Sarma et a L , 1975). Under a v a r ie ty  o f
circum stances, many sites o f reaction , have been reported  inc lud ing  N -7, 
0 -6 ,  N -3, 2-N H 2 and C-8 o f guanine, 6NH2, N-1, N-3 and N-7 o f 
adenine; N-1 , N-3 and C-5 o f cytos ine ; and 0 -4  o f thym ine. In
ad d ition , phosphodiester backbone o f DNA is also susceptib le  fo r  
carcinogenic a ttack . In  fac t there  are v e ry  few positions o f  DNA th a t 
have not been reported to be invo lved w ith  carcinogen in te rac tion  in 
v ivo  o r jn  v itro  (M ille r and M ille r, 1971; I r v in g ,  1973; Sarma et a [ . , 
1975; Lawley, 1976; M ille r, 1978).
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A lthough all carcinogenic chemicals so fa r  stud ied have been found 
to react cova len tly  w ith  RNA, the pa tte rn  o f reaction d if fe rs  w ith  
d if fe re n t RNAs. For example, e th ionine and 2-AAF appear to have a 
special a f f in ity  fo r tra n s fe r RNAs, whereas o the rs , such as d im e thy l- 
nitrosam ine are less selective (see Sarma e t a L , 1975 fo r  fu r th e r
re fe rences). With p ro te in s , the re  is considerable se le c tiv ity  both in the 
type o f p ro te in  (S oro f, 1969) as well as in the nature  o f the ta rg e t 
amino acids; h is tid in e , m ethionine, cys te ine , tryp to p h a n  and ty ros ine  
appearing to be especially reactive  w ith  some carcinogens.
T a rge t cells show not on ly  a lte ra tions in macromolecules in response 
to carcinogens, b u t also a lte ra tions in v ir tu a lly  all components o f the  
ce lls , inc lud ing  membranes o f the endoplasmic re ticu lum , m itochondria , 
ribosomes, nuclei and nuceloli (F a rb e r, 1973; Svoboda and R eddy, 
1975). In  a d d ition , carcinogens cause in te rfe rence  w ith  a v a r ie ty  o f 
major ce llu la r fu n c tio n s , such as DNA synthesis and metabolism, RNA 
synthesis and metabolism, p ro te in  synthesis etc (see F a rbe r, 1976 fo r  
re fe rences). The m ajority  o f these changes appear to be repa irab le .
Removal o f Macromolecule-Bound Carcinogen and Repair o f Damage
An im portant aspect o f the in te rac tion  o f carcinogens w ith  
macromolecules is the repa ir o f such lesions. V ir tu a lly  all liv in g  
organisms have one or more systems fo r  rep a iring  damage to DNA, a 
process th a t must be a con tinu ing  one, g iven the u ltra v io le t and o the r 
forms o f damaging rad ia tion  and the many chemical hazards and v iru se s  
presen t in the environm ent. One example o f the possible im portance o f 
DNA repa ir in carcinogenesis is in re la tion to ind iv idua ls  w ith  xeroderm a 
pigmentosum (Robbins et a l. ,  1974). These ind iv idua ls  show both an
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increased su sce p tib ility  to epidermal carcinoma and melanoma, and a 
de fect in DNA repa ir can be demonstrated in the m a jority  o f these 
pa tien ts . Norm ally, exposure to u ltra v io le t lig h t leads to d is tin c tiv e  
damage to DNA -  predom inantly the production  o f pyrim id ine  dim ers. 
This damage is recognized by most ce lls , inc lud ing  those o f human and 
o f o the r mammalian and bacteria l species and repa ir is in a large measure 
by excision and nucleotide inse rtio n . Patients w ith  xeroderma 
pigmentosum e ith e r lack or have low levels o f the f i r s t  enzyme, an 
endonuclease, which in itia tes  the repa ir process. Not on ly  are the cells 
o f these patients poor in the re p a ir o f damage by U .V . l ig h t,  b u t also o f 
damage by some chemical carcinogens (C leaver, 1968, 1970; E pste in , 
1970; Robbins et al_., 1974).
Several aspects o f DNA re pa ir have been investiga ted  in bacteria 
and cells in cu ltu re  fo llow ing exposure to u ltra v io le t rad ia tio n , ion iz ing 
rad ia tion and a lky la tin g  agents (Sarma e t a j . , 1975). V e ry  lit t le  is
known, however, about re p a ir o f DNA damage by chemical carcinogens in 
an in ta c t animal. The enzymology o f the steps invo lved in DNA re p a ir 
has been elucidated in bacteria and may o ffe r a guide to s tu d y  in 
mammalian systems. Some o f the probable steps in the removal o f  bound 
carcinogens and subsequent rep a ir o f DNA damage include recogn ition  
and incision by means o f endonucleases, removal o f the lesion by 
exonucleases, repa ir rep lica tion  by DNA polymerases and re jo in ing  or 
ligation by po lynucleotide ligases. The specific  enzymes o f im portance 
and the detailed steps in mammalian liv e r have ye t to be established 
(Sarma e t a L , 1975).
Several studies have noted the induction  o f hepatic DNA s tran d  
breaks jn  v ivo  fo llow ing the adm in is tra tion  o f carcinogens to ra ts  o r mice
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(Sarma e t a L , 1975). A good corre la tion  appears to e x is t among the 
degree o f s trand  b reaks, the e x te n t o f in te raction  o f the carcinogen w ith  
DNA and the dose o f the carcinogen adm in istered. In  a d d itio n , i t  
appears th a t w ith  some non-carcinogenic damaging agents, DNA damage 
is ra p id ly  repaired as judged by a lka line sucrose g rad ien t techn ique . 
However, w ith  many hepatocarcinogens, the re p a ir is slow, tak ing  often 
weeks fo llow ing a single episode o f damage.
In  ad d itio n , a few stud ies have been ca rried  ou t to determ ine the 
k ine tics  o f removal o f DNA bound carcinogen o r its  metabolites and the 
subsequent rep a ir o f DNA damage from d iffe re n t regions o f ch rom atin - 
DNA (Sarma e t a l . , 1978). These stud ies demonstrated th a t DNA-bound 
carcinogens or th e ir  metabolites were removed fas te r from some regions 
o f chrom atin-D NA than o the rs . In  o ther studies it  was found th a t 
spermine and distam ycin A , which in te ra c t w ith  specific  regions o f DNA, 
inh ib ited  m v it ro  m ethylation o f DNA by the carcinogen m e th y ln itro so - 
urea (M NU), bu t not by the carcinogen methylmethane su lfonate (MMS) 
(Rajalakshmi e t a L , 1978; Sarma e t a l . , 1978). These fin d in g s
suggested a p re fe ren tia l in te rac tion  o f carcinogen w ith  d if fe re n t regions 
o f chrom atin-D NA and subsequent repa ir and the importance o f conform a­
tion  o f DNA in its  in te raction  w ith  carcinogens.
There is a need, in the fu tu re , fo r studies o f DNA-carcinogen 
in te raction  and repa ir hn v ivo  under conditions leading to cancer. Such 
investiga tions appear to be more feasible w ith  the development o f  a model 
using liv e r ,  in which the c r itic a l period o f in itia tio n  can be c lea rly  
defined and the presence o f in itia tio n  can be measured.
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The Pattern o f C e llu la r and Tissue Response o f the L ive r to  Chemical 
Carcinogens
Chemical carcinogens a fte r  activa tion  by microsomal enzymes lead to 
not on ly damage o f DNA b u t also to ER and o ther ce llu la r membranes. 
G lycopro te ins, which function  in in te rce llu la r communication, are 
synthesized in ER, and damage to these membranes may re su lt in 
g lycopro te in  synthesis which may have bearing on malignancy (W arren et 
a[.., 1978). E rro rs  in g lycop ro te in  synthesis as seen in human and 
experim ental animals, accounts fo r  the major pathological cha rac te ris tics  
o f cancer (hyperp las ia , metaplasia, invasion and m etastases). Changes 
in g lycopro te in  o f the cell surface (g lycoca lyx) re su lt in in te rc e llu la r 
communication and ce llu la r adhesion, associated w ith  hyperp lasia  and 
metaplasia and metastases. Changes in the g lycop ro te ins  o f  the 
lysosomal membranes and enzymes re su lt in loss o f  s ta b ility  o f the 
lysosomes resu lting  in increased a c tiv ity  o f cy to d e s tru c tive  lysosomal 
enzymes, leading to invasion.
In a d d ition , many hepatocarcinogens induce a v a r ie ty  o f a lte ra tio n - 
associated acute liv e r cell in ju ry .  With re la tive ly  large doses, rap id  
liv e r cell death has been found w ith  several carcinogens (F a rb e r, 1976). 
With many, i f  not most o f these carcinogens, piecemeal o r zonal necrosis 
is commonly seen.
Carcinogenesis: A M ultis tep Process
A w ide ly held view th a t carcinogenesis is a m u ltis tep  process has 
evolved from abundant observations in human and in experim ental animals 
concerning cancer development at m ultip le  sites (Friedewald and Rous, 
1944; Berenblum and S hub ik , 1947).
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Chemical Carcinogenesis in the S k in : Carcinogenesis is a slow ,
m ultis tep process d u rin g  which irre v e rs ib le  s tru c tu ra l and functiona l 
a lte ra tions occur in cells and tissues before the ultim ate m anifestation o f 
cancer. The stepwise phenomenon is illu s tra te d  in the classical 
two-stage mouse skin  carcinogenesis, which consists o f  in itia tio n  and 
promotion (B ou tw e ll, 1974; Berenblum , 1975). In itia tio n  represents a 
ra p id , p robab ly  irre v e rs ib le  change in a ce ll, mutagenic o r ep igenetic in 
o r ig in , which resu lts  in a preneoplastic state th a t is inh e rita b le . 
Promotion is considered ne ithe r carcinogenic nor mutagenic when alone, 
b u t ra th e r a slow process which g re a tly  enhances tum or frequency and 
shortens the la tent period fo r tum or development when g iven a fte r  an 
in it ia to r . In  a dd ition , a broader concept to the two stage hypothesis 
was form ulated by Foulds (1969) to include the progression o f tum or 
from its  ea rlies t detectable form usua lly  a benign lesion, to a ra p id ly  
g row ing , h ig h ly  m alignant, invasive and m etastatic neoplasm.
The common model fo r the detailed dem onstration o f  the 
in itia tion -p rom otion  system is shown in F igure  1 .7 , which shows the 
basic conditions necessary to confirm  the two stage carcinogenesis. As 
shown in groups 1 and 2, ne ithe r in itia tio n  nor promotion alone induces 
any tumors (Berenblum  and S hub ik , 1947; 1949). However, when
in itia tion  is followed immediately by prom otion, a h igh incidence o f  
tum ors w ith  shortened la tent period appear (g roup  3 ). Even w ith  a 
delay in the application o f tum or promotor fo r  as long as one ye a r, 
tum or form ation occurs bu t in reduced y ie ld  (g roup  4 ). I f  the in it ia to r ,  
promoter sequence is reversed , no tumors are seen (g roup  5) (Roe, 
1959; Van D uurren  et a [ . , 1975). T h u s , in itia tio n  and promotion are 
considered as two separate, incomplete events which have q u a lita tiv e ly
Groups Tumor Incidence
1. i ______  _ _ _ ___________ -ve
xxxxxxxxxx -ve
T xxxxxxxxxx +ve
4- XXXXXXXXXX +ve
XXXXXXXXXX 4- -ve
Time Scale
T = In it ia to r  Applied X = Promotor Applied
t  = Tumor Scored
Figure 1.7 Classical experimental skin model system demonstrati 
the two-stage carcinogenesis.
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d iffe re n t roles in tum origenesis. The best experim ental sk in  model 
system so fa r has been the use o f urethane as a "p u re " in it ia to r  w ith  
phorbol este r as the promoter (G ra ffi et a L , 1953; Salaman and Roe, 
1953; Haran and Berenblum , 1956; R itch ie , 1957).
Accumulated evidence suggests th a t the concept o f in itia tio n -p ro m o -
tion is applicable in o ther organs as well e .g . the th y ro id  g lan d , the 
l iv e r ,  the stomach, the esophagus, the lu n g , the b reas t, the b ladder 
e tc. and recen tly  in cells grown in tissue c u ltu re . One o f the 
promotable organs is the liv e r  which w ill be discussed la te r in deta il tha t 
m ight allow a stepwise analysis o f the neoplastic process. In  organs 
such as esophagus, colon and u r in a ry  b ladde r, the systems are 
analogous to the skin  in th a t the in itia tio n  process is tr ig g e re d  by a
carcinogen followed by a secondary ch ron ic  d ie ta ry  prom oting in fluence .
For example, ce rta in  endogenous substances such as b ile  acids have been 
shown to e lic it promoting action on colorectal tum or induced by 
N -m e thy l-N -n itro -N -n itro so g u an id in e  in ra ts  (Narisawa e t a l . ,  1974). The 
a r t if ic ia l sw eetner, saccharin , can act as promoting agent in the 
induction  o f b ladder carcinoma induced by MNU (H icks e t a h , 1973; 
1975).
In  |n  v it ro  carcinogenesis, S ivak and Van Duuren (1967, 1968, 
1970) were able to demonstrate the induction  o f transform ed colonies by 
tumor promoting agent, phorbol este r in aged 3T3 and SV40 transfo rm ed 
mouse cell line . Mondal et a| (1976a; 1976b) also dem onstrated an 
apparent two stage carcinogenic process in C3H/10T1/2 cells by using 
U V -irra d ia tio n  and several po lycyc lic  aromatic hydrocarbons as in it ia to rs  
and 12-0-tetradecanoyl phorbol-13-acetate (TPA) as prom otor.
31
An im portant area pe rta in ing  to the |n  v it ro  system is the 
observation th a t tum or prom oting phorbol esters p a rtic u la r ly  TPA can 
induce a spectrum o f phenotyp ic changes in normal cell cu ltu re  which 
mimic many o f the cells transform ed by chemical carcinogens o r v iruse s . 
These include changes in m orphology and g row th  con tro l (Diamond e t 
a L , 1974; Blumberg et a [ . , 1976; Weinstein e t a l . , 1978, 1979), a lte red 
cell surface p roperties  (B lum berg e t a l . , 1976; Weinstein e t cH., 1977; 
F ischer et a [ . , 1979), induction  o f plasminogen a c tiva to r (W igler et a L , 
1976; Weinstein e t a | . , 1977, 1978) o rn ith in e  decarboxylase (Yuspa e t 
a L , 1976) and prostag land in  syn thesis (Ohuchi and Levine, 1978). When 
added to transform ed cells TPA can also enhance the acqu is ition  o f 
several m arkers o f  transform ation  (Weinstein et a l . , 1977; Bissel e t a [ . , 
1974; F ischer e t a l . , 1979). A nother unusual p ro p e rty  o f TPA and 
re lated compounds is th e ir  a b ility  to in h ib it both term inal d iffe re n tia tio n  
and the synthesis o f specific  macromolecules associated w ith  the 
d iffe re n tia ted  phenotype in a v a r ie ty  o f ce lls . R ecently, i t  has been 
reported th a t in some murine e ry th ro leukem ic cell lines and prem yelocytic 
leukemia cells TPA induces ra th e r than in h ib its  d iffe re n tia tio n  (Miao et
a ]. ,  1978; Rovera e t a j . , 1979; Huberman and Callaham, 1979).
Oncogenes and Carcinogenesis
From the above discussion it  is c lear th a t while several f in e r deta ils 
o f chemicals, be they  in itia to rs  or promoters have been described 
p rob ing  into  the processes o f in itia tio n  and promotion has been on ly  a t 
the phenomenological leve l. A lthough several biochemical stud ies have 
been ca rried  out to understand the carcinogenic process, attem pts to 
understand the process a t gene level is minimal.
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One o f the exc iting  developments th a t occurred  in recent years in 
the fie ld  o f carcinogenesis is the rea lization th a t carcinogenesis can be 
studied a t the level o f gene. Th is rea lization is becoming a c e rta in ty  
because o f the d iscovery  o f proto-oncogenes and the regu la tion  o f  th e ir  
expression. The oncogenes o r "trans fo rm ing  sequences" are a d is t in c t 
p a rt o f re tro v iru se s  genome which are not requ ired  fo r th e ir  rep lica tion .
I t  was discovered th a t the oncogenes o f the re tro v iru se s  are 
transduced from ce llu la r DNA sequences called "proto-oncogenes". (B is te r 
and D uesberg, 1982; Aaronson, 1983). and these proto-oncogenes are 
h ig h ly  conserved d u rin g  evo lu tion . In  the past few years the activated 
forms o f proto-oncogenes have been isolated from human and animal 
tumors (Shamon et aL , 1984; Yaswen e t a l. ,  1985).
Mechanisms o f A c tiva tio n
There is no un iversa l mechanism by which proto-oncogenes ge t 
ac tiva ted . However, in a broader view proto-oncogenes can be activa ted 
e ithe r by ( i)  an enhanced expression ("q u a n tita tiv e  hypo thes is") (Todaro 
and Heubner, 1972) a n d /o r by ( i i)  a lte ra tion  in th e ir  s tru c tu re s  ( "q u a li­
ta tive  hypothes is") (Tem in, 1972).
( i)  A c tiva tion  by Enhanced Expression
Enhanced expression o f proto-oncogenes can be achieved at the 
level o f
( i) D N A -transcrip tiona l acivation
( i i)  RNA p o s t-tra n sc rip tio n a l ac tiva tion  and
( i i i)  p ro te in  post-trans la tiona l ac tiva tion
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( ii)  T ranscrip tio na l A c tiva tio n
A t the DNA level increased tra n s c r ip ts  occur e ith e r by enhanced 
ra te  o f  tra n sc rip tio n  o r increased gene copies. The form er includes: 
(A ) Promoter or enhancer insertion  (B ) Translocation o r gene rea rrange ­
ment (C) Hypom ethylation and the la tte r includes (D) Gene am plifica tion .
A . Promoter a n d /o r Enhancer Inse rtion
Two lines o f evidence suppo rt proto-oncogene activa tion  by 
promoter inse rtio n . (a) Molecular analysis o f v ira l induced tum ors 
reveals a site specific  jux tapos ition  o f v ira l promoter to ce llu la r 
oncogenes like c -m yc f c -s rc , c-m os# c -e rb  B f in t 1 and in t 2 (P o tte r 
and M ush insk i, 1984; Corcoran et a h , 1984). (b ) In  molecular
construc ts  v ira l LTR 's confer transform ation  potentia l to ce llu la r 
proto-oncogenes (C ullen et a L , 1984).
B. Translocation and Gene Rearrangement
These invo lve  a reciprocal translocation  between two chromosomes 
resu lting  in gene rearrangem ents which has one o r more o f the fo llow ing 
e ffe c ts . The translocated fragm ent supplies (a) a new promoter 
sequence (K le in , 1985), (b ) a new tissue specific  enhancer sequence 
(Hayday et a l. ,  1984) (c) trunca ted  genes which has lost its  regu la to ry  
sequences (Saito e t a l . ,  1983; Rosson and Reddy, 1986) (d ) tra n s c r ip ts  
which are no longer sub ject to tra n sc rip tio n a l con tro l (Darveau et a h , 
1985) examples are c-m yc translocation seen in B u rk it t  lymphoma, m urine 
plasmacytoma (Kozbor et a L , 1986) and c-ab l translocation in ch ron ic  
myelogenous leukema (Kozbor e t a L , 1986).
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C. Hypomethylation
Hypopm ethylation was f i r s t  demonstrated in lung and colon carc ino­
mas where c-H a-ras and c -k i- ra s  were hypom ethylation (Fe inberg and 
Vogelste in , 1983; Hoffman, 1984).
D. Gene Am plifica tion
Gene am plification seen in solid tumors resu lts  in gross chromosomal 
abnorm alities inc lud ing  "homogenously s tian ing  regions (H S R ),"  e x tra -  
chromosomal DNA called "double m inutes" and "abnorm ally banded 
re g io n s ."  A m plifica tion o f c-m yc is seen in several tumors and cell 
lines, the most in te res ting  o f which is the neuroblastoma where myc is 
am plified on ly  in stage I I I  and IV  (B radeu r et a L , 1984). In  add ition  to 
c-m yc, c -m yb , c -ras  and c-ab l are am plified in human colon carcinom a, 
mouse adrenal co rtico id  tumor and ch ron ic  myelogenous leukemia cell lines 
respective ly  (McCoy e t , 1983; Schwab e t a ] , , 1984)
( i i i )  P ost-T ranscrip tiona l A c tiva tion
The concept o f increasing mRNA tra n s c r ip ts  by s ta b iliz in g  them has 
developed v e ry  rece n tly . Th is has been documented in the case o f 
c-myc and c-m yb which are transcrib ed  c o n s titu tiv e ly  b u t the h a lf life  o f 
the mRNA is 30 m inutes. Increased mRNA due to s tab iliza tion  is seen 
tra n s ie n tly  when the cells are stim ulated to d iv id e . Prolonged s ta b ili­
zation is th o u g h t to re su lt in uncon tro lled  p ro life ra tio n  (B lanchard  et 
a l . , 1985; Thompson e t aL , 1986).
( iv ) Post-T ransla tiona l A ctiva tion
A lthough inconclus ive , recent evidences suggest th a t src  and e rb  B 
may be regulated p o s t-tra n s la tio n a lly . A lte ra tion  o f the amino term inal 
o f src  p roduc t pp 60 regulates its kinase a c tiv ity  (B rugge  e t a l . ,  1985)
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and post-trans la tiona l m odification o f erb  B p roduct (trunca ted  epidermal 
g row th fac to r receptor) in the Goigi regulates the amount o f receptor 
reaching the plasma membrane (P riva lsky  et a h , 1984; Schm idt et a [ . , 
1985).
I I I .  A c tiva tion  by A lte red  Expression
Many o f the well stud ied oncogenes appear to be activa ted  by 
"m utations" th a t a ffe c t the s tru c tu ra l and functiona l in te g r ity  o f th e ir  
encoded p ro d u c t. In  these cases a ltered p ro te in  b u t not the q u a n tity  
seems to  p lay a role in trans fo rm a tion . Examples are ras , ab l, fe s /fp s , 
s rc , ebB and neu (Newbold, 1984; Spandidos e t a l . , 1984; Foster e t 
aL , 1985; Shalloway et aL , 1984).
Mode o f Action o f Oncogenes
The oncogene products  extend from the plasma membrane to the 
heart o f the cell nucleus exem plify ing  d iverse  roles as (a) "g row th  
fac to rs" (b ) "recep to r fo r  g row th  fa c to rs ,"  (c) "tra nsd u ce rs " w ith in  the 
cell th a t can ram ify a signal by phosphory la tion  o f p ro te in  o r lip id s  and 
(d ) "nuc lear e ffec to rs " acting as tran sa c tiva to rs  o f tra n s c r ip tio n  and 
agents o f ce llu la r im m ortalization.
To date , some 30 or more proto-oncogenes have been ide n tifie d  and 
eve ry  ind ica tion  is th a t th e ir  number is increasing . How and d u rin g  
what phases o f  the carcinogenic process these proto-oncogenes p lay a 
role is s til l not ye t c lea r. The observations th a t 100% mouse mammary 
tumors induced by MNU exh ib ited  mutation in Ha-ras and th a t mice 
in itia te d  w ith  a skin  carcinogen and la te r exposed to Ha-ras developed 
skin tumors suggest th a t it  w ill become possible in the near fu tu re  to
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design experim ents to exp lore the role o f proto-oncogenes in d if fe re n t 
phases o f the carcinogenic process.
Chemical Hepatocarcinogenesis
L ive r cancer has been induced in experim ental animals w ith  a wide 
v a r ie ty  o f chemicals (Tomatis et ajl. ,  1973; Wogan, 1976; M ille r, 1978) 
and at least by two v iruses  (Stenback e t a L , 1973; Lapis e t aL , 1975). 
By fa r  the m a jo rity  o f  stud ies have used chemicals e ith e r as continuous 
or d iscontinuous fashion (F a rb e r, 1986; Wogan, 1976; Farber and 
Cameron, 1980). These stud ies have revealed a v a r ie ty  o f ce llu la r and 
tissue changes which re g u la rly  occur long before the appearance o f 
cancer. O f these, fo u r populations are considered to be p re cu rso r o f 
live r cancer namely i)  h ype rp las tic  islands or fo c i; ii) ea rly  and iii)  late 
hyperp las tic  nodules and iv ) hyperbasoph ilic  areas (F a rb e r, 1976) and 
these have been iden tified  as p a rt o f a "m ateria l co n tin u ity  (Fou lds, 
1969, 1975; Farber and Cameron, 1980). The various cell populations 
have more or less d is tin c tiv e  biochemical, b io logical and s tru c tu ra l 
p rope rties  which are well characterized .
i) H yperp lastic  is lands, o r enzym e-altered fo c i. These are the 
ea rlies t preneoplastic populations iden tifiab le  m icroscopically by 
histochemical methods th a t appear w ith in  a few weeks o f the exposure to 
a v a r ie ty  o f carcinogens inc lud ing  DENA, n itrosom orpholine and MNU etc 
(K itagawa, 1971; Scherer e t a L , 1972; F a rbe r, 1973; Scherer and 
Emmelot, 1975; Kitagawa and P ito t, 1975; Solt e t a l. ,  1977; Ogawa et 
a L , 1980). Such small hepatocyte populations show decrease in
histochemical s ta in ing  fo r glucose 6-phosphatase, ATPase, 8 -g lu cu ro n i­
dase, serine dehydra tase , glycogen phosphorylase, ribonuclease,
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deoxyribonuclease (Scherer et a L , 1972; Scherer and Emmelot, 1975; 
Kitagawa and P ito t, 1975) and an increase in ^ -g lu ta m y l transfe rase  
(Kalengayi e t a L , 1975; Ogawa, 1977; Cameron et a[. , 1978; P ito t et 
a L , 1978; Ogawa e t a L , 1980), DT-diaphorase (Schor e t a L , 1978), 
U D P -g lucuronyl transferase (Bock et aL , 1982), g lu ta th io n e -
S-transferases inc lud ing  th a t o f the placental o r ig in  (GST-P) and 
g lu ta th ion e . A whole spectrum o f combinations o f increased and 
decreased enzyme pa tte rn  is encountered represen ting  a d iv e rs ity  o f 
phenotyp ic expression cha rac te ris tic  o f almost all p reneoplastic cell 
popu la tions, as well as hepatocellu lar carcinoma (Pugh and G o ld fa rb , 
1978; Ogawa et a l. ,  1980). O ther noticeable histochemical tra its  are the 
loss o f the a b ility  to store iron (William and Yammoto, 1972) and the 
in a b ility  to mobilize hepatic g lycogen d u rin g  fasting  (Epstein et a [ . , 
1967; Bannasch, 1968; Ogawa e t a l . , 1979).
ii)  E a rly  H yperp lastic  Nodules
These are la rge , d iscre te  focal co llections o f slow ly p ro life ra tin g  
hepatocytes which show cha rac te ris tic  enzym ic, a rch itec tu ra l and 
cyto logica l changes. The hepatocytes are arranged in 2 o r more cell 
th ic k  plates and in ac in i. In  a d d itio n , they  show abundant SER, which 
gives the nodule hepatocytes a "g ro u n d -g la ss " appearance (resem bling 
the HBs A g -p os itive  g round-g lass hepatocyte in in fected human l iv e r ) .  
A few o ther no tew orthy p roperties  associated w ith  nodules are the 
appearance o f an an tigen ic m arker, PN antigen (O kita  et £ [ . ,  1975) and 
an acquired resistance to the cy to tox ic  e ffects  o f carcinogens (F a rb e r e t 
al_., 1976). The nodules contain b ile  du c ts , b u t the arrangem ent does not 
follow the normal p a tte rn . For instance, the nodules show no po rta l 
tr ia d s . The compact spheroidal ou tline  o f nodules fre q u e n tly  compresses
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the su rround ing  live r tissue , d is to rtin g  the pa tte rn  o f liv e r cell plates 
and o f sinusoids.
The ea rly  nodules undergo a "m atura tion" o r "rem ode lling" process 
d u rin g  which some re v e rt towards normal looking adu lt liv e r tissue in 
many m orphological, enzymic and functiona l ch a rac te ris tics .
i i i)  Late H yperp lastic  Nodules
These are also called pe rs is ten t nodules, and are ind is tingu ishab le  
from ea rly  nodules in many respects. B u t they do not "remodel" o r 
"m ature" toward normal looking live r and re ta in  the biochemical, 
functiona l and u ltra s tru c tu ra l markers cha rac te ris tic  o f hyperp las tic  
nodules.
iv ) H yperbasophilic  Population
The pe rs is ten t nodules may show, embedded in th e ir  s tru c tu re , 
collection o f hyperbasoph ilic  cells o ften re fe rre d  to as "nodules in 
nodules" w ith  some resemblance to hepatocellu lar carcinoma, such as 
increased cytoplasm ic basophilia , g rea te r nucelo/cytoplasm ic ra tio , more 
frequen t m ito tic figu res  and a typ ia . H yperbasophilic  cells show ATPase 
a c tiv ity  spread over the whole cell su rface , decrease in RNAse and 
DNAse ac tiv itie s  and an accelerated RNA and DNA synthesis (K a rasak i, 
1972, 1976; Fontaniere and Daoust, 1973; Daoust and Calamai, 1975).
The re la tionsh ip  o f  the above mentioned populations to each o the r 
and to  hepatocellu lar carcinoma has not been unequivoca lly  established at 
the present time. However, in one live r carcinogenesis model the 
resistance hepatocyte model (see be low ), the material co n tin u ity  between 
these populations was demonstrated and the hypothesis th a t these cell 
populations form a sequence in the development o f hepatocellu lar 
carcinoma has been advanced (F a rbe r, 1973).
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Experimental Models o f Chemical Carcinogenesis in the L ive r
E arly  stud ies on liv e r  carcinogenesis invo lved continuous or 
in te rm itte n t chron ic  exposure o f animals to the carcinogen, e ith e r in the 
d ie t o r in the d r in k in g  w ater. Such systems, a lthough e ffec tive  in 
y ie ld ing  a h igh incidence o f live r cancer, were not usefu l fo r  the 
analysis o f the carcinogenic process since they re su lt in overlap o f a 
m ix tu re  o f responses to in ju ry ,  and o f sequences o f ce llu la r changes 
often  unre la ted to the cancer process. In  recent yea rs , carcinogenic 
regimens a ttem pting to segregate va rious phases o f the carcinogenic 
process in the liv e r have been designed by various g roups . In  fact
the re  are now a t least 9 models fo r  the s tudy  o f live r cancer
development w ith  chemicals (Table 1.2) (Fa rbe r and Sarma, 1987).
1) The o rig ina l model, f i r s t  developed by Sasaki and Yoshida in 
1933-1935 and stud ies in g rea t detail by K inosita (1936) and o the rs ,
invo lved observations o f liv e r a lte ra tions a t many time po in ts d u rin g  the 
long-te rm  continuous exposure to a carcinogen in the d ie t. Azo dyes 
(O-aminoazotoluene and p-dimethylaminoazobenzene) were most fre q u e n tly  
used in it ia l ly .  The lack o f synch rony  in the development o f new cell 
population and the re fo re  the in a b ility  to d issect step by step the
possible re levan t changes from the many irre le v a n t ones makes th is  model 
v iru ta lly  non-analyzable fo r  sequence.
2) A m odification o f th is  model, in te rm itte n t ch ron ic  exposure to a 
carcinogen, has proven to be v e ry  usefu l in genera ting  large hepatocyte 
nodules fo r  biochemical and biological stud ies (R euber, 1965; Epstein e t 
a L , 1967; Teebor and Becker, 1971). Th is model su ffe rs  from the same 
deficiencies as does model 1.
Table 1.2
Models o f liv e r  cancer development in the ra t
Model
A . S ingle Agent
( i)  Long-term  continuous exposure to a carcinogen
( ii)  In te rm itte n t ch ron ic  exposure
(Mi) The stop model
( iv )  Chronic exposure to peroxisome p ro life ra to rs  
(hypolip idem ic agents, phthalates)
B . In itia tion -P rom otion -P rogress ion
(v ) C hronic enzyme induction  model (PB)
(v i)  Resistant hepatocyte model
(v i i)  C ho line-m eth ion ine-defic ien t model
( v i i i)  OA model
C. D ie ta ry Deficiency
( ix )  C holine-devoid low methionine d ie t w itho u t added
carcinogens
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3) Bannasch and colleagues (Bannasch e t a l . , 1982, 1984) have 
described what they call a ‘stop model1 in which ra ts  are exposed to a 
hepatic carcinogen, such as N -n itrosom orpho line , fo r  several weeks and 
then re tu rned  to a basal d ie t w itho u t carcinogen.
4) Reddy and coworkers (Reddy and Lalwani, 1983) and o thers 
have described the development o f hepatocellu lar carcinoma in ra ts  w ith  
the use o f hypolip idem ic agents and some phthalates (p la s tic is e rs ) , th a t 
are active in inducing  p ro life ra tio n  of* peroxisomes in the liv e r .
5) A new type  o f model, one using in itia tio n  and promotion was 
in troduced  by Peraino and colleagues (1971). I t  f i r s t  u tilized  d ie ta ry
exposure to 2-AAF fo r in itia tio n  and long term d ie ta ry  phenobarb ita l 
(PB) fo r  promotion (as prom otor) fo r several months. Th is two step 
protocol resu lted in an increased induction  o f nodules and hepatocellu lar 
carcinomas in the experim ental animals compared to the con tro l g roup
rece iv ing  on ly 2-AAF. I t  has been extended by Schulte-Herm ann and
colleagues who have used d ich lo rod ipheny ltrich lo roe thane  (D D T ), 
cypro terone acetate and po lych lorina ted  b iphenyls as promoters instead 
o f PB. Besides 2 -A A F , o ther carcinogens have been found e ffe c tive  in 
the in itia l treatm ent (Peraino e t a l . , 1971; P ito t and S irica , 1980;
Schulte-Herm ann et cM. ,  1981). Th is system is c lea rly  s im ila r to the 
classical sk in  model in th a t a t least two p e rtu rba tio ns  are necessary to 
induce liv e r  cancer. These models do not show synch rony  o f 
development o f preneoplastic and prem alignant lesions.
6) Scherer and Emmelot and th e ir  colleagues (1972, 1975, 1976), 
employed a single exposure to DENA o r o ther carcinogens in in ta c t 
female ra ts o r in female ra ts 20 to 24 hours a fte r pa rtia l hepatectomy. 
The num ber, size and pa tte rn  o f  behaviour o f h ype rp las tic  is lands
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d e fic ien t in ATPase o r glucose-6-phosphatase a c tiv itie s  were h istochem i- 
ca lly measured. L ive r cancer, however d id  not develop unless the 
animals were exposed subsequently to low levels o f DENA. The
Scherer-Emmelot model allows some degree o f synch rony and quan tita tio n  
o f ea rly  steps in carcinogenesis.
7) The model system developed by P ito t (1978) is a combination o f 
Peranio's and Scherer-Emmelot model, in th a t adu lt ra ts are subjected to 
pa rtia l hepatectomy and w ith in  24 hours th e re a fte r, the animals are g iven 
a single dose o f DENA o r o ther carcinogens. A fte r  a res ting  period o f 2 
months, the animals are fed a d ie t conta in ing 0.05% PB fo r 6 m onths. 
Under these cond itions, a number o f islands o f cells w ith  decreased 
G6Pase, ATPase and increased y-G T  as well as hepatocellu lar carcinoma 
were observed.
8) Choline-m ethionine de fic ien t model. Th is model has been
developed by Lom bardi, Shinozuka and th e ir  associates (Sell e t a L ,
1979; Shinozuka e t a L , 1979) w ith  e a rlie r w ork o f  Newburne and
coworkers (1976). In it ia tio n  is by a single exposure to a carcinogen and 
promotion is by feeding a cho line-devo id  (CD) d ie t fo r  many weeks. 
The resu lts  show th a t a s ig n ifica n t number o f foci o f a lte red , y -G T  
positive  hepatocytes were observed in CD g ro u p . Thus feeding a CD
d ie t may also e xe rt a promoting e ffec t on the evolution o f liv e r  cells
in itia ted  by chemical carcinogens. I t  appears th a t the development o f 
nodules in th is  model is non-synchronous.
9) Resistant hepatocyte model (RH model) .  U tiliz ing  a new 
approach, S o lt, Farber and th e ir  colleagues in 1976 (Solt and F a rb e r, 
1976; Solt e t a L , 1977; Farber, 1980) in th is  labora to ry  developed a 
model fo r  the sequential analysis o f liv e r carcinogenesis. Th is  is based
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on the hypothesis th a t exposure to a necrogenic dose o f the carcinogen 
resu lts  in the form ation o f a lte red  hepatocytes which are re s is tan t to the 
cy to tox ic  e ffec t o f carcinogens and hepatotoxins (Solt and F a rbe r, 1976). 
These res is tan t hepatocytes respond to cell p ro life ra tiv e  stim uli such as 
PH or CCI4 and grow p re fe re n tia lly  when the animals are maintained on a 
d ie t such as one conta in ing 0.02% 2-AAF which in h ib its  cell p ro life ra tio n  
o f the u n in itia ted  or normal hepatocytes. Normal hepatocytes metabolize 
2-AAF to an active m ito in h ib ito ry  d e riva tive  and hence are unable to 
respond to the cell p ro lfe ra tive  s tim u lus, whereas the a lte red cells are 
res is tan t to the an tim ito tic  e ffe c t o f  2-AAF and the re fo re  respond to the 
cell p ro life ra tiv e  s tim u lus. Such selective grow th  resu lts  in the 
appearance o f foci o f preneoplastic hepatocytes which are pos itive  fo r  
y -G T . These foci as a population are one site  fo r ce llu la r evo lu tion  to 
liv e r cancer development and thus represent ea rly  in itia te d  hepatocytes 
(F a rbe r and Cameron, 1980).
The S o lt-F a rber model has several advantages over the e a rlie r ones 
in th a t one can obtain a fa ir ly  homogeneous preneoplastic cell population 
in a sh o rt period o f time (4-5 weeks fo llow ing the in itia l in jection  o f the 
carcinogen) and the model lends its e lf to easy m anipulation. With th is  
regimen, a va r ie ty  o f chemical carcinogens inc lud ing  po lycyc lic  aromatic 
hyd roca rbons, n itroso  amines, n itrosoam ides, aromatic amines and o ther 
chemicals e ithe r alone or coupled w ith  PH have been shown to induce 
"2-A A F  res is tan t" hepatocyte (Tsuda et a L , 1980). Ito  and colleagues 
(1980) have modified th is  model w ith  the use o f live r carcinogen o the r 
than 2-AAF fo r selection. Th is model was designed p r im a rily  fo r  the 
biochemical and molecular analysis o f ind iv idu a l steps in the carc inogenic 
process.
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10) O ro tic  acid model. Th is model is being developed by Sarma, 
Rajalakshmi, Rao, and th e ir  colleagues (Columbano et a L , 1982; Rao et 
a l . , 1983). In itia tio n  by a s ing le  dose o f DENA or o ther carcinogens 
and promotion by d ie ta ry  o ro tic  ac id , the nautra l p recruso r in pyrim id ine  
syn thes is . The nodules appear to develop qu ite  sych ro no u s ly , even 
though th e ir  ra te  o f appearance is slower than in the RH model.
11) C holine-devoid low methionine d ie t w ithou t added ca rc inogen . 
Mikol e t a j (1984), Choshal and Farber (1984) and Yokoyama et (1985) 
have found th a t ra ts  fed d ie t de fic ien t in choline and low in methionine
w ithou t any known addition  o f a carcinogen develop qu ite  h ighe r
incidence o f live r cell cancer.
Resistance Phenomenon E xh ib ited by Hepatic Nodules
An in te res ting  fea ture  o f the nodule development is th a t they grow  
in an environm ent which is tox ic  to  the normal hepatocytes. For example 
a vast m a jority  o f chemical carcinogens are m ito in h ib ito ry  a n d /o r 
cy to to x ic . However, the nodules grow  in these environm ents. Nodules 
developed in choline de fic ien t d ie t e x h ib it fa r  less fa t accumulation 
compared to the su rrou n d in g  liv e r o r normal liv e r .  In  fac t resistance to 
the m ito in h ib ito ry  e ffects o f 2-AAF is the basis on which RH model is 
developed. I t  is not known w hether development o f resistance is an 
essential component fo r  the development o f hepatic nodules o r nodules 
once formed develop the resistance p ro p e rty . The fac t th a t in itia te d
hepatocytes grow to form foci and nodules in the presence o f  2-AAF
suggests perhaps acqu is ition  o f resistance is one o b lig a to ry  step fo r  the 
development o f nodules at least in RH model. T he re fo re , i t  is o f  g re a t 
in te re s t to characterize  the resistance phenomenon and la te r evaluate the
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sign ificance o f the acqu is ition  o f resistance phenomenon fo r  the 
development o f hepatocellu lar nodules and hepatocellu lar carcinoma.
The resu lts  o f the present s tudy  revealed th a t irresp e c tive  o f how 
the hepatic nodules are generated they ail exh ib ited  decreased levels o f 
phase I components inc lud ing  cytochromes P-450 o f the d ru g  metabolizing 
system. In  a d d itio n , the nodules generated by the in itia tion -p rom o tion  
protocols exh ib ited  increased phase I I  components. Th is un ique 
biochemical pa tte rn  is geared fo r resistance. In te re s tin g ly  nodules 
generated by hypolipidem ics in ra ts  o r the ones generated in mice 
a lthough they exh ib ited  decreased phase I components d id  not e x h ib it 
increased phase I I  components.
A ttem pts to understand the molecular mechanisms o f th is  resistance 
phenomenon revealed th a t lead n itra te  induces in the normal hepatocytes 
the unique biochemical pa tte rn  seen in hepatic nodules. Th is  model w ill 
be po ten tia lly  v e ry  exc iting  because the unique biochemical machinery 
can be induced w ith in  30 hours fo llow ing lead n itra te  compared to months 
requ ired  to develop hepatic nodules.
CHAPTER 2
STUDIES ON THE RESISTANCE PHENOMENON 
IN HEPATIC NODULES OF RAT
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Chapter 2
STUDIES ON THE RESISTANCE PHENOMENON 
IN HEPATIC NODULES OF RAT
In tro d u c tio n
The process o f cancer development as studied in many tissues 
inc lud ing  skin  (Rous and K idd , 1941; Berenblum and S hub ik , 1949; 
Slaga et a L , 1978), mammary gland (Medina, 1976), u r in a ry  b ladder
(Hies and Chowaniec, 1968), vagina (H e rb e rt et a L , 1971) and liv e r
(Peraino et a L , 1980; Fa rbe r, 1980, 1982) o f both animal and man 
appears to be a m ultistep process occu rring  over many months to years 
(Fou ld , 1975; Farber and Cameron, 1980; Berenblum , 1982). Hepato- 
cyte  nodules (HN) are generated d u rin g  the process o f liv e r cancer
development in response to chemical carcinogens (Okuda and Peter, 1976; 
F a rbe r, 1980; William, 1980) and d ie ta ry  manipulation (Newberne, 1976; 
S e l le t a L ,  1979; Shinozuka e t a L , 1979; P o irie r e t aL , 1983; Ghoshal 
and F a rbe r, 1984). HN are one p recu rso r population o f cells from which 
hepatocellu lar carcinoma can develop (F a rb e r, 1982). They occupy a
unique position in the sense th a t no m atter how the HN are generated 
using d iffe re n t in itia to rs  and prom oters, th e ir  fu r th e r  progression to 
cancer is independent o f any exogenous agent (F a rb e r, 1984a).
Since HN grow in an otherw ise tox ic  environm ent induced by 
in it ia to rs  and promoters (F a rb e r, 1984b), it  is considered th a t 
hepatocytes o f the nodule represent a res is tan t phenotype and the 
process o f generation o f hepatic nodules re flec ts  one o f the physio logical
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adaptive options o f the hepatocyte. Indeed the phenomenon o f resistance 
formed the basis fo r  the development o f the res is tan t-hepa tocyte  (RH) 
model (So lt and F a rbe r, 1976; Tsuda e t <d., 1980) to s tudy  ra t live r 
carcinogenesis. I t  became the re fo re  im portan t to probe in to  the 
phenomenon o f resistance exh ib ited  by HN w ith  a hope to understand the 
genesis o f HN.
Resistance can be acquired at various levels s ta rtin g  from up take , 
metabolic ac tiva tion , de tox ifica tion  o f the chemical and at o ther ce llu la r 
responses to the agent (F a rb e r, 1984d).
In  the presen t s tu d y  resistance to xenobiotics was investiga ted  by 
m onitoring phase I and I I  d rug  metabolizing systems. Phase I 
components are those related to  the metabolism o f xenobiotics and include 
microsomal cytochromes P-450 and m ixed -function  oxygenase a c tiv it ie s . 
Phase I I  components are those related to the conjugation and
de tox ifica tion  reactions o f xenobiotics and th e ir  metabolites and include 
g lu ta th io n e -tra ns fe ra se s , U D P -g lucuron ly  transferase and g lu ta th ion e . 
In the in itia l experim ents the phase I and I I  components were examined
in the HN generated by the RH model f i r s t  as a possible basis fo r  the
resistance phenotype o f the hepatocytes in the nodules. These
components are considered to be re lated to the metabolism o f many 
carcinogens and o the r xenobiotics (W attenberg, 1978; Cha and B ued ing , 
1979; Chasseaud, 1979; O rren ius et a iL , 1980; Jakoby, 1980; 1981; Cha 
and Heine, 1982; Ericksson e t a l . , 1983; K e tte r e t a L , 1983; M eister 
and A nderson, 1983). The s tu d y  was then extended to hepatocyte 
nodules generated by o ther models. Included are data on nodules 
transp lan ted  to the spleen o f syngeneic animals th a t were never exposed 
to carcinogens.
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The resu lts  obtained c lea rly  indicated th a t HN generated by 
in itia tion -p rom o tion  protocols exh ib ited  a decrease in phase I components 
and an increase in phase I I  components o f d rug  metabolizing system. 
Th is  unique biochemical m achinery appears to be exh ib ited  by HN 
irrespec tive  o f the chemical na ture  o f in it ia to r  or promoter used in the 
in itia tion -p rom o tion  protocols (Roomi et a L , 1984a,b, 1985a).
Materials and Methods
Animals
Young male F ischer F344 ra ts , e ithe r weanling or w eighing from 130 
to 150 g and 5 to 6  weeks o ld , and male Sprague-Dawley ra ts , weanling 
or young adults  weighing from 150 to 170 g (both from Charles R iver 
Breeding Laboratories, W ilm ington, M A ), were used. The ra ts  were 
maintained on a sem isynthetic moderately h ig h -p ro te in  (26%) basal d ie t 
(D ye ts , Bethlehem, PA) and a 12 -hr lig h t and 12-hr d a rk  da ily  cyc le . 
They were g iven food and water ad lib itum  and were acclimatized to th e ir  
environm ent fo r a t least 1 week before th e ir  use in any experim ent.
Diets and Chemicals
The choline-m ethionine de fic ien t (CM D), and 0 . 0 2 % 2-acetylam ino- 
fluorene ( 2 -A A F) d ie ts were from Dyets (Bethlehem, PA) (Nos. 100670 
and 101121, re sp e c tive ly ). The CMD d ie t was the same as th a t used by 
Sells et aL (1979) and Shinozuka et a[. (1978). The phenobarb ita l (PB) 
d ie t was the same basal d ie t as used fo r  the 2-AAF d ie t and contained
0.05% PB.
49
The fo llow ing chemicals were purchased from Sigma Chemical C o ., 
S t. Louis, MO: D-glucose 6 -phosphate (disodium s a lt) ;  NADP+;
g lucose- 6 -phosphate dehydrogenase (catalogue No. G8875; approxim ate ly 
600 u n its /m l) ; n icotinam ide; L -y -g lu ta m y l-p -n itro a n ilid e ; g ly c y lg ly -  
c ine ; g lu ta th ione  (G SH); 1-ch lo ro -2 ,4 -d in itrobenzene  (C D N B ); 5 ,5 '-d i-  
th io b is (2 -n itrob enzo ic  a c id ); and bovine serum album in. Sodium d ith io -  
n ite  and am inopyrine were from A ld rich  Chemical C o ., M ilwaukee, WI. 
A ll chemicals were o f the h ighest reagent g rade.
Experimental Design
Hepatocyte nodules were generated in ra ts  w ith  4 d if fe re n t 
regimens.
Resistant Hepatocyte (RH) Model. The protocol fo r  generation o f 
HN by RH model is shown in F ig .2 .1 . F ischer ra ts  were in itia te d  in 
Group A w ith  d ie thy ln itrosam ine  (D EN A), 200 m g/kg  body w e igh t, g iven  
i . p . ;  and in Groups B and C, w ith  DENA, 50 m g/kg body w e igh t, g iven
i.p .  a t 18 h r a fte r pa rtia l hepatectomy. Animals o f a ll 3 g roups were 
placed on the basal d ie t fo r 2  weeks. Those in the con tro l g ro u p . 
Group C, were continued on the basal d ie t fo r  an additional 52 weeks. 
For selection o f res is tan t hepatocytes, those in Groups A and B were 
placed on the 0 . 0 2 % 2-AAF d ie t fo r  2  weeks and received CCI^ (0 .2  
m l / 1 0 0  g body w e igh t, d ilu ted  1 : 1  w ith  corn o il;  i . g . )  a t the m idpo in t, 
at the end o f 1 week (Solt and F a rbe r, 1976; Solt e t aL , 1977; Tsuda 
et a L , 1980)). The animals were placed on the basal d ie t a fte r  the  end 
o f the 2-week 2 AAF d ie t and remained so fo r  52 weeks.
The RH model was also used to generate hepatocyte nodules th a t 
were transp lan ted  to the spleen. For th is  purpose Fischer ra ts  were
Figure 2.1 50
Protocols to Generate Hepatocyte Nodules 
in Rats by Resistant Hepatocyte Model.
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Abbreviations
2-AAF =  2-acetylaminofluorene 
DENA =  diethyl nitrosamine 
PH =  partial (2/3) hepatectomy
Figure 2.2
Implantation of Hepatocyte Nodule (HN)
into a Rat Spleen
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7Z diet
0 2 4 25
/ /
Weeks
Recipient:
HN implanted 
into the spleen Sacrifice
Basal Diet
0 35 70
Weeks
Fig. 2 .6 .  L ive r  showing hepatocyte  nodules produced by res isan t 
hepatocyte  model in ra t .
F ig. 2.7 Section o f  ra t  l iv e r  showing hepatocyte nodules p roduced  by  
re s is ta n t  hepatocyte model.
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Fig. 2 .8 .  Section o f  ra t  l iv e r  showing hepatocyte  nodules p roduced  by  
re s is ta n t  nodules p roduced by re s is ta n t  hepatocyte  mode! 
and sta ined fo r  y -G T  X 6.
Fig. 2.9 Hepatocyte nodules g row ing  in spleen o f  normal ra t  not 
exposed to any ca rc inogen.
Jfj
(§ ' ■ 'U  W ,  i:'-
%.* *yr 
! '  r-* 
X  fi'
Fig. 2.10 A fu l ly  grown hepatocyte  nodule in spleen o f  normal ra t  not 
exposed to any carc inogen.
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in itia te d  w ith  DENA, 200 m g/kg body w e igh t, g iven i .p .  A fte r  a 
recovery period o f 2  weeks, the animals were selected fo r res is tan t 
hepatocytes by d ie ta ry  2-AAF fo r 2  weeks coupled w ith  pa rtia l
hepatectomy midway a t the end o f 1 week. The animals were then placed
on the basal d ie t fo r 21 weeks a t which time the liv e r  contained from 5 
to 1 0  pe rs is ten t hepatocyte nodules. The g ra y ish -w h ite  nodules were 
dissected c leanly from the su rroun d ing  live r and were coarsely minced. 
A liquots were transp lan ted  in to  the spleens o f normal F-344 ra ts  w ithou t 
any exposure to in it ia tin g  o r selecting procedures and allowed to grow 
into nodules fo r  70 weeks [F ig . 2 . 2 ) .  A t th is  tim e, the nodules measured 
from 2 to 4 cm, were un ifo rm ly  g ra y is h -w h ite , and on m icroscopic 
examination were typ ica l o f hepatocyte nodules w itho u t evidence o f
hepatocellu lar carcinoma (F igs . 2.9 and 2 .10 ).
Choline Methionine D efic ient (CMD) Model. In  the CMD model,
Sprague-Dawley ra ts  were in itia ted  in Group A w ith  DENA, 200 m g/kg 
body w e igh t, i .p .  and in Croup B w ith  DENA 50 m g/kg  body w e igh t, 
g iven  i .p .  a t 18 h r a fte r pa rtia l hepatectomy (F ig .2 .3 ) . Animals in
Group C were not in itia te d . Two weeks la te r, animals o f all 3 g roups
were placed on the CMD d ie t fo r 52 weeks.
Chronic Enzyme Induction  Model o r Phenobarbital (PB) Model. In
the Peraino model (Peraino et a [ . , 1971 , 1978) (F ig .2.4) weanling
Sprague-Dawley ra ts  were fed the 0.02% 2-AAF d ie t fo r  14 days followed 
by the basal d ie t fo r 7 days. They were then placed on the basal d ie t 
conta in ing 0.05% PB fo r  50 weeks. Animals in the con tro l g roup  (G roup 
B) were placed on the 0.05% PB d ie t fo r 50 weeks w itho u t p r io r  in itia tio n  
w ith  2 -A A F.
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Figure 2.3
Protocols to Generate Hepatic Nodules by 
Choline-Methionine Deficiency (CMD) Model.
Group A
I DENA
1 200 mg/kg
Sacrifice
1
C M D //d ie t
Group B
UDENA 50 mg/kg
Basal
diet CMD //d ie t
Sacrifice
I
Group C
Basal
diet CMD //d ie t
Sacrifice
I
- Ih
50 52 54
Weeks
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Figure 2.4
Protocols to Generate Hepatic Nodules by 
Chronic Enzyme Induction Models.
Peraino Model: 
Group A
2AAF-diet
0 .02%
Basal
diet 0.05% PB
Group B
Basal diet 0.05% PB
Sacrifice
V
diet
Sacrifice
yf
diet
1 2 3 4 5 6
-fh
49 51 53
Pitot Model:
Weeks
Group A
0.05% PB dietPH I I DENA 
w w 10 mg/kg
dietBasal diet 0.05% PB
Basal diet
0.05% PB diet
Group B
0.05% PB dietBasal diet
Basal diet
I I I___ I___ I__ L
1 2 3 4 5 6
Hh 45 47 49 51
Weeks
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In the P ito t model (F ig . 2.4) (P ito t e t a l . , 1978, P ito t and S irica , 
1980), F ischer ra ts  were in itia te d  w ith  a single dose o f DENA, (10 m g/kg 
body w eigh t) in jected i .p .  a t 2 0  h r a fte r pa rtia l hepatectomy. A fte r  
being fed the basal d ie t fo r 3 weeks, they were placed on the basal d ie t 
conta in ing 0.05% PB fo r 48 weeks o r fo r  44 weeks plus basal d ie t w ithou t 
PB fo r 4 weeks. A con tro l g roup  o f animals were fed the PB d ie t fo r 48 
weeks o r fo r  44 weeks plus 4 weeks basal d ie t w ithou t PB.
O rotic  Acid (OA) Model . In  one experim ent (F ig . 2 .5 ; N o .1 ) 
F ischer 344 weanling ra ts  were g iven DENA, (10 m g/kg  body w e igh t)
in jected i .p .  A fte r  five  weeks on the basal d ie t, they were placed on the
basal d ie t conta in ing 1% OA fo r  48 weeks. In  the second experim ent 
(F ig .2 .5 ; N o.2 ) , F ischer ra ts  were in itia te d  w ith  1,2 -d im e thy lh yd ra z in e , 
2HCI, (100 m g/kg  body w eigh t) in jected i .p .  a t 18 h r a fte r  p a rtia l
hepatectomy. The animals were placed on the basal d ie t con ta in ing  1%
OA fo r  48 weeks. A ll animals received a sing le  necrogenic dose o f CCI4  
in corn oil a t 7 weeks (Rao et a L , 1983; Laurie r e t a L , 1984). A 
contro l g roup  received the same d ie ta ry  regimen w itho u t p a rtia l 
hepatectomy plus 1 , 2 -d im e thy lhyd raz ine  i.e . w ithou t in it ia tio n .
For ha rvesting  o f nodules, the animals were anesthetized w ith  e th y l 
e th e r, and the live rs  were ra p id ly  removed, ch ille d , and weighed. The 
hepatocyte nodules were easily ide n tifie d  by th e ir  g ra y ish -w h ite  co lor 
and sharp demarcation from the su rround ing  redd ish -b row n  l iv e r .  The 
nodules ranged from 0.5 to 3.5 cm in diam eter. No obvious hepatocel­
lu la r carcinomas were inc luded. Th is was checked by h isto log ica l 
examination o f a portion  o f each nodule. The nodules were ra p id ly  
separated from the su rround ing  l iv e r ,  and all the nodules (2 to 5 per
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Figure 2.5 Sacrifice
Orotic acid model
NO. 1 v
Fischer 344, weanling male rats
1% Orotic acid diet
t
DENA (10 mg/kg)
■ 7 ^4 6 48 50
Weeks of treatment
No. 2
Sacrifice
1 % Orotic acid
H  I
|DMH* (100 mg/kg) I 
PH
1 i I i I i I i I i I / ,  I i I i I ■ I
2 4 6 8 10 46 48 50
* DMH =  1,2-Dimethylhydrazine
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live r) from each animal were pooled. Each such pool was considered as 
a single specimen.
Preparation o f Serum and Tissue Fractions and Determ inations
Blood was w ithdraw n by cardiac punctu re  or from the aorta from 
anesthetized animals. Serum was collected fo r  determ ination o f 
y -g lu tam y ltrans fe ra se  (y -G T ) a c t iv ity .  C a re fu lly  dissected hepatocyte 
nodules and su rroun d in g  live r and live rs  from con tro l animals were 
rinsed  tw ice w ith  ice-cold 0.09% NaCI so lu tion , weighed, and homogenized 
in 3 volumes o f 0.05 M 4 -(2 -h y d ro x y e th y l)-1  p iperazineethanesu lfon ic 
acid (Hepes) b u ffe r  (pH 7 .0) conta in ing 0.2 M sucrose and 1 mM EDTA. 
Homogenates were cen trifuge d  at 10,000 x g fo r 30 m in, and the 
postm itochondria l supernatan t (PMS) removed and cen trifu ge d  a t 100,000 
x  g fo r  60 m in. The microsomal pe lle t was re-homogenized in 
Hepes b u ffe r and resedimented once a t the o rig ina l speed. Measured 
a liquots were removed from the whole homogenate and from  the PMS.
y -G T  a c tiv ity  (EC 2 .3 . 2 . 2 ) was determ ined in serum and whole 
homogenates by the method o f Szasz (1976) using y -g lu ta m y l-p -n itro -  
an ilide  as substra te  and g lycy lg lyc in e  as g lutam yl recep to r. Total 
soluble s u lfh y d ry l content ("G SH ") was determ ined by the method o f 
Ellman (1959) using the superna tan t a fte r adding 0 . 2  ml o f 25% 
trich lo roace tic  acid to 0.2 ml o f 25% liv e r homogenate and c e n tr ifu g in g  a t 
3000 x g fo r 10 min.
Am inopyrine-N -dem ethylase (APD) a c tiv ity  (EC 1 .14 .14 .1 ) was 
measured in the PMS in a to ta l volume o f 5 ml conta in ing 0 . 0 2  M potas­
sium phosphate b u ffe r ,  pH 7 .4 , 0.2 mM NADP+ , 8  mM glucose
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6 -phosphate , 10 mM nicotinam ide, 5 mM MgCI2, 1 mM am inopyrine , 3 
un its  o f glucose 6 -phosphate dehydrogenase, 20 to 25 mg o f PMS pro te in  
and water to volume. A fte r  incubation at 37° fo r 30 m in, the reaction 
was stopped by adding 4 ml o f 1 0 % (w /v )  ZnCI2, and a fte r  m ix ing , 2  ml 
o f saturated Ba(O H )2. Five ml a liquots from the superna tan t a fte r 
ce n trifu ga tio n  at 3000 x g fo r  10 min were used to measure form aldehyde 
by the method o f Nash (1953). A standard cu rve  fo r form aldehyde, run  
w ith  eve ry  g roup  o f de term inations, was used to calculate nmol o f 
form aldehyde generated.
Cytochromes P-450 and cytochrome b 5  were determ ined in the 
microsomal fra c tio n . The to ta l cytochrome P-450 was measured in 
microsomal a liquots conta in ing p ro te in  ( 2  mg/m l) by the method o f Omura 
and Sato (1964). Cytochrome b 5  was measured in microsomal a liquots o f 
the same concentra tion  by the method o f Mazel (1971). Total microsomal 
heme was determ ined by the method o f Paul e t aL (1953).
G lutathione S -transfe rase  (EC 2 .4 .1 .1 8 ) (GST) a c tiv ity  was 
determ ined in the cytoso lic fra c tio n . The to ta l cytoso lic  GST a c tiv ity  
was assayed by the method o f Habig e t a[. (1974), using CDNB as
ind ica to r.
Protein concentrations in all frac tions  were determ ined by the 
method o f Lowry et a l. (1951) as modified by M ille r (1959) w ith  bovine 
serum albumin as s tandard . AH determ inations were expressed as 
concentrations per mg o f p ro te in . DNA was determ ined by the method o f 
Burton (1956).
S tudent's  t  te s t was used to assess the degree o f s ign ificance and 
F isher's  transform ed corre la tion  coe ffic ien t to assess the degree o f 
association between d iffe re n t biochemical procedures (Snedecor and
62
Cochran, 1967). Results were obtained using the H ew lett-Packard 
programmable ca lcu la tor (H ew le tt-P ackard , Loveland, CO).
Results
Histological Examination o f Hepatocyte Nodule (HN) and Hepatocellu lar 
Carcinoma
(i) Resistant Hepatocyte Model. The animals in the RH model th a t 
received DENA, 200 m g/kg  body w e igh t, fo r in itia tio n  (G roup A) had 
one hepatocellu lar carcinoma each a t 52 weeks, as reported  p re v io u s ly  
fo r  o the r experim ents (Solt et a [ . , 1983). O f these, 25% showed lung 
metastases. O f the 5 animals in Group B, 2 had carcinomas w ith  no 
metastases. The carcinomas measured from 3.5 to 5 cm in g rea test 
diameter and showed the typ ica l gross appearance o f necrosis, 
hem orrhage, and um bilica tion . A ll the animals in Groups A and B had 
hepatocyte nodules (F igs . 2 .6 -2 . 8 ) .  These were g ra y ish -w h ite  and 
fa ir ly  c ircum scribed and measured from 2 to 3 cm in d iam eter. These 
pe rs is ten t nodules (Enomoto and F a rbe r, 1982; Tatematsu e t a L , 1983) 
were qu ite  un ifo rm ly  g ra y ish -w h ite  on section and showed no gross (o r 
m icroscopic) evidence o f cancer (F igs . 2 . 1 1  and 2 .1 2 ). Each liv e r 
contained from 7 to 10 such nodules, which were easily d is tingu ished  
from the cancers. One o f the 5 con tro l animals (G roup C) contained a 
v e ry  small nodule measuring 2  mm in diam eter, while the o thers were 
w ithou t nodules.
( i i)  Choline-M ethionine D efic ient Model. The animals in the CMD 
model showed on ly  a ve ry  mild fa tty  liv e r  w ith  on ly minimal f ib ro s is . 
The animals in itia te d  w ith  DENA, 200 m g/kg  body w eight (G roup A ) ,  
showed a 20% incidence o f carcinoma (2 o f 5) w ith  no metastases, while
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Fig. 2.11 Hepatocyte nodule p roduced by res is tan t  hepatocyte  
model (H and E, X 125).
64
Fig. 2.12 Hepatocellu lar carcinoma ins ide nodule p roduced by  
re s is ta n t  hepatocyte model (H and E, X 65).
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the animals in itia te d  w ith  DENA, 50 m g/kg  body w eigh t (G roup B ) , 
showed no liv e r cancer at 52 weeks. A ll animlas in Group A and B had 
g ra y ish -w h ite  nodules th a t ranged from 1.5 to 3 cm in diameter and 
numbered from 5 to 12 per liv e r .
The live r cancers in Group A measured from 2.5 to 5 cm in
diameter and were typ ica l fo r hepatocellu lar carcinomas w ith  um bilica tion, 
necrosis, and hemorrhage. The nodules were read ily  d is tingu ished  from  
the cancers.
( i i i )  Phenobarbital Model. The animals in the PB model, both 
Peraino and P ito t typ e s , had la rge r live rs  in the con tro ls  because o f the 
induc tive  e ffects o f the phenobarb ita l. A ll the animals had g ra y ish -w h ite  
nodules th a t va ried  from 0.5 to 3.5 cm in d iam eter, b u t no liv e r  cancers 
could be iden tified  e ith e r g ross ly  o r m icroscopically.
( iv )  O rotic Acid Model. The animals in the OA model, 6  per
g ro u p , each showed one hepatocellu lar carcinoma and several g ra y is h -
w hite  hepatocyte nodules. The carcinomas measured from 4 to 6  cm in 
diameter and showed the usual necrosis, um bilica tion , and hem orrhage. 
The nodules measured from 1 to 3.5 cm in diam eter. Two to 10 were
present per liv e r. The su rrou nd in g  live r showed on ly  minimal fa tty
change w ith  no fib ro s is . The contro l animals on OA w ithou t in itia tio n
had ne ithe r nodules nor cancer and were m inimally fa tty .
The histo logical and cyto logica l appearances o f the nodules in the 4 
d iffe re n t models and in the nodules generated in the RH model and
transp lan ted  to the spleen were rem arkably s im ila r, as described
p rev ious ly  fo r  o ther models (F a rb e r, 1973, 1976), w ith  one d is t in c tiv e  
fea tu re  fo r the PB models, the obvious excess p ro life ra tio n  o f  smooth 
endoplasmic re ticu lum  in both the su rround ing  and nodule hepatocytes.
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A ll the nodules showed a sim ilar phenotype w ith  respect to  o rgan iza tion , 
a rch ite c tu re , and cyto logica l ch a rac te ris tics . Unlike normal liv e r  w ith  its  
predom inant a rch ite c tu ra l pa tte rn  as s ing le -ce ll plates (R appaport, 1979), 
the hepatocytes in the nodules in the d if fe re n t models are a rranged in 
plates usua lly  2 o r 3 cells th ic k  or in a g landu la r arrangem ent. The 
hepatocytes often show the presence o f g lycogen and considerable 
eosinophilic cytoplasm corresponding usually  to abundant smooth 
endoplasmic re ticu lum . As expected, th is  is p a rtic u la r ly  obvious in the 
hepatocytes in both the nodules and su rround ing  live r in the PB models. 
Many i f  not the m ajority  o f hepatocytes in the nodules from d iffe re n t 
models show nuclear changes in th a t there  is a more "open" appearance 
w ith  more obvious euchromatin and less obvious heterochrom atin. 
Whether th is  is re flected in isolated chromatin has not been re p o rted .
Resistance Phenomenon
The resistance phenomenon was stud ied f i r s t  in RH model. The 
protocol used to generate HN is shown in F ig. 2.1 and the resu lts  o f 
phase I and phase II  d rug  metabolizing components are summarized in 
Tables 2 . 1  and 2 . 2 . A s ig n ifica n t decrease was observed in cytochromes 
P-450 content and am inopyrine N-demethylase a c tiv ity  in HN compared to 
co n tro l. A no ther microsomal cytochrom e, cytochrome b5 , was also well 
below the normal levels. Total microsomal heme and dea lky la tion  using 
two d if fe re n t subs tra tes , e th o xy - and pen toxyreso ru fin  also showed a 
s ig n ifica n t decrease in HN, the resu lts  o f which are discussed in 
Chapter 9.
In con tras t to phase I components, the phase I I  components showed 
a large increase. For example, HN showed a s ig n ifica n t e levation o f
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total s u lfh y d ry l content (Ellman's method, 1959) compared to con tro l 
l iv e r .  HN also showed a s ig n ifica n t increase in y -G T  a c tiv ity  in tota l 
homogenate. Two o the r phase I I  components, U D P -g lucuronyl tra n s ­
ferase and D T-diaphorase which w ill be discussed in detail in Chapter 9,
also showed a large increase compared to the co n tro l. The HN showed a 
s ig n ifica n t elevation o f GST a c tiv ity  using CDNB as the sub s tra te . Th is 
substra te  is usefu l as a general one fo r  GST a c t iv ity .
The p ro te in  concentration in d if fe re n t frac tions  and DNA conten t in 
contro l ra t live r and pe rs is tan t hepatocyte nodule generated by RH model 
are shown in Table 2 .3 . The pro te in  concentra tion was s ig n ific a n tly  
decreased in all frac tions  except in the cytosol fra c tio n . However, DNA 
conten t was unchanged.
Results from contro l tissue and nodules were pooled, and co rre la tion
coe ffic ien ts  were ca lcu la ted. As recorded in Table 2.4 exce llent
co rre la tions were obtained between the levels o f microsomal cytochromes 
P-450 and am inopyrine N-dem ethylase, the 2 phase I components and 
between GST versus GSH and GSH versus y -G T . The co rre la tion  
coe ffic ien t was smaller between GST and y -G T . The co rre la tion  
coeffic ien ts between the ac tiva ting  system fo r xenob io tics, the phase I 
components, and the conjugation and de tox ifica tion  system fo r xenobiotics 
and these metabolites, the phase I I  components, were qu ite  large and 
negative . Thus th is  s tu d y  shows th a t HN generated by RH using two 
d if fe re n t protocols e x h ib it a decrease in phase I d ru g  m etabolizing 
components such as cytochromes P-450 and cytochromes P-450 dependent 
enzymes and an increase in phase I I  components such as g lu ta th io n e , 
g lu ta th ione  S -trans fe rase , U D P-g lucuronyl transfe rase  and D T-d iaphorase 
which partc ipa te  in de tox ifica tion  o f xenobiotics and carcinogens.
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Table 2.3
Protein concentration in d if fe re n t frac tions and DNA 
content in con tro l ra t live r and p e rs is ten t 
hepatocyte nodule generated by res is tan t 
hepatocyte model
No. D iffe re n t fractions Rat live r
P ers istent
hepatocyte
nodule
S ignificance
P
mg pro te in per g liv e r
1 . Homogenate 281.0 ± 15.0 215.0 ± 1 0 . 0 < 0 . 0 0 1
2 . 1 0 , 0 0 0  x g pellet 34.6 ± 1 . 8 29.0 ± 2 . 6 < 0 . 0 2
3. 1 0 , 0 0 0  x g 
supernatant
147.0 ± 3.0 115.0 ± 5.0 < 0 . 0 0 1
4. Microsomal frac tion 22.7 ± 1 . 8 1 1 . 1 ± 1 . 2 < 0 . 0 0 1
5. C ytosolic fraction 1 1 2 . 0  ± 
mg DNA
5.0
per g I
1 0 2 . 0
live r
± 1 1 . 0 NS
Total homogenate 3.0 ± 0 . 2 3.2 ± 0.3 NS
* Mean o f 4 samples ± SD
NS = not s ig n ifica n t
P values are calculated fo r  nodules vs contro l ra t liv e r
71
Table 2.4
C orre la tion  o f Phase I and I I  d ru g  metabolizing enzymes in 
hepatic nodules generated in res is tan t hepatocyte model
Results from contro l and nodules were pooled and corre la tion  
coe ffic ien t was ca lcu lated. C orre la tion studies were ca rrie d  out among 
phase I and phase I I ,  and phase I vs phase I I  d ru g  metabolizing 
enzymes. An exce llent co rre la tion  was obtained amongst phase I and 
phase I I  enzymes. However, it  showed a negative co rre la tion  when 
phase I enzymes were corre la ted  w ith  phase I I  enzymes.
Results o f C orre la tion Analysis
Variable Analyzed
Phase I Enzymes
Cytochrome P-450 vs
Am inopyrine N-demethylase
Phase I I  Enzymes
G lu ta th ione -S -transfe rase  vs 
G lutathione
G lutath ione vs
G lu ta th ione-S -transfe rase
G lu ta th ione-S -transfe rase  vs 
y-G lu tam yl transfe rase
Phase I vs Phase I I  Enzymes
Cytochrome P-450 vs 
G lu ta th ione-S -transfe rase
Cytochrome P-450 vs 
G lutathione
Cytochrome P-450 vs 
y-G lu tam yl transferase
v
0.95
0.81
0.86
0.62
-0.75
-0.90
-0.80
< 0.001
< 0.001 
< 0.001 
< 0.001
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Since in RH model the HN are generated in a m ito - in h ib ito ry  
environm ent created by 2 -A A F , it  may be argued th a t it  is not too 
su rp ris in g  to expect th a t HN generated in th is  model do e xh ib it such a 
biochemical machinery geared fo r  resistance. In  o rde r to determ ine the 
g e n e ra lity  o f th is  phenomenon HN generated by o ther in itia tion -p rom o tion  
protocols were examined fo r the phase I and I I  components o f d ru g  
metabolizing system.
For th is  purpose nodules were generated by conventional in itia tio n  
and promotion model which include OA, CMD and PB models. In  all 
these models in itia tio n  was ca rried  out w ith  DENA and promotion by OA, 
CMD and PB. The protocols fo r generation o f hepatocyte nodules using 
d if fe re n t in itia to rs  and promoters are shown in F igs. 2 .3 , 2.4 and 2 .5 .
The hepatocyte nodules seen in the live rs  o f ra ts w ith  CMD, PB 
and OA models show the same common biochemical pa tte rn  o f change seen 
in the HN generated RH model (Table 2 .5 ) . The microsomal phase I 
components, cytochromes P-450, cytochrome b 5  and am inopyrine 
N-demethylase showed a consistent decrease compared to th a t in the 
approp ria te  co n tro ls . In  add ition  all the HN showed an increased phase 
I I  components such as g lu ta th ione , g lu ta th ione  S -transfe rase  and y -G T . 
Sim ilar to RH model, the serum from these nodu le-bearing  animals showed 
a consistent e levation o f y -G T  a c tiv ity .
In the above s tu d y , the hepatocyte nodules examined showed a 
reduction  in phase I and an increase in phase I I  d ru g  metabolizing 
enzymes. In all those studies the hepatic nodules were obtained from  
ra ts  exposed to one o r more xenob io tics.
I t  became o f in te res t th e re fo re , to determ ine w hether th is  un ique 
p ro p e rty  exh ib ited  by HN is in response to xenobiotics o r a co n s titu tive
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Table 2.5
Comparison of Phase 1 and Phase II drug metabolizing components in hepatocyte 
nodules generated by different models
Model Cytochromes
P-450
Cytochrome
bs
APD y - g t GSH GST
OA-model,
Control
OA-nodule 1 (n=6) 
OA-nodule 2 (n=6)
CMD-Model
CMD-control (Group C) 
(n=5)
0.68 ± 0.08 
0.16 ± 0.06 
0.11 ± 0.02 
P<0.001
0.7 ± 0.07
0. *I8±0.03 
0.22±0.06 
0.3210.07 
P <0.001
0.4 ±0.04
15.1 ± 0.2 1.6 ±0.2
5.1 ± 1.3 41.2 ±12.0
4..1 ± 1.8 30.7±9.5
' P<0.001 P< 0.001
8.5 ± 1.7 1,9±0.3
6.1 ± 0.9
13.3 ± 2.5 
14.8 ± 3 . 5  
P <0.001
6.4 ± 0.4
0.8 ± 0.1 
3.25 ± 0 . 6  
2.64 ± 0.6  
P<0.001
0.77 ± 0.08
CMD-Group A-nodule (n=4) 0.15 ± 0.08 0.2 ±0.06 3.7 ± 1.0 50.0±10.0 20.4 ± 2 . 0 2.9 ± 0.6
CMD-Group A -surr (n=5) 0.83 ± 0.11 0.56+0.07 13.6 ± 2.0 9.9±0.8 6.7 ± 2.1 1.981 0.2
CMD-Group B-nodule (n=4) 0.12 ± 0.02 0.14+0.05 4.4 ± 0.5 20.8±5.9 16.1 ± 7.1 3.16± 0.92
CMD-Group B -surr (n=5) 0.64 1 0.04 0.5 +0.08 6.9 ±1 . 1 3.5 ±1.1 4.8 ± 1.0 1.791 0.42
PB-model
eraino-model
B-control (Group B + PB) 0.71 ± 0.11 34.6 ± 8.1 3.1 ± 0.4
*
1.91 0.32
(n = 4)
B-nodule (+ PB; n -  4) 0.97 ± 0.10 35.6 ± 5.0 10.5± 4.0 2.10± 0.43
, B-surr (+ PB; n = 9) 1.5 ± 0.18 31.2 ± 3.9 3.8± 1.7 1.4 ± 0.2
itot model
B-nodule (Group A + PB) 0.89 ± 0.14 46.5 ± 5.1 18.3 ±12.3 4.461 1.68
(n = 3)
B-surr (Group A + PB) 1.06 ± 0.10 24.1 ± 1.9 1.9 ± 1.0 2.7 ± 0.25
(n = 3)
B-control (Group A -  PB) 0.59 ± 0.16 11.3 ± 4.2 2.4 ± 0.2 1.441 0.16
(n = 2)
B-nodule (Group A - PB) 0.22 ± 0.06 5.9 ± 1.6 22.2 ±19.6 2.8
(n = 3)
B-surr (Group A -  PB) 0.96 ± 0.05 14.7 ± 2.4 1.9 ± 0.5 1.7 ± 0.26tnIIC
xperimental protocols are given in Figure 2.4 and other details are given in the text. In PB-model the rats were 
illed either when they were on PB (+PB) or o ff PB (-PB ) diets.
ytochromes P-450 and cytochrome bs = nmol/mg protein 
minopyrine N-demethylase (APD) = nmol/hr per nig protein 
-Glutamyl transferase (y-G T) = mU/mg protein 
lutathione (GSH) = pg/mg protein
lutathione-S-transferase (GST) = pmol/min per mg protein
i
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p ro p e rty  o f HN. To answer th is  question HN were grown in the spleen
o f ra ts  not exposed to any carcinogen and a fte r 70 weeks o f g row th  in
spleens the ra ts  were k ille d . Like the HN, nodules grown in the spleen
showed a s ig n ifica n t decrease in phase I components such as cytochromes
P-450, cytochrome b 5  content and am inopyrine N-demethylase a c tiv ity  
and an increase in phase I I  components which include g lu ta th ion e , GST 
and y -G T  (Table 2 . 6 ) .  Serum y C T  showed a s lig h t b u t s ig n ifica n t 
a c t iv ity ,  These biochemical p roperties  o f nodules grown in spleen match 
w ith  those o f nodules developed by in itia tion -p rom otion  p ro toco ls . This 
s tudy  shows th a t the d is t in c t biochemical pa tte rn  o f HN was maintained 
even when the HN are grown in a v e ry  d iffe re n t su rrou n d in g  not 
exposed to xenobiotics and have undergone several cell cyc les . These 
data thus suggest th a t the newly acquired p ro p e rty  by HN has become 
co n s titu tive  because it  is retained in the nodule cells even a fte r  70 
weeks o f g row th  in the absence o f any exposure to exogenous 
xenob io tics.
Discussion
I t  is ev iden t from the resu lts  o f th is  s tu d y  th a t hepatocyte nodules 
in 4 d if fe re n t models o f liv e r carcinogenesis, the RH, CMD, PB, and OA 
models, have a common biochemical pa tte rn  geared fo r resistance w ith  
respect to some microsomal, cy toso lic , and o ther components. These 
resu lts  are in unusua lly  good agreement w ith  studies o f hepatocyte 
nodules generated in qu ite  d if fe re n t models such as continuous o r 
in te rm itte n t exposure to 2-AAF o r eth ion ine (Table 2 .7 ) . T h u s , as 
recen tly  summarized, the hepatocyte nodules can now be considered as 
having at least 14 biochemical components in common. To these can be
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Table 2.6
Comparison o f Phase I and Phase I I  d rug  metabolizing components 
o f the host live r and o f hepatocyte nodule grown 
in spleen o f untreated ra t
Biochemical
Parameters
Host
(n
L ive r 
= 5)
Hepatocyte 
Nodule in Spleen 
(n = 5)
S ignificance
P
Phase I component
Cytochromes P-450 
(nmol/mg p ro te in )
0.77 ± 0.07 0.32 ± 0.1 < 0 , 0 0 1
Cytochrome b 5  
(nmol/mg p ro te in )
0.5 ± 0.06 0.35 ± 0.06 < 0 . 0 0 1
Microsomal heme 
(nmol/mg p ro te in )
2 . 0 ± 0 . 2 0.95 ± 0.23 < 0 . 0 0 1
Am inopyrine N-demethylase 
(nm o l/h r per mg p ro te in )
12.7 ± 3.1 6.4 ± 2 . 6 < 0 . 0 1
Phase II  component
y-G T (m ll/m g p ro te in ) 2.4 ± 0.9 18.7 ± 6 . 6 < 0 . 0 0 1
GSH (yg/m g p ro te in ) 5.0 ± 1 . 1 13.4 ± 4.2 < 0 . 0 0 1
GST (ymol/m in per mg p ro te in ) 1 .64 ± 0.35 4.0 ± 0.9 < 0 . 0 0 1
y-G T = y-G lu tam yl transfe rase
GSH = G lutathione
GST = G lu ta th ione-S -transfe rase
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added ce llu la r organization and a rch ite c tu re , blood su p p ly , several 
histochemical ch a rac te ris tics , and gross appearance. Even though all 
p rope rties  have not been examined in nodules from eve ry  model, the re  is 
a s u ffic ie n t spread to indicate the likelihood o f an unusual degree o f 
s im ila r ity  among the nodule population from several d if fe re n t models. 
The levels o f the microsomal cytochromes P-450 as well as the a c tiv ity  o f 
am inopyrine-N -dem ethylase in hepatocyte nodules in the 5 model systems 
used in th is  s tudy  were compared w ith  published values fo r  nodules 
generated in qu ite  d if fe re n t models, especially the models th a t use 
periods o f exposure to d ie ta ry  2-AAF o r e th ionine a lte rna tin g  w ith  
exposure to contro l d iets (Gravela et a l. ,  1975; Cameron et a L , 1976; 
Fiala e t a [ . , 1976; Okita e t a l . , 1976; Feo e t a L , 1978; Bock e t 
aL , 1982; Astrom  et a L , 1983; Ericksson e t a L , 1983). As recorded in 
Table 2 .7 , the mean value fo r  the P-450 cytochromes in nodules in 8 
published reports  using the o ther models is 0.35 w ith  a range o f 0.20 to 
0.50 as compared to  0.29 (0.20 to 0.42) in th is  s tu d y . For am inopyrine - 
N -dem ethylase, the mean value from 5 published reports  (G ravela e t a !. ,  
1975; Feo e t a | . , 1978; Sato e t a L , 1981; Bock e t a l . , 1982; Astrom  
e t aL , 1983) is 0.39 (0.24 to 0.50) as compared to 0.35 (0.12 to 0.50) in 
th is  s tu d y .
With respect to g lu ta th ione , all the nodule populations s tud ied  
showed s ign ifica n t elevated levels o f to ta l soluble s u lfh y d ry l con ten t 
compared to contro l liv e rs . The range o f increm ent was from 2 to 
6 -fo ld . A lthough  the method o f Ellman (1959) measures all soluble 
s u lfh y d ry l g roups, the major co n tr ib u to r to th is  pool is g lu ta th io n e . In  
a comparison between the values w ith  Ellman's method and w ith  the more
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specific method o f G r if f ith  (1980), the d iffe rences in va rious live rs  were 
small and not o f major magnitude (R obert et a L , 1983).
The large elevation in y -G T  o ffe rs  q u an tita tive  agreement w ith  the 
histochemical fin d in g s  o f increased y -G T  a c tiv ity  in the nodules in each 
model s tud ied (Fiala e t a h , 1976; Cameron e t a l. ,  1978; P ito t e t 
a L , 1978; Pugh and G o ld fa rb , 1978; Sell et a l. ,  1979; Tsuda et a [ . , 
1980; Schulte-Hermann e t a[ . , 1981; Conway e t a l . , 1983; Rao e t aL ,
1983). Previous q u a n tita tive  stud ies on nodules w ith  o the r models 
(Cameron e t a l . , 1976; Fiala e t a h , 1976; Bock e t a l . , 1982; E ricksson 
e t a L , 1983) show an even la rg e r increase in the a c tiv ity  o f y -G T  (Table 
2 .7 ). An in te res ting  fin d in g  in th is  s tu d y  was the consis ten t e levation 
o f serum y-G T  a c tiv ity  in eve ry  model (Table 2 .8 ).
Does the suggested commonality in phenotyp ic expression pe rta in  
not on ly  to each nodule population b u t also to each ind iv idu a l nodule? 
This im portant question was not the ob jective  o f the c u rre n t s tu d y  and, 
th e re fo re , no data are available . Even though ind iv idua l m icroscopic foci 
o f a lte red ce lls , the p recursors  fo r  nodules, do v a ry  considerab ly  in 
some histochemical p ro p e rtie s , such as y -G T , g lucose-6-phosphatase, 
ATPase, and microsomal epoxide hydrolase (P ito t e t a h , 1978; Pugh and 
G o ld fa rb , 1978; Ogawa et a L , 1980; Enomoto et a L , 1981), the
patte rns in g ross ly  v is ib le  nodules, both ea rly  and p e rs is te n t, are much 
more un ifo rm . For example, well over 90% o f hepatocytes in nodules in 
the RH model show increased s ta in ing  fo r  epoxide hydrolase (Enomoto e t 
a h , 1981), y -G T , and DT-diaphorase (quinone reductase) (Ogawa et a l . , 
1980). A lso , w ith  the same model, over 90% o f hepatocyte nodules show 
increased sta in ing  fo r GSH (A h luw a lia , 1984; Ahluwalia and F a rbe r,
1984). Using a d if fe re n t model, in te rm itte n t exposure to 2 -A A F , Astrom
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Table 2.8
A c tiv itie s  o f y -g lu tam y l transfe rase  in serum o f 
ra ts  w ith  d if fe re n t models o f hepatocarcinogenesis
Model y-G lu tam yl transfe rase  
(u n its / l it re )
Resistant Hepatocyte Model
Group C (5 )a ND
Group A (5) 68.0 ± 16.0
Group B (5) 18.0 ± 3.0
Resistant Hepatocyte
Nodules transp lan ted  to spleen 10.0 ± 4.0
Choline Methionine D efic ient Model
Group C (5) ND
Group A (10) 15.0 ± 6.0
Group B (5) 13.0 ± 5.0
O rotic  Acid Model
C ontrol ND
Experimental 49.0 ± 3.0
?Number o f animals in parentheses 
NDf not detectable 
Values are means ± S .D .
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et aL (1983) found th a t "sm all" (1 to 3 mm in d iam ete r), "medium" (3 to 
5 mm in d iam ete r), and "la rg e " ( 5 mm in diameter) a ll showed the same
levels o f the cytochromes P-450, NADPH-cytochrome c reductase, epoxide 
hydro lase, and GST. A lso , ind iv idu a l nodules in the same live rs  were 
qu ite  s im ilar in th e ir  biochemical pa tte rn s . Solt e t aL (1977) and
Conway e t a l. (1983) found th a t ind iv idua l nodules above 1 mm in
diameter were s im ilar in respect to the decrease in th e ir  po rta l blood 
supp ly . C lea rly , the re  is a need fo r fu r th e r  comparative stud ies in 
d if fe re n t models and w ith  more m arkers. However, the available
evidence points to the v is ib le  hepatocyte nodules being qu ite  s im ilar in
a t least several phenotyp ic cha rac te ris tics  inc lud ing  the organ ization and 
arrangem ent o f th e ir  contained hepatocytes and th e ir  blood su p p ly . I t  
should be emphasized th a t the normal liv e r  shows qu ite  a range o f 
phenotyp ic expressions in d if fe re n t zones (R appaport, 1979), and it  is 
d oub tfu l whether the range among d if fe re n t nodules is any la rg e r. A t 
least in the RH model, nodules arise random ly th ro u gh o u t the liv e r 
acinus (Solt e t a L , 1977) and may in p a rt re fle c t th e ir  s ite  o r o r ig in .
The find ings  w ith  respect to the hepatocyte nodules, generated in 
the RH model and grown in the spleen, are p a rtic u la r ly  in te re s tin g  w ith  
regard to the o rig in  o f the common phenotyp ic p a tte rn . Since the 
nodules in the spleen were examined more than 1 year a fte r  tra n sp la n ta ­
tio n , it  is v ir tu a lly  impossible to ascribe the nodule phenotyp ic pa tte rn  
to an induction  phenomenon by exogenous xenob io tics. Th is is made 
even more improbable in view o f the resu lts  in the host l iv e r . The 
values in the la tte r were in the same general ranges when compared to 
the con tro ls  fo r  the various experim ental g roups (Tables 2 .6 ) . T h u s , i t
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appears h ig h ly  lik e ly  th a t the new biochemical pa tte rn  in the hepatocyte 
nodules is co n s titu tiv e , not induced (Roomi e t a L , 1984a,5, 1985a).
Th is p ro b a b ility  is fu r th e r  increased by the pa tte rn  o f components 
measured. As indicated p rev ious ly  (E ricksson e t a | . , 1983), the p a tte rn  
seen is not th a t o f any single type  o f ch ron ic  exposure to an inducing  
agent. Th is  unique biochemical pa tte rn  is d if fe re n t from th a t seen in 
normal l iv e r ,  fo llow ing exposure to many d if fe re n t xenobiotics or 
carcinogens o r the live r from the neonate, fe tus and p a rtia lly  
hepatectomized ra ts .
The biochemical pa tte rn  observed in the hepatocyte nodules, 
consisting  o f low levels o f microsomal ac tiva ting  enzyme components 
(cytochromes P-450, some m ixed-function  oxygenases), h igh levels o f 
epoxide hydro lase , DT-diaphorase (quinone reductase ), g lu ta th ione , 
GST, and one U D P -g lucurony l-trans fe rase  is v e ry  approp ria te  fo r  a 
resistance phenotype (Farber et a l . , 1976; Schor e t a L , 1978; S tout 
and B ecker, 1978; W attenberg, 1978; Chausseaud, 1979; Farber and 
Cameron, 1980; Jakoby, 1980; O rren ius et a L , 1980; Jakoby, 1981;
Cha and Heine, 1982; Ericksson e t a L , 1983; K e tte re r e t a l . , 1983; 
K itahara a t a l. , 1983; Meister and A nderson , 1983; Robert et a l . , 
1983). Decreased a b ility  to generate reactive  moieties from some 
xenobiotics and increased a b ility  to inactiva te  w hatever becomes activa ted 
are an unusua lly  e ffec tive  combination fo r  the expression o f resistance 
by hepatocyte nodules, as evidenced b y : (a) more e ffice n t excre tion  o f 
one carcinogen, 2 -A A F, by animals w ith  many hepatocyte nodules in 
th e ir  liv e r (Spiewak and E ricksson, 1983); (b ) a resistance o f nodules 
to induction  o f cell death |n  v ivo  by CCI4 and d im ethyln itrosam ine 
(DMNA) (Fa rbe r et a [ . , 1976); (c) dim inished "b in d in g " o f DMNA and
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2-AAF to DNA, RNA, and p ro te in  in nodules (Farber e t a l . , 1976); (d ) 
resistance o f isolated nodule hepatocytes to some hepatotoxins such as 
a fla tox in  B1 and 2-AAF (Peraino e t a L , 1971; Gravela e t a L , 1975;
K e tte re r e t a L , 1983); (e) resistance to some cy to tox ic  e ffec ts  o f DENA
(Gans, 1976); and ( f)  most im po rta n tly , a b ility  to grow in an 
environm ent th a t severely in h ib its  cell p ro life ra tion  o f the b u lk  o f the 
liv e r  cells (Solt and F a rbe r, 1976).
The "resistance phenotype" o f the hepatocyte nodules must be 
re la ted to something o ther than its  role in the expansion o f an in itia ted  
res is tan t hepatocyte population (F a rb e r, 1980; Farber and Cameron,
1980). C onceivably, th is  phenotype is a re flec tion  o f an even more basic
type o f adaptation to xenobiotics as represented by the hepatocyte
nodules. I t  is possible th a t the hepatocyte nodule represents a form o f 
physio logical response to a hazardous environm ent in which a sensitive  
hepatocyte population is replaced by a re s is ta n t one th a t enables the 
host organism to cope more e ffic ie n tly  w ith  some forms o f xenobio tics 
(F a rbe r and Cameron, 1980; Fa rbe r, 1982). The re d iffe re n tia tio n  o f  the 
hepatocyte nodule to a norm al-appearing mature live r (Tatematsu e t a l . , 
1983) could conceivably be a p a rt o f th is  fundamental response to 
exposure to xenob io tics. I f  th is  v iew po in t is v a lid , the response o f the  
liv e r  to an in it ia to r and a promoting env ironm ent, w ith  hepatocyte 
nodules as a common end po in t d u rin g  the f i r s t  steps in hepatocarc ino- 
genesis, can be in te rp re te d  as a physio logical adaptation to  tox ic  agents.
CHAPTER 3
STUDIES ON RESISTANCE PHENOMENON IN HEPATIC NODULE INDUCED BY 
HYPOLIPIDEMIC AGENT, CIPROFIBRATE (CF)
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CHAPTER 3
STUDIES ON RESISTANCE PHENOMENON IN HEPATIC NODULE INDUCED BY 
HYPOLIPIDEMIC AGENT, CIPROFIBRATE (CF)
In tro d u c tio n
In Chapter 2, stud ies were ca rried  out on the resistance 
phenomenon in hepatocyte nodule (HN) generated by conventional 
methods o f in itia tio n  and promotion p ro tco ls . I t  is ev iden t th a t HN 
generated by 4 d if fe re n t models o f liv e r carcinogenesis, the res is tan t 
hepatocyte (R H ), choline methionine de fic ien t (CM D), phenobarib ta l (PB) 
and o ro tic  acid (OA) models showed a common biochemical pa tte rn  namely 
a decrease in phase I and an increase in phase I I  d ru g  metabolizing 
components. These enzyme a lte ra tions are induced ea rly  in the process 
o f carcinogenesis and appear to be a common phenomenon in lesions 
induced by various mutagenic hepatocarcinogens (F a rb e r, 1984a; Roomi 
e t aL , 1985a).
R ecently, several s tru c tu ra lly  d iss im ila r and unre la ted hypolip idem ic 
compounds w ith  the common p ro p e rty  o f p roducing peroxisome p ro life ra ­
tion in hepatocytes have been found to be hepatocarcinogenic in ra ts  and 
mice (Reddy and Rao, 1977; Reddy et a [ . , 1980; Kluwe et a L , 1982; 
Reddy and Lalwani, 1983). These compounds d if fe r  from classical 
carcinogens in two respects: i) they are not mutagenic in the
Salmonella/microsome assay and ii) they  do not cova len tly  b ind to and 
damage DNA, a step considered essential fo r the in itia tio n  phase o f 
carcinogenesis w ith  most chemical carcinogens (Warren e t a l . , 1980;
Gupta et a L , 1985). The exact mechanism by which these compounds
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induce carcinogenesis is not c lea r, b u t it  has been postu lated th a t an 
increase in the ce llu la r concentration o f hydrogen perox ide , possib ly  due 
to peroxisomal p ro life ra tio n , can g ive  rise to DNA damage which in tu rn  
can resu lt in mutational events and eve n tu a lly , neoplasia (Reddy et a l . , 
1982; Reddy and Lalwani, 1983). C hronic adm in istra tion  o f h yp o lip i­
demic agents in ra ts and mice re su lt in the development o f hepatocellu lar 
carcinomas which may be preceded by the form ation o f foci and nodules 
(Rao et aL , 1984).
Because o f these d iffe rences in the mechanisms by which DNA- 
damaging chemical carcinogens and the hypolip idem ic agents induce HN, 
it  became o f in te res t to ascertain w hether HN induced by hypolip idem ics 
also e x h ib it the same unique biochemical pa tte rn  o f resistance th a t is 
exh ib ited  by HN generated by DNA-damaging chemical carcinogens.
The resu lts  obtained are su rp ris in g  in th a t un like  the HN induced 
by DNA-damaging carcinogens, the HN induced by c ip ro fib ra te , a 
hypolip idem ic agent, d id  not e xh ib it the unique biochemical pa tte rn  o f 
phase I and phase I I  components associated w ith  resistance.
Materials and Methods
Young male Fischer F344 ra ts (Charles R iver Breeding Labora tories, 
W ilm ington, MA) weighing 100-120 g were housed in groups o f two in 
suspended steel w ire cages. The ra ts  were maintained on Purina ra t 
chow and a 12-hr lig h t and d a rk  da ily  cyc le . They were g iven food and 
water ad lib itum  and were acclimatized to th e ir  environm ent fo r  a t least 1 
week before th e ir  use in any experim ent.
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Experimental Design
Hepatocyte nodules were generated in ra ts using two d if fe re n t
treatm ent regimens:
(i) Hypolipidem ic agent model. The protocol used to generate
hepatocyte nodules by feeding an hypolip idem ic agent is shown in F igure
3 .1 . Rats in th is  model were fed powdered Purina ra t chow conta in ing
0.025% c ip ro fib ra te  (S te rlin g  W inthrop Research In s titu te  Renssebar, NY) 
fo r 60 weeks at which time they  were d iv ided  in to  two g roups . One 
g roup  (Group A) was continued on c ip ro fib ra te  d ie t while  in the o ther 
Group B c ip ro fib ra te  treatm ent was d iscontinued and was fed Purina ra t 
chow. Rats in both groups were sacrificed  at 68 weeks. A contro l 
g roup was fed Purina chow from the beg inn ing .
( i i)  Resistant hepatocyte (RH) model. Rats in Group A were (F ig . 
3 .2) in itia te d  w ith  DENA (200 m g/kg  body w e igh t, i . p . ) .  A fte r  2 weeks 
on Purina chow they were g iven 2-acetylam inofluorene (2 -A A F) (20 
m g/kg body w t) i .p .  da ily  fo r  3 days, followed by a 2/3 p a rtia l 
hepatectomy on the 4th day. A fte r  25 weeks the ra ts were d iv ided  into 
two g roups. One g roup  was continued on Purina ra t chow whereas the 
o the r g roup  was fed powdered Purina chow conta in ing  0.025% 
c ip ro fib ra te . Rats in the two groups were sacrificed  8 weeks th e re a fte r . 
A no ther set o f ra ts were fed Purina chow conta in ing 0.025% c ip ro fib ra te  
(G roup B) fo r  8 weeks before k ill in g . The con tro l g roup  was fed Purina 
chow.
The animals were anesthetized w ith  e thy l e the r and the live rs  were 
ra p id ly  removed, ch illed  and weighed. The nodules were ca re fu lly  and 
ra p id ly  dissected from the su rround ing  live r and co llected. A ll nodules
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Figure 3.1
Generation of Hepatocyte Nodules 
by feeding Hypolipidemic Agent, Ciprofibrate (CF)
SacrificeI
Group CF-diet 0.025%
CF-diet 0.025% j  j
Group B -’' Purina Chow
Purina Chow
2 4 6 8 10
- Ih J  I _ l
60 64 68
Weeks
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Figure 3.2
Effect of Ciprofibrate (CF) on Hepatocyte Nodules 
Generated by Resistant Hepatocyte Model
Group A
Sacrifice
DENA
200 mg/kg
PH
Purina Chow
Purina Chow /  /
ttt
2AAF
CF-diet 0.025%
20 mg/kg 
i-9-
Group B Purina Chow
Purina Chow j j
CF-diet 0.025%
-n -
25 29 33
Weeks
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from each animal were pooled and each such pool was considered as a 
single specimen.
Preparation o f Serum and Tissue Fractions and Determ inations
Blood was w ithdraw n by cardiac punctu re  or from the aorta from 
the anesthetized animal. Serum was collected fo r determ ination o f 
y -g lu tam yl transferase  (y-G T) and g lycy lp ro lin e  d ip e p tid y l am inopepti- 
dase (GPDA) a c tiv it ie s . C are fu lly  dissected hepatocyte nodules and 
su rrou n d in g  l iv e r ,  and liv e r from contro l animals, were rinsed tw ice w ith  
ice-cold 0.9% NaCI so lu tion , weighed and homogenized in 3 volumes o f 
Hepes b u ffe r  pH 7.0 conta in ing 0.2 M sucrose and 1 mM EDTA. Various 
frac tions were isolated by cen trifu ga tio n  as p re v ious ly  described in 
Chapter 2. In  b r ie f ,  the postm itochondria l supernatan t was collected by 
cen trifu ga tio n  at 10,000 x g fo r 30 m in, and microsomes were sedimented 
a t 105,000 x  g fo r 60 m in. Several o f the procedures were described in 
the previous chapte r and those not described ea rlie r are g iven  here in 
de ta il.
y -G T  a c tiv ity  (EC 2 .3 .22) was determ ined in serum and whole
homogenate by the method o f Szasz (1976) using y -g lu tam yl p -n itro a n ilid e  
as substra te  and g lycy lg lyc in e  as g lu tam yl receptor.
G lutath ione as to ta l soluble s u lfh y d ry l content (GSH) was d e te r­
mined by the method o f Ellman (1959).
Cytochrome P-450 in washed microsomes was determ ined accord ing to
Omura and Sato (1964) at a concentration o f 2 mg microsomal p ro te in  per
-1  -1ml. A molar ex tin c tion  coe ffic ien t o f 91L. mmol cm was used fo r  the
optical dens ity  d iffe rence  (450-480 nm) o f the spectrum in d ith io n ite  and
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carbon monoxide. Cytochrome b5 was measured by the method o f Mazel 
(1971).
Am inopyrine N-demethylase a c tiv ity  was measured in the postm ito- 
chondria l supernatan t essentia lly  according to Nash (1953). Total 
microsomal heme was determ ined by the method o f Paul e t a l. (1953).
GPDA a c tiv ity  was determ ined in serum and to ta l homogenate 
according to the method o f Kojima (1980) using g ly c y lp ro ly l-p -n itro a n ilid e  
as substra te  and g lycy lg lyc in e  as g ly c y lp ro ly l acceptor.
G lutathione S -transfe rase  (EC 2 .4 .1 .18 ) a c tiv ity  was determ ined in 
cytoso lic  frac tion  according to Habig et aL (1974) using c h lo ro -2 ,4 - 
d in itrobenzene (CDNB) as in d ica to r.
U D P-g lucuronyl transfe rase  a c tiv ity  was determ ined in the m icroso­
mal frac tion  using p -n itropheno l and U D P-g lucuron ic ac id , according to 
the procedure o f Zakim and Vessey (1973). D T-d iaphorase a c tiv ity  was 
assayed in cytosolic fra c tion  using 2 ,6 -d ich lo rophenol indophenol as 
substra te  by the procedure o f  E rn s te r (1967).
Protein concentrations in all frac tions  were determ ined by the 
method o f Lowry e t a\. (1951) as modified by M ille r (1959) w ith  bovine 
serum albumin as s tandard . A ll determ inations are expressed as 
concentration per mg o f p ro te in .
SDS-PAGE was ca rried  out by the system o f Laemmli (1970).
Results
HN in the live rs  o f the ra t trea ted  w ith  c ip ro fib ra te  are shown in 
C harts 3.1 and 3 .2 . They all show m ultip le  g ro s s ly -v is ib le  lesions 
ranging from 2 to 5 mm. The live rs  o f con tro l ra ts  fed c ip ro fib ra te  fo r  
8 weeks were enormously large and weighed 7 gm per 100 gm body
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w e igh t, compared w ith  3 gm per 100 gm body w eight fo r  con tro l liv e r 
(see C hart 3 .3 ) .
Figures 3.3 and 3.4 summarize the a c tiv itie s  o f the phase I and 
phase I I  d ru g  metabolizing enzymes o f HN generated by continuous 
feeding o f CF fo r 68 weeks (G roup A ) ,  and also a fte r w ithdraw al o f CF 
fo r 8 weeks (C roup B ).
Like the HN generated by the in itia tion -p rom o tion  p ro toco ls , the  HN 
generated by CF also showed a decrease in cytochrome P-450, cy to ­
chrome b 5, to ta l microsomal heme content and am inopyrine N-demethylase 
a c t iv ity .  However, in con tras t to the RH nodules, CF nodules showed 
s ig n ific a n tly  low a c tiv itie s  in phase I I  d rug  d e to x ify in g  enzymes such as 
GST, U D P -g lucuronyl transfe rase  and D T-d iaphorase. y -G T  a c t iv ity  also 
was s ig n ific a n tly  low in these nodules and its  a c tiv ity  could not be 
detected in the serum o f these animals. The g lu ta th ione  level was 
unchanged (F ig . 3 .4 ) .
In o rde r to elim inate the p o ss ib ility  th a t the lack o f  increase in 
phase I I  components is because o f some d ire c t e ffec t o f CF on these 
parameters two kinds o f stud ies were made. In  one set o f experim ents , 
HN were analyzed 8 weeks a fte r w ithdraw al o f CF. In  the second 
approach, ra ts  w ith  RH nodules were exposed to CF; the resu lts  on HN 
analyzed 8 weeks a fte r w ithdraw al o f CF, are shown in F igure  3 .3 . 
These nodules s t i l l  show a decrease in cytochrome P-450 and to ta l 
microsomal heme content and am inopyrine N-demethylase a c tiv ity  
compared w ith  contro l animals. The phase I I  components showed a 
re tu rn  to the usual phenotyp ic pa tte rn  exh ib ited  by RH nodules and 
th e ir  values were sim ilar to co n tro l, and low compared w ith  RH nodules. 
(F ig . 3 .4 ).
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H isto log ica lly  g roup  A and B nodules showed sim ilar lesions to RH 
nodules (C harts  3 .4 . and 3 .5 ) . Group A nodules were histochem ically 
y-G T and placental form g lu ta th ion e -S -trans fe ra se  (GST-P) negative 
(C harts  3.6 and 3 .7 ) . However, Group B nodules were y-G T  negative 
bu t GST-P positive  (C harts  3.8 and 3 .9 ).
C hart 3.10 shows the SDS-PAGE o f microsomal and cytoso lic  p ro te in  
pa tte rn  o f Group A nodules. Microsomal p ro te in  showed a decrease in 
the region o f cytochromes P-450 and the induction  o f a new cytochrome 
P-452 (Gordon e t a l . , 1982, 1984, 1985). I t  also showed an increase in 
a po lypeptide  o f m o l.w t. 80 kD , which has been shown to be peroxisome- 
p ro life ra tive  associated po lypeptide (Reddy and Lalwani, 1983). The 
cytoso lic  p ro te in  pa tte rn  shows i) a decrease in GST su b un it reg ion ; ii)  
the to ta l absence o f GST-P (26 k D ); i ii)  an increase in heme b in d ing  
pro te in  (14 kD) (V incen t and E berhard , 1985) and iv ) an increase in 
po lypeptide o f m ol.w t 80 and 60 kD .
In the second set o f experim ents where ra ts  w ith  RH nodules were 
exposed to CF and analyzed a fte r 8 weeks th e re a fte r, these nodules 
showed an increase in cytochrome P-450 content and am inopyrine 
N-demethylase a c tiv ity  bu t a decrease in cytochrome b 5 (F ig . 3 .5 ) . 
However, GST, U D P -g lucuronyl transferase and D T-d iaphorase a c tiv it ie s  
were s ig n ific a n tly  decreased and the g lu ta th ione  conten t was u na lte red . 
Hepatic y -G T  was decreased and serum showed no y -G T  a c tiv ity  (F ig . 
3 .6 ) . These nodules were sim ilar to RH nodules in h isto log ica l lesions 
(C harts  3.11 and 3 .1 2 ). However, these nodules were y -G T  negative 
bu t GST-P positive  (C harts  3 .13 -3 .16 ). C ontro l ra ts  th a t were exposed 
to CF showed no change in hepatic cytochrome P-450 conten t b u t showed 
a decrease in cytochrome b5 and to ta l microsomal heme conten t and a 
decrease in am inopyrine N-demethylase a c t iv ity .  The phase I I  enzymes
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Char t  3.1 Late nodules and ea r ly  cancer produced by  con t inuous  
feeding o f  c ip ro f ib ra te  fo r  68 weeks.
Char t  3.2 Late nodules and ea r ly  cancer produced by  feed ing 
c ip ro f ib ra te  fo r  60 weeks fol lowed by  Pur ina chow fo r  8 
weeks .
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Char t  3.3 A. Rat l i ver  f rom ra t  fed c ip ro f ib ra te  fo r  8 weeks. 
B.  Contro l  ra t  l i ve r .
C hart 3.
I
Char t  3.5
Hepatocyte nodule (HN) produced by con tinuous  feed ing o f
c ip ro f ib ra te  fo r  68 weeks (H and E X 125).
' - /
t
Hepatocyte nodule (HN) produced by feeding c ip ro f ib ra te  
f o r  60 weeks fol lowed by Pur ina chow fo r  8 weeks (H and E 
X 125).
C hart 3.6 Hepatocyte nodule p roduced by  con tinuous feed ing o f
c ip ro f ib ra te  fo r  68 weeks. The r.odule is y -G T -n e g a t iv e .
C har t  3.7 Hepatocyte nodule p roduced by  cont inuous  feed ing o f  
c ip ro f ib ra te  fo r  68 weeks. The nodule is G S T-P -nega t i ve .
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Chart  3.8 Hepatocyte nodule produced by  feeding c ip ro f ib ra te  fo r  60 
weeks fol lowed by Pur ina  chow fo r  8 weeks. The nodule is 
y - G T -n e g a t i v e .
Char t  3.9 Hepatocyte nodule p roduced by  feeding c ip ro f ib ra te  fo r  60 
weeks fol lowed by  Pur ina  chow fo r  8 weeks. The nodule is 
G S T-P -pos i t i ve .
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Char t  3.10 Analyses by  SDS-PAGE (12.5% po lyacry lamide)  o f  the 
microsomal and cy toso l ic  po lypep t ides o f  l i ve rs  and o f  
hepatocyte nodules.  Slots 1-4 microsomes; 6-9 l i ve r
cy toso l .  1. Con t ro l ;  2. HN (R H ) ;  3. HN by cont inuous
feeding o f  CF fo r  68 weeks; 4. S u r ro u n d in g ;  5. M arke rs ;  
6. Con t ro l ;  7. HN (R H ) ;  8. HN by  cont inuous  feed ing o f
CF; 9. S u r ro u n d in g ;  10. M arke rs .  The gel was stained
w i th  Coomassie blue B. The markers  were phosphory lase B
(94.000) ,  bovine serum albumin (67 ,000) ,  ova lbumin
(47 .000) ,  carbon ic  anhydrase  (30 ,000) ,  t r y p s i n  i n h ib i t o r  
(21 ,000) and iysozyme (14,000) .
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C h ar t  3.11 Hepatocyte nodule induced by RH model (H and E X 125).
Char t  3.12 Hepatocyte nodule induced by RH model and exposed to CF 
fo r  8 weeks (H and E X 125).
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F igure 3.13 Hepatocyte nodule p roduced by  RH model. The nodu la r  
area is y - G T  pos i t i ve  X 125.
F igure 3.14 Hepatocyte nodule produced by  RH model. The nodu la r  
area is GST-P posi t ive X 125
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Char t  3.15 RH nodules exposed to CF fo r  8 weeks. The nodule is 
•y -GT-negat ive X 125.
Char t  3.16 RH nodules exposed to CF fo r  8 weeks. The nodule is 
G ST-P -pos i t i ve  X 125.
C hart 3.17 Contro l l iv e r  (H and E X 125).
C h a r t  3.18 Control  l i v e r  exposed to CF fo r  8 weeks (H and E X 125).
106
' ~mt » # !*■
Char t  3.19 Contro l  l i ver  showing d u c tu la r  cel ls pos i t ive  fo r  y - G T .
Char t  3.20 Control  l i ve r  stained fo r  GST-P.
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Char t  3.21 Contro l  l i ve r  exposed to CF fo r  8 weeks. Note the absence 
o f  y - G T - p o s i t i v e  areas.
Char t  3.22 Contro l  l i ve r  exposed to CF fo r  8 weeks. Note the absence 
o f  G ST-P-pos i t i ve  areas.
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Char t  3.23 Analyses by  SDS-PACE (12.5% po lyacry lamide)  o f  the 
microsomal and cy tosol ic  po lypep t ides  o f  l i ve rs  and 
hepatocyte nodules.  Slots 1-4 l i ve r  o r  HN microsomes; 6-9 
l i ve rs  o r  HN cy toso l .  1. Con t ro l ;  2. Contro l  + CF; 3. 
RH; 4. RH + CF; 5. M arke rs ;  6. Con t ro l ;  7. Contro l  + 
CF; 8. RH; 9. RH + CF. The gel was stained w ith 
Coomassie blue B. The markers  were the same as in C h a r t  
3.10.
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GST, U D P-g lucuronyl trans fe rase , DT-diaphorase and y -G T ) showed a 
s ig n ifica n t decrease. In te re s tin g ly , sera o f ra ts  bearing HN from RH 
model and CF model exh ib ited  an increased levels o f an enzyme 
g lycy lp ro lin e  d ip e p tid y l aminopeptidase a c tiv ity  (Table 3 .1 ) . Its  a c tiv ity  
was unchanged in RH nodule homogenate. However, it  exh ib ited  a d rop  
in contro l o r nodules produced or exposed to CF.
C hart 3.18 shows the h isto logical lesions produced by feeding CF 
fo r  8 weeks which has been compared w ith  contro l ra t liv e r  (C ha rt 
3 .17 ). CF induced a d iffu se  enlargement o f hepatocytes th ro u g h o u t the 
lobule. H istochem ically the liv e r was y -G T  and GST-P negative (C harts  
3 .19 -3 .22 ).
C hart 3.23 shows the SDS-PAGE o f microsomal and cytoso lic  p ro te in  
pa tte rn  o f RH nodules and contro l ra t liv e r exposed to CF. Microsomal 
p ro te in  pa tte rn  o f both show an increase in new cytochrome P-452 and 80 
kD po lypeptides. The cytosolic p ro te in  pa tte rn  shows a decrease in GST 
subun it region and GST-P (26 kD) and an increase in 80, 67 and 14 kD 
po lypeptides.
Discussion
The resu lts  presented in th is  Chapter c lea rly  show th a t HN 
generated by CF, a hypolipidem ic agent, a lthough e xh ib itin g  a decrease 
in phase I components, do not show an increase in phase I I  components. 
Th is  observation was ra the r su rp ris in g  because both DNA-damaging 
carcinogens and hypolipidem ics induce a s im ilar sequence o f neoplastic 
events i.e . fo c i, hepatic nodules and u ltim a te ly  hepatocellu lar carcinoma 
(R eubert, 1965; Kalengayi and Desmet, 1975; Solt e t a l . , . 1977; F r ith  
e t a [ . , 1980; Rao et a l . , 1984). However, the foci generated by
hypolip idem ics, un like  those generated by DNA-damaging carcinogens are 
ne ithe r y-G T nor GST-P positive  (Rao e t a l . , 1986; Roomi et a l . ,  1987).
n o
Table 3.1
G lycy lp ro line  d ip e p tid y l aminopeptidase (GPDA) 
a c tiv ity  in serum and tissue homogenate o f 
hepatic nodule generated by continuous exposure to 
c ip ro fib ra te  (CF) fo r  68 weeks (A ) o r CF fo r 60 weeks 
followed by pu rina  chow fo r 8 weeks (B ) and RH nodule 
and contro l live r exposed to CF fo r 8 weeks
Treatm ent Serum Homogenate
IU / l i t re  mU/mg pro te in
± 2.8 26.8 ± 2.41. Control ra t live r 27.8
2. Hepatic nodule 98.5
(R -H  model)
3. Hepatic nodule 94.8
(CF 68 wks) (G roup A)
4. Hepatic nodule 77.4
(CF 60 w ks, Group B)
5. Hepatic nodule 93.7
(RH model + CF 8 wks)
6. Control ra t live r + 30.3
CF 8 wks
± 17.2 25.9 ± 0.8
± 25.0 11.9 ± 2 . 4
± 21 .0 24.3 ± 5 . 4
± 13.5 18.2 ± 2.2
± 4.1 13.3 ± 1.2
mThe lack o f  increase in phase II  components in HN generated by CF 
could be because ( i)  the molecular mechanisms o f induction  o f HN by CF 
are d if fe re n t from those which generate HN by DNA-damaging ca rc ino ­
gens (Reddy et a L , 1976) or ( i i)  the CF induced HN are identica l in 
th e ir  biochemical pa tte rns to HN generated by DNA damaging agents b u t 
an increase in phase II  components could not be seen because CF m ight 
in h ib it the phase II  enzyme a c tiv it ie s  (Furukaw a, 1985). The la tte r 
argum ent derives some sup po rt from the observations th a t hypolip idem ics 
in h ib it y -G T  a c tiv ity  (Rao e t a j . , 1982)). The observation th a t
w ithdraw al o f CF a fte r the induction  o f HN resu lted  in an increase levels 
o f phase I I  components compared to those when the ra ts  were on CF, 
and the observation  th a t RH nodules when exposed to CF resu lted  in a 
decreased level o f phase I I  components perhaps ind icate th a t HN 
generated by hypolipidem ics (CF) and by DNA-damaging agents are 
basically s im ila r. Furtherm ore, m v it ro  studies c lea rly  demonstrated 
th a t CF at a concentra tion  from 0.01-3 mM had no in h ib ito ry  e ffe c t on 
U D P-g lucuronyl trans fe rase , y -G T  and GST a c tiv it ie s . S im ila rly , feeding 
ra ts  w ith  nafenopin in d ie t, a lthough m arkedly decreased g lu ta th ione  
peroxidase leve ls, m v i t r o , addition  had no such e ffe c t except a t v e ry  
h igh  concentration (Furukawa et a l. ,  1985). However, the fac t th a t CF- 
generated HN d id  not e x h ib it an increased phase I I  components over th a t 
o f su rroun d ing  (data not g iven) o r con tro l non-trea ted  ra t l iv e r ,  even 
upon w ithdraw al o f CF, raises the p o ss ib ility  th a t these HN are 
d if fe re n t. U n fo rtuna te ly  in ou r experim ents the w ithdraw al period was 
only 8 weeks and it  is not clear w hether fu r th e r  prolonged w ithdraw al o f 
CF would have rendered these HN to e x h ib it an increased phase I I  
components like the HN generated by DNA damaging agents. Nonethe-
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less, the least we can in fe r  from th is  s tu dy  is th a t HN induced by CF, 
like  those induced by DNA-damaging agents d id  e x h ib it decreased phase 
I components (Rao e t a l . ,  1986; Roomi e t a l. ,  1987).
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CHAPTER 4
STUDIES ON THE RESISTANCE PHENOMENON IN HEPATIC NODULES
IN THE MOUSE
In tro d u c tio n
Studies described in Chapter 2 have shown th a t hepatic nodules 
(HN) generated by several d if fe re n t models using various in itia to rs  and 
prom oters, show a novel biochemical p a tte rn . They all showed a 
reduction  in phase I and increase in phase I I  d ru g  metabolizing enzymes. 
This pa tte rn  is qu ite  d if fe re n t from th a t seen in fe ta l, neonatal o r 
p a rtia lly  hepatectomized liv e r o r liv e r o f xenobiotic o r carc inogen- 
exposed animal (E ricksson e t a [ . , 1983; Fa rbe r, 1984b; Roomi e t a L , 
1985a). Th is biochemical pa tte rn  seen in HN has been considered to be 
responsible fo r  the resistance o f HN towards the to x ic ity  o f  several 
xenobiotics (H u tte re r et a L , 1969; Farber e t a l . , 1976; Farber,
1984b). However, HN generated by continuous feeding o f the 
hypolip idem ic agent c ip ro fib ra te  (CF) exh ib ited  a d if fe re n t biochemical 
p a tte rn . The HN induced by CF showed a decrease in phase I 
components such as cytochromes P-450, cytochrome b5 , to ta l microsomal 
heme content and am inopyrine N-demethylase a c t iv ity .  In  co n tra s t, CF 
nodules d id  not e x h ib it an increase in phase II components, instead they  
showed a decrease in phase II enzymes such as g lu ta th ione -S -tra ns fe rase  
(G S T), U D P -g lucuronyl trans fe rase , and D T-d iaphorase; serum y -g lu ta -  
myl transferase (y -G T ) a c tiv ity  was undetected while hepatic y -G T  
showed a decrease, and placental g lu ta th ione  S -transfe rase  (GST-P) was 
to ta lly  undetected in the nodules (Rao e t a l. ,  1986; Roomi e t a l . ,  1987).
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This va ria tion  in d if fe re n t types o f HN prompted to examine HN 
induced by in itia tion -p rom otion  protocols in another species such as 
mouse. The resu lts  indicated th a t mouse HN induced by in it ia t io n -  
promotion p ro toco l, like  those in ra t l iv e r ,  exh ib ited  a decrease in phase 
I components. However, un like  the ra t HN, the mouse HN d id  not 
e x h ib it any increase in phase I I  components (Roomi et <j[. 1985b, 1986b; 
Becker and S tou t, 1984; S tout and Becker, 1986).
M aterials and Methods
A ll chemicals were o f the h ighest reagent grade and are described 
in detail in Chapter 2.
Animals
Male Swiss mice weighing 20-22 gm (from  Jackson Laboratories) were 
housed in groups o f five  in p lastic  cages in a tem perature (22°C) and 
lig h t con tro lled  (12 h r lig h t and 12 h r d a rk  cycle) room. They were fed 
Purina chow and water ad lib itum  and acclimatized to th e ir  environm ent 
fo r a t least 1 week before th e ir  use.
Experimental Design
Male Swiss mice were g iven d ie thy ln itrosam ine  (DENA) 75 m g /kg
i .p .  ( F ig .4 .1 ) .  A fte r  two weeks o f recovery pe riod , they were placed
on a basal d ie t conta in ing 0.02% 2-acetylam inofluorene (2-A A F) fo r  one
week. The mice were then subjected to a standard pa rtia l hepatectomy 
(PH) and continued fo r  an additional one week on the 0.02% 2-AAF 
conta in ing d ie t. The rea fte r the mice were re tu rned  to the basal d ie t. 
The con tro l mice were w ithou t any treatm ent and fed a standard
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commercial Purina mouse d ie t. A ll the animals were sacrified  a t the end 
o f 10 months.
For ha rvesting  the nodules, the animals were anesthetized w ith  
e thy l e ther and the live rs  were ra p id ly  removed, ch illed  and weighed. 
The nodules were ca re fu lly  dissected out o f the su rrou n d in g  tissue . 
The nodules from each animal were pooled, and each pool was considered 
as a sing le specimen.
C are fu lly  dissected hepatocyte nodules and su rround ing  liv e r and 
live rs  from contro l animals were rinsed tw ice w ith  ice cold 0.9% NaCI 
so lu tion , weighed and homogenized in 3 volumes o f HEPES b u ffe r ,  pH 7.0 
conta in ing 0.2 M sucrose and 1 mM EDTA. Preparation o f various 
subcellu la r frac tions are g iven in Chapter 2.
Determ ination o f cytochrome P-450, cytochrome b5 am inopyrine
N-dem ethylase, y -g lu tam yl transfe rase  (y -G T ), g lu ta th ione  (CSH) and
g lu ta th ione -S -trans fe rase  (GST) are described in C hapter 2.
NADPH-cytochrome c reductase was measured according to the method o f
Williams and Kamin (1962), using cytochrome c and NADPH. The a c t iv ity
- 1  - 1was calculated from the molar ex tinc tion  coe ffic ien t o f 19.1 cm mM 
from the d iffe rence  between reduced and oxid ized cytochrome c by 
m onitoring the change in optical d ens ity  a t 550 nm per min.
Iden tifica tion  o f placental form o f g lu ta th ione -S -trans fe rase  (C ST-P) 
in the cytoso lic frac tion  o f the nodules and o f con tro l mouse live r was 
made using a n t i- ra t GST-P (g if t  from D r.S . Sato, Department o f Bio­
chem is try , H irosaki U n iv e rs ity , School o f  Medicine, H irosak i, Japan) and 
the im m unoprecipitation was ca rried  out by double d iffu s ion  in agar by 
O uchterlony technique (1958).
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Results
The content o f cytochromes P-450 and cytochrome b5 and a c tiv it ie s  
o f NADPH-cytochrome c-reductase and am inopyrine N-demethylase in HN, 
su rround ing  live r and in contro l live rs  are summarized in Table 4 .1 . 
The levels o f cytochromes P-450 and cytochrome b5 were s ig n ific a n tly  
decreased, and NADPH-cytochrome c-reductase and am inopyrine
N-demethylase a c tiv itie s  were m arkedly decreased compared to the
co n tro l. The su rroun d in g  liv e r  showed sim ilar values to co n tro l. y-G T
and GST a c tiv itie s  were una lte red , however GSH content was lower in 
HN (Table 4 .1 ).
Hepatocyte nodules generated by various methods in ra t showed a 
marked increase in the amount o f a po lypeptide  o f 26 kD which has been 
iden tified  as placental GST (G S T -P ). A detailed s tudy  o f mouse GST-P 
and a comparison w ith  ra t HN-GST-P are described in Chapter 6. Like 
ra t HN, mouse HN showed an increase in GST-P (F ig .4 .2 ) . However, 
un like  contro l ra t l iv e r ,  con tro l mouse liv e r  also shows a s ig n ifica n t 
amount o f a po lypeptide which reacts w ith  a n t i- ra t GST-P by double
d iffu s ion  in agar.
Discussion
I t  is ev iden t from the resu lts  o f th is  s tu d y  th a t mouse HN shows a 
decrease in phase I d rug  metabolizing components such as cytochromes 
P-450, cytochrome b5, NADPH cytochrome c-reductase and cytochrom e 
P-450 dependent enzymes. Thus mouse HN resembles ra t HN produced 
by in itia tio n  and promotion protocols as well as HN produced by the 
hypolipidem ic agent, c ip ro fib ra te  (Cameron e t a L , 1976; E ricksson e t 
a l . ,  1983; F a rbe r, 1984b; Roomi et a l. ,  1985a, 1987; Rao e t a l . ,  1986).
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React iv i t y  o f  cy tosol  o f  l i ve r  f rom con t ro l  r a t ,  mouse, 
ra t  hepatocyte nodule ( H N ) ,  mouse nodule and 
s u r ro u n d in g  w i th  a n t i - r a t  GST-P in 1.5% agar  by  
immunod if fus ion techn iques .  Centra l  well had 
an t i -G S T-P  ( A b ) ,  wells 1 and 3 had cytoso l  f rom 
con t ro l  mouse, well 2 f rom con t ro l  r a t ;  well 4 the 
cytosol  f rom rat  HN; well 5 mouse HN and well 6 
cytosol  f rom mouse s u r ro u n d in g  l i v e r .
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Mouse HN, however, was d iffe re n t from those ra t HN generated by 
in itia tio n  and promotion protocols in th a t no increase in y -G T  and GST 
a c tiv itie s  were observed (Roomi e t a h , 1986b; S tout and Becker, 1986). 
In  a dd itio n , mouse HN instead o f e xh ib itin g  an increase in GSH con ten t, 
actua lly  showed a decrease (Roomi e t a L , 1986b). Mouse HN exh ib ited  a 
s trong  band which cross-reacted w ith  an ti-G S T-P  (Roomi et a L , 1985c, 
1986c; Satoh e t a l . , 1985). However, even the su rrou n d in g  non-
nodular liv e r and contro l mouse liv e r not exposed to any carcinogen also 
contained the po lypeptide th a t cross-reacted w ith  an ti-G S T -P . There 
are d iffe re n t types o f responses in the cells d u rin g  liv e r carcinogenic 
process.
These resu lts  thus suggest th a t two groups o f enzymes may be 
a ffec ted . One, comprises the cytochrome P-450 mediated monooxygenase 
system which is de fic ien t in all HN s tu d ied , in ra t induced by in it ia tio n -  
promotion or hypolip idem ics, in mouse induced by in itia tion -p rom o tion  
protocols and in the spontaneous HN in mouse (S tout and Becker, 1984, 
1986) and in humans (El Mouelhi et a L , 1987). The second group
comprises the phase I I  components which however d iffe rs  in the d if fe re n t 
types o f HN.
The fac t th a t HN irrespec tive  o f how they  are generated i.e . by 
DNA-damaging agents, non-genotoxic agents o r spontaneous, in mouse, 
ra t o r human, e x h ib it a decreased phase I components makes one wonder 
w hether such a phenotyp ic expression g ives any advantage fo r the 
nodule cell towards g rea te r g row th  potentia l a n d /o r neoplastic 
progress ion . In  th is  re g a rd , it  w ill be o f in te res t to analyze the 
nodules generated by portocaval shunt fo r  phase I components, la rge ly  
because these nodules have not ye t been shown to develop in to  hepato­
ce llu la r carcinomas (Weinbren and W ashington, 1976; W einbren, 1982).
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CHAPTER 5
ANALYSIS OF THE DECREASED CYTOCHROMES P-450 
IN HEPATIC NODULES
In tro d u c tio n
The resu lts  presented in Chapters 2, 3 and 4 c lea rly  ind ica ted th a t
no m atter how the nodules are generated and irrespe c tive  o f the species
in which they are generated, hepatocyte nodules (HN) e xh ib ited  a 
decreased cytochromes P-450. The s ign ificance o f th is  observation  lies 
in the fac t th a t the nodu lar hepatocyte is re la tive ly  re s is tan t to the
m ito - in h ib ito ry  and cy to tox ic  e ffects  o f xenobiotics th a t requ ire  metabolic 
activa tion  fo r them to e xe rt th e ir  tox ic  e ffects (H u tte re r e t a L , 1969; 
Farber et aL , 1976; Ericksson et a L , 1983). Th is ch a rac te ris tic
phenotype could p rov ide  a selective advantage th a t would enable these 
cells to su rv ive  and p ro life ra te  in response to chem ically induced
hepatocellu lar in ju ry  and u ltim ate ly g ive  rise to malignancy (F a rb e r, 
1984c). Th is resistance arises p a rtly  from metabolic a lte ra tion  th a t 
dim inishes the ce ll's  capacity to activa te  xenobiotic to reactive  species 
and it  is la rge ly  a ttr ib u te d  to decreased amounts o f cytochromes P-450, 
the term inal e lectron acceptors o f the  monooxygenase system (O yanagui 
e t a L , 1974; Cameron et a l . , 1976; Okita et a L , 1976). Because o f 
th is , i t  became im portant to determ ine the biochemical basis fo r  the
decrease in cytochromes P-450 in HN. A cco rd in g ly , several questions 
were asked. For example: Is the re  a decrease in o the r heme con ta in ing  
enzymes? Is the decrease in cytochromes P-450 because o f a decrease 
in heme a n d /o r apoprotein? I f  it  is heme where is the lesion and i f
apoprote in is the ta rg e t is it  a t the level o f tra n s c r ip t io n , tra n s la tio n  or
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at posttrans la tion  level? In  th is  s tudy  two o ther heme conta in ing 
enzymes were stud ied  and a detailed investiga tion  o f heme syn thesis was 
made. U n fo rtu na te ly  due to lack o f  time b iosynthesis o f apoprote in  was 
not investiga ted .
The resu lts  obtained indicated th a t in add ition  to cytochromes 
P-450, and cytochrome b5, catalase and tryp to p h a n  2,3-d ioxygenase were 
also found to be low in HN. In  a dd ition , HN exh ib ited  low levels o f 
to ta l microsomal heme. A ttem pts to locate the s ite  o f lesion in the heme 
synthesis revealed th a t de lta -A LA -syn the tase , the f i r s t  rate lim iting  
enzyme in heme synthesis was low in HN (G ra n ick , 1966; G ranick and 
Sassa, 1971). These resu lts  suggest one o f the reasons fo r  the 
decreased levels o f heme and heme conta in ing enzymes may be because o f 
its  reduced synthesis (Roomi e t a j . , 1984c).
Materials and Methods
Unless otherw ise stated experim ental protocols and methods are 
identica l to  those detailed in Chapters 2 and 3.
Chemicals
A ll the chemicals were o f the h ighest reagent grade and were from
Sigma Chemical C o ., inc lud ing  the fo llow ing , g lyc in e , p y ridoxa l
phosphate, tr ich lo roa ce tic  ac id , E h rlich  reagent, and heme.
Catalase was measured according to Bergmeyer et aL (1958) w ith
samples prepared as described by Reddy e t aL (1974). An e x tin c tio n
-1  -1coe ffic ien t o f 0.04 jjM cm was used to calculate H20 2 concen tra tion . 
T ryp tophan  2 ,3-d ioxygenase was assayed according to the method o f 
Knox e t a l. (1971). Cytosol was pre incubated w ith  heme to sa tu ra te  the
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apoenzyme w ith  heme p r io r  to assay. Changes in absorbance were
-1 -1measured a t 360 nm and an ex tinc tion  coe ffic ien t o f 4.53 mM cm was
used to calculate k inu ren ine  concen tra tion . Iron  was determ ined in
various frac tions  according to  the method o f Persijn  e t £ l. (1971).
D elta -A LA -syn the tase  a c tiv ity  was determ ined according to the
method o f  Sassa in the 8,000 x g pe lle t (1979). The homogenate was
incubated w ith  g lyc ine  and py ridoxa l phosphate in the presence o f an
exogenous succinyl Co-A generating  system. ALA formed in 30 min
incubation at 37° was estimated by conversion to a p y rro le  and reacting
w ith  E hrlich  reagent. A ll a c tiv it ie s  were corrected fo r  b lanks in which
trich lo roa ce tic  acid was added a t zero incubation time. Heme oxygenase
was assayed by the method o f Tenhunan e t a l. (1969). B iliru b in  formed
- 1  -1was calculated using an ex tinc tion  coe ffic ien t o f 40 mM cm a t 468 nm. 
Results
F igure 5.1 (A -D ) shows the levels o f cytochromes P-450 and
cytochrom e b 5 and a c tiv itie s  o f two heme-containing enzymes, catalase 
and tryp to p h a n  2 ,3-d ioxygenase. The concentra tion o f two heme 
pro te ins  cytochromes P-450 (F ig . 5.1 A) and cytochrome b 5 (F ig . 5.1 B) 
and the a c tiv itie s  o f two heme enzymes catalase (F ig . 5.1 C) and 
tryp to p h a n  2 ,3-d ioxygenase (F ig . 5.1D) were s ig n ific a n tly  decreased. 
Tables 5.1 and 5.2 summarize the in tra ce llu la r d is tr ib u tio n  o f 
cytochromes P-450 and cytochrome b5 con ten t. The h ighest cytochrom es 
P-450, and cytochrome b 5 contents were found in the microsomal 
frac tions and both were decreased in HN (Tables 5.1 and 5 .2 ) .  The 
cytochrome P-450 levels were low in to ta l homogenate, 800 x g pe lle t and
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Figure5.1A
Cytochrome P-450 content 
in control and hepatocyte nodule
p < 0 .0 0 1
□  Control (n =  5)
■  Hepatocyte (n =  5) 
nodule 
T  Mean ±  S.D.
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Figure 5.1 B 
Cytochrome b5
p<0.05
□  Control 
(n =  4)
■  Hepatocyte 
nodule 
(n =  4)
Figure 5.1 C 
Catalase in control hepatocyte nodule
p <  0.001
□  Control (n =  5)
■  Hepatocyte 
nodule (n =  5)
Mean ± S.D.
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Figure 5.1 D
Tryptophan 2,3-dioxygenase 
in control and hepatocyte nodule
40.0
30.0
20.0
10.0
p <  0.001
□  C ontro l (n =  5)
0  Hepatocyte 
nodule (n =  5)
Mean ±  S.D.
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Table 5.1
Cytochrome P-450 content in d if fe re n t frac tions  o f 
ra t live r and hepatocyte nodule
D iffe re n t Rat live r Hepatocyte S ignificance
frac tions Nodule P
(n — 4) (n = 4)
Total homogenate 0.17 + 0.02 0.09 + 0.02 < 0.001
800 x g pelle t 0.08 + 0.01 0.04 + 0.01 < 0.001
10,000 x  g supernatan t 0.14 + 0.01 0.07 + 0.01 < 0.001
Microsomes 0.68 + 0.05 0.27 + 0.08 < 0.001
Cytochromes P-450: nmol/mg pro te in
Data are Mean ± SD
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Table 5.2
Cytochrome b 5 conten t in d if fe re n t frac tions  
o f contro l ra t liv e r and hepatocyte nodule
D iffe re n t
frac tions
Rat I 
(n =
ive r
4)
Hepatocyte 
nodule 
(n = 4)
S ignificance
P
Homogenate 0.12 ± 0.01 0.12 + 0.01 NS
800 x g pe lle t 0.14 ± 0.01 0.16 + 0.04 NS
10,000 x  g supernatan t 0.09 ± 0.01 0.09 + 0.03 NS
10,000 x  g pe lle t 0.11 ± 0.01 0.15 + 0.02 NS
Microsomes 0.33 ± 0.04 0.24 + 0.05 < 0.05
Cytochrome b5: nmol/mg pro te in
Data are Mean ± SD 
NS = not s ig n ifica n t
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10,000 x g superna tan t frac tions o f HN whereas the cytochrome b 5 
content was unchanged.
In o rde r to ascerta in w hether the decrease in cytochromes P-450 
and o ther heme enzymes is due to a decrease in heme syn thes is , the 
total microsomal heme content was determ ined. As shown in F igure  5.2 
HN showed a s ig n ifica n t decrease in to ta l microsomal heme content 
compared to co n tro l. Th is decrease in to ta l heme appears to be presen t 
in all the frac tions  tested (Table 5 .3 ) . In  o rde r to determ ine w hether 
th is  decrease in heme content is due to a decrease in iron  con ten t 
a n d /o r its  syn thes is , the tota l iron  content and a few key enzymes 
invo lved in heme synthesis were determ ined. Iro n  (Fe2+) was 
determ ined in the microsomal and to ta l homogenate frac tions  and was 
found to be m arkedly decreased in HN compared to contro l (F ig . 5 .3 ) .
In the next series o f experim ents de lta -A LA -syn the tase , the f i r s t  
ra te  lim iting  enzyme o f p o rp h y rin  b iosynthesis and the last enzyme heme 
oxygenase, the rate lim iting  enzyme in heme degradation were measured. 
These resu lts  are shown in F igure 5 .4 . D e lta -A LA -syn the tase  showed a 
decreased a c tiv ity  (F ig . 5 .4 A ), however heme oxygenase was unchanged 
in liv e r nodules compared to the corresponding contro l (F ig . 5 .4 B ). 
The various parameters in cytochrome P-450 and heme syn thesis were 
corre la ted  in microsomal and homogenate fra c tio n s . They all showed an 
excellent co rre la tion  in microsomal frac tion  and good co rre la tion  in 
homogenate frac tion  (Table 5 .4 ).
Discussion
The resu lts  o f th is  s tudy c lea rly  revealed th a t in add ition  to 
cytchrom es P-450 and cytochrome b 5 two o the r heme-containing p ro te in s ,
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Figure 5.2
Microsomal heme content 
in control and hepatocyte nodule
1.5
p<0.001
□  Control (n =  5) 
■  Hepatocyte (n 
nodule 
Mean ±  S.D.
=  5)
1.0
0.5
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Table 5.3
Heme content in d if fe re n t fra c tion s  o f contro l ra t liv e r 
and hepatocyte nodule
D iffe re n t
frac tions
Rat live r 
(n = 4)
Hepatocyte 
nodule 
(n = 4)
S ignificance
P
Total homogenate 0.61 ± 0.07 0.48 ± 0.06 <0.05
800 x g pellet 0.60 ± 0.08 0.44 ± 0.05 <0.05
10,000 x supernatan t 0.52 ± 0.03 0.27 ± 0.02 <0.001
10,000 x pelle t 0.54 ± 0.05 0.43 ± 0.05 <0.02
Microsomes 1.6 ± 0.08 0.87 ± 0.11 <0.001
Total heme con ten t: nmpl/mg p ro te in
Data are Mean ± SD
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Table 5.4 
C orre la tion  studies 
n = 8
No, Variab le  analysed
Result o f 
C orre la tion 
analysis
S ignificance
P
1. In  microsomal frac tion
a) Cytochromes P-450 vs
microsomal heme 0.93
b) Cytochromes P-450 vs iron 0.97
c) Microsomal heme vs iron 0.97
< 0.001 
< 0.001 
< 0.001
2 . In  homogenate
a) Cytochromes P-450 vs
heme content 0.78
b) Cytochromes P-450 vs iron 0.78
c) Heme content vs iron 0.63
< 0.05
< 0.05
< 0.05
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catalase and tryp topha n  2,3-d ioxygenase were also decreased in HN. 
These observations thus suggest th a t the decreases may be p a rt o f a 
much b igger lesion in the haem p ro te ins . F u rth e r, th is  decrease
appears to be a re flec tion  o f decreased heme (Roomi et a L , 1984c). 
A ttem pts to understand the reasons fo r th is  decrease in heme revealed 
th a t HN exh ib ited  a de fic iency in iron as well as in the a c tiv ity  o f 
de lta -A LA -syn the tase , the f i r s t  rate lim iting  enzyme in heme syn thesis  
(G ra n ick , 1966; G ranick and Sassa, 1971). However, HN d id  not e x h ib it 
any increased heme oxygenase. These re su lts , th u s , c lea rly  ind icate 
th a t one o f the lesions responsible fo r decreased cytochromes P-450 
seems to be a t the level o f haem syn thes is . The p o ss ib ility  th a t the
decreased cytochromes P-450 in HN could be because o f a defect in 
apoprotein is not ye t ru led  o u t.
The resu lts  presented c lea rly  indicated th a t hepatocyte nodule 
exh ib ited  a decrease in cytochromes P-450, suggesting perhaps th is  may 
be the p rim ary  adaptive mechanism by which cells develop resistance. 
Thus decreased levels o f cytochromes P-450 and decreased capacity  to 
oxid ise xenobiotics are ch a rac te ris tic  o f HN. Seventy per cent o f  heme 
synthesized by the hepatocyte is u tilized  fo r cytochromes P-450, which 
in tu rn  depends upon haem synthesis (Meyer and Schm idt, 1978). Thus 
the low levels o f cytochromes P-450 suggest th a t HN may not synthesize 
su ffic ie n t haem to maintain its normal levels. To apprecia te  the 
im plication o f these resu lts  b e tte r, a b r ie f descrip tion  o f the biogenesis 
o f heme and haem pro te ins is approp ria te  a t th is  place.
V ir tu a lly  all cells in h ighe r animals are capable o f haem syn th e s is , 
e ithe r continuously th roughou t life  o r a t some stage o f  th e ir
development. The heme thus made serves as the p ros the tic  g ro up  in a
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v a rie ty  o f p ro te ins concerned w ith  i) carriage and tra n s fe r o f oxygen 
w ith in  and among cells ( e .g . ,  hemoglobin, m yog lob in ); ii)  the pro tection  
o f cells against tox ic  ox id iz ing  species (catalase, perox idase); iii)  the  
o rd e r ly  and e ffic ie n t tra n s fe r o f e lectrons w ith  a ttendant syn thesis o f 
ATP (m itochrondria l cytochromes) and iv ) microsomal metabolism o f fa t ty  
ac ids, stero ids and xenobiotics (microsomal cytochrom es). Developing 
e rth rocy tes  account fo r  most o f the heme produced by h igher animals, 
b u t the liv e r is a second major locus o f heme syn thes is .
The steps in the pathway are ou tlined  in F igure 5.5 (A and B ). 
Work ca rried  out in the laboratories o f Shemin and G ranick in the United 
States, and Remington and Neuberger in Great B rita in  resu lted in 
e lucidation o f the protoheme b iosyn the tic  pathw ay. Th is w ork has been 
pu t toge ther by De Matteis (1978).
In  the f i r s t  s tep , succ iny l-C o A is condensed w ith  g lyc in e , fo rm ing 
the interm ediate a -am ino-$-keto  ad ip ic  acid which is decarboxylated to 
delta am inolevulin ic acid (A L A ). Th is reaction is catalyzed by the 
enzyme de lta -A LA -syn the tase  (E .C .2 .3 .1 .3 7 ). Two molecules o f ALA are 
condensed to form porphobilinogen (PBG ), the m onopyrrole p re cu rso r o f 
p o rp h y rin s . Th is reaction is catalyzed by the enzyme d e lta -A L A -d e - 
hydratase (E .C .4 .2 .1 2 4 ). Four molecules o f PBG are u tilize d  fo r  the 
formation o f u roporphyrinogen  I I I  and requ ire  two enzymes. These two 
enzymes are u roporphyrinogen  synthetase (E .C .4 .3 .1 .8) also called PBG 
deaminase and u roporphyrinogen  I I I  cosynthetase. In  the absence o f 
u roporphyrinogen  I I I  cosynthetase, u roporphyrinogen  I is form ed. In  
the next s tep , u roporphyrinogen  decarboxylase (E .C .4 .1 .1 .37) converts 
u roporphyrinogen  I I I  to coproporphyrinogen I I I  by a stepwise 
decarboxylation o f fo u r acetic acid side chains. C oproporphyrinogen I I I
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then undergoes ox ida tive  decarboxyla tion  to p ro to p o rp h y rin  IX  by
coproporphyrinogen  oxidase (E .C .1 .3 .3 .3 . ) .  Inse rtion  o f  fe rrous  ion by
ferrochelatase (E .C .4 .99 .1 .1 ) re su lt in the form ation o f protohaem. The 
in itia l and fina l steps in protoheme synthesis take place in m itochondria 
whereas the interm ediate steps takes places in the cytosol (F ig . 5 .6 ) . 
Protohaem then serves as the p ros the tic  g roup  fo r a v a r ie ty  o f 
hemoproteins such as hemoglobin, m yoglobin, the cytochrom es, 
peroxidase, catalase and tryp to p h a n  py rro lase . Normally the pathway is 
ca re fu lly  con tro lle d . P o rphyrins  and o ther interm ediate p roducts are 
formed on ly  in a v e ry  small amounts (T a it,  1978). Hepatic heme is 
catabolized by the microsomal enzyme, haem oxygenase (E .C .1 .14 .99 .3 ) 
the last ra te  lim iting  enzyme in haem degradation (Tenhunen et a L , 
1969). A major s ite  fo r  con tro l o f  the hepatic haem b iosyn the tic  pathway 
is a t the level o f ALA form ation by feedback repression exerted  by 
protohaem on A LA -synthe tase at a po s ttranscrip tiona l s ite . I t  is 
hypothesized th a t the re  e x is t a "re g u la to ry "  o r "rep re sso r" heme pool 
which t ig h t ly  con tro ls  A LA -synthe tase a c tiv ity  (G ra n ick , 1966; T sch u d y , 
1974; Meyer and Schmid, 1978; T a it, 1978).
From the foregoing steps invo lved in heme syn thes is , i t  is c lear
th a t the resu lts  presented indicate th a t the decrease in cytochromes 
P-450 is p robab ly  due to i) decrease in haem synthesis a t delta 
A LA -syn the tase  leve l, which resu lts  not on ly  in a decrease in 
cytochromes P-450 and cytochrome b 5 bu t also in o the r heme enzymes 
catalase and try p to p h a n , 2 ,3-d ioxygenase (Roomi et a L , 1984c; S tout 
and Becker, 1987) and ii)  iron de fic iency in these lesions.
The resu lts  reported  here raise several in te res ting  questions. For 
example whether the decreased synthesis is a t the level o f  tra n s c r ip t io n .
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trans la tion  o r a t post-trans la tiona l level (T a it, 1978). Does th is  lesion 
occur d u rin g  the in itia tio n  phase itself? Is it  a common lesion
responsib le fo r the decreased cytochromes P-450 content in HN induced 
by o the r protocols such as hypolip idem ics, a non-DNA damaging class o f 
carcinogens or in spontaneously generated HN? Answers to these
questions may help us understand be tte r the resistance phenomenon 
exh ib ited  by hepatic nodules.
CHAPTER 6
IDENTIFICATIO N OF THE RAT HEPATOCYTE NODULE POLYPEPTIDE P-26, 
AND THE PEPTIDE OF NORMAL MOUSE LIVER CYTOSOL, AS 
PLACENTAL GLUTATHIONE TRANSFERASE (GST-P)
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CHAPTER 6
IDENTIFICATIO N OF THE RAT HEPATOCYTE NODULE POLYPEPTIDE P-26, 
AND THE PEPTIDE OF NORMAL MOUSE LIVER CYTOSOL, AS 
PLACENTAL GLUTATHIONE TRANSFERASE (GST-P)
In tro d u c tio n
In Chapters 2, 3 and 4 the phenomenon o f resistance exh ib ited  by 
hepatocyte nodule (HN) generated by several models has been analyzed. 
Results indicated th a t irrespec tive  o f the mode o f genera tion , the HN 
c lea rly  exh ib ited  a decrease in phase I components. However, on ly  HN 
generated by res is tan t hepatocyte (RH) model and by o ther in it ia t io n -  
promotion protocols exh ib ited  an increase in many phase I I  components.
In subsequent experim ents the mechanisms which may be responsib le  fo r  
the decreased cytochromes P-450 in HN have been examined in deta il 
(C hapter 5 ). In  the fo llow ing experim ents some o f the phase I I  
components in RH nodules have been investiga ted . Th is  chapte r 
describes studies on placental g lu ta th ione  S -transferase  (G S T -P ), a 
neutra l form o f GST and the fo llow ing Chapter deals w ith  y -g lu tam y l 
transferase (y -G T ).
GST a c tiv ity  in HN o f the RH model was always found to  be h igh  
when 1 -ch lo ro -2 ,4 -d in itrobe nzene  (CDNB) was used as su bs tra te . Th is 
prompted the examination o f the SDS-PAGE e lectrophore tic  p a tte rn  o f 
HN. A comparison was also made between the e lectrophore tic  p a tte rn  o f 
the cytosolic po lypeptide from a d u lt, fe ta l and neonatal ra ts , from  
regenerating ra t live rs  and from live rs  o f ra ts  trea ted  w ith  some 
inducers , inc lud ing  carcinogens.
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A lthough the HN showed a series o f d iffe rences on SDS-PAGE, fo u r 
po lypeptide  bands w ith  m o l.w t. 32, 30, 26 and 14 kD showed
cha rac te ris tic  d iffe rences. Polypeptides w ith  m o l.w t. 30 and 14 kD were 
m arkedly decreased whereas the po lypeptide w ith  m o l.w t 26 kD (P-26) 
was s ig n ific a n tly  increased (E ricksson e t a l . , 1983). Since th is
po lypeptide (P-26) band appears in GST reg ion , th is  p ro te in  band was 
studied in de ta il. A ttem pts were made to characterize  the p ro te in  and 
evidence is p rov ided to ind icate th a t P-26 is identica l w ith  placental GST 
(G S T -P ).
In an attem pt to understand the sign ificance o f the induction  o f 
GST-P in ra t HN, stud ies were also undertaken to determ ine w hether 
GST-P is unique to HN o r occurs in the live rs  o f o the r species (Roomi e t 
a [ . , 1985c). Results obtained indicate th a t the normal male mouse
contains a large amount o f th is  p ro te in  in the live r cy toso l, while the 
female mouse has considerably less (Roomi and F arbe r, 1986c).
Materials and Methods
Nodules were produced by the method o f Solt and Farber in male 
F ischer 344 ra ts . In  some experim ents ra ts  were also in jected w ith
various xenob io tics , d ie thy ln itrosam ine  (D EN A), 2-acetylam inofluorene 
(2 -A A F ), phenobarb ita l (P B ), 1,2 -d im e thy lhyd raz ine  (DM H), 3 -m e thy l- 
cholanthrene (3-MC) and 3 '-m ethyl-4-d im ethylam inobenzene (3 '-M e-D A B ). 
The dosages o f most o f these agents were as described p rev ious ly
(Ericksson e t a l . , 1983). 1 ,2-DMH which was adm inistered i .p .  a t 100
mg per kg , the ra ts  being k illed  4 days la te r.
Male and female mice o f d if fe re n t s tra ins  (Sw iss, C57 B L /6 ,
C 3H /B i, DBA and CD-1) were obtained from Jackson Labora tories, Bar
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H arbor, Maine. Nude male and female mice were from a local colony at 
Hospital fo r Sick C h ild ren , T o ron to , Canada. The live rs  o f various 
o ther species used in the present investiga tion  were obtained e ith e r from 
the D ivision o f Laboratory Animal Science, U n ive rs ity  o f Toron to , 
Toron to , Canada, o r th ro u gh  the co u rtes ty  o f D r. M .A . Hayes, V e te r i­
n a ry  School, U n ive rs ity  o f Guelph, G uelph, Canada.
P rior to ha rvesting  the nodules, the live rs  were perfused w ith  ice 
cold 0.25 mM sucrose conta in ing 1 mM p hen y lm e thy lsu lfony lfluo ride  
(PMSF) (Sigma Chem icals), a protease in h ib ito r  and 1 mM EDTA. 
Cytosol frac tions  were prepared by homogenizing tissue (1 gm per 3 ml 
o f medium) in 0.25 M sucrose conta in ing PMSF and EDTA. Homogenates 
were cen trifuged  at 105,000 x g fo r 1 h r and the clear supernatants 
were frozen at -70° u n til used. Protein estimation was by the method o f 
Lowry et aL (1951).
Im m unoprecipitation was ca rried  out by double d iffu s io n  in agar by 
the s tandard m icrod iffus ion  procedure o f O uchterlony (1958) w ith  1.5% 
agar in T r is -N a 2E D TA -boric  acid b u ffe r ,  pH 8.4 and immunoelectro- 
phoresis was perform ed according to Scheidegger (1955). SDS-PAGE was 
perform ed as described by the system o f Laemmli (1970). Western 
b lo tting  was ca rried  out according to Towbin e t a l. (1979) and B u rne tte  
(1981). Proteins from unstained polyacrylam ide gels were tra n s fe rre d  
e lec trophore tica lly  onto n itroce llu lose  paper w ith  a Bio-Rad b lo ttin g  
appara tus. The b lo t was incubated w ith  3% bovine serum albumin (BSA) 
fo r 1 hour at 37°C and then in 3% B S A -T ris  0.05 M pH 7.4 and 
an ti-C S T -P  fo r 12 hours at 4°C. A fte r  washing w ith  PBS, the b lo t was 
treated fo r  3 hours w ith  p ro te in  A , labelled w ith  125I fo r  
im m unoprecip itation o f large antigens and washed again w ith  PBS. The
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polypeptide was then detected by au to rad iography (C raw fo rd  and Lane, 
1977; Brockm ann, 1978).
Results
F igure 6.1 shows a typ ica l po lypeptide pa tte rn  on SDS-PAGE o f 
cytosols from contro l ra t liv e r and ra t HN; from liv e r cytosol 35 
po lypeptides have been resolved on these ge ls. The hepatic nodule 
cytosol showed a marked increase over co n tro l, in the amount o f a 
po lypeptide o f m o l.w t. 26 kD . Scanning indicated th a t th is  po lypep tide  
was increased approxim ate ly te n -fo ld  over co n tro l. A second consisten t 
d iffe rence  was an increase in a po lypeptide o f m ol.w t 32,000 (P-32) and 
a reduction  in the amount o f the po lypeptides o f m o l.w t. 14,000 (P-14) 
and m o l.w t. 30,000 ( P—30). The natures o f P-32, P-30 and P-14 are not 
known and were not fu r th e r  inves tiga ted . However P-14, appears on 
m ol.w t basis to be a hem e-binding p ro te in  which has rece n tly  been 
isolated and characterized (V incen t and M y lle r-E b e rh a rd , 1985). Since 
P-26 appears in the GST subun it area, and also as the a c t iv ity  o f GST 
is m arkedly increased in HN, th is  po lypeptide  band was th o u g h t to be 
related to the GSTs and there fo re  was stud ied in de ta il.
R ecently, Sato and coworkers have isolated and p u rif ie d  a neu tra l 
form o f GST from ra t placenta (GST-P) and have shown it  to be p resen t 
in re la tive ly  h igh concentra tion  in HN, in comparison to  the low levels 
present in normal con tro l live r (K itohara  e t aL , 1984; Sato e t a j . , 1984; 
Satoh et a L , 1985; Tatematsu et a L , 1985). Using the an ti GST-P 
an tibody , th is  enzyme was shown to be m arkedly increased and localized 
in y -G T  positive  foci and HN (Tatematsu et a L , 1985). Since the two 
polypeptides (P-26 and GST-P) have a s im ilar molecular w e ig h t, we
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Figure  6.1 Analyses by  SDS-PACE (15% polyacry lamide)  o f
cy tosol ic  po lypep t ides  o f  cont ro l  ra t  l i ve r  and ra t  
hepatocyte nodule.  1. Contro l  r a t ;  2. hepatocyte 
nodule;  3. marker  p ro te ins .
Approx im ate ly  30 yg o f  p ro te in  o f  each cy toso l i c  
f rac t ion  analyzed was subjected to e lec t ropho­
resis.  The gel was stained w i th  Coomassie blue 
B. The markers  fo r  est imat ion o f  Mr were phos-  
phory lase B (94,000) ,  bovine serum albumin
(67.000) ,  ovalbumin (47 ,000) ,  carbon ic  anhydrase
(30.000) ,  t r y p s i n  in h ib i t o r  (21 ,000) and lysozyme
(14.000) .
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investiga ted  w hether anti GST-P cross-reacted  w ith  hepatocyte nodule 
cytoso l. Using Sato's an ti-G S T-P  evidence has been provided to  ind icate  
th a t P-26 po lypeptide and GST-P isolated from ra t p lacenta, are 
iden tica l, o r a t least v e ry  s im ila r. P roof th a t P-26 po lypeptide  is GST-P 
was obtained from an immunoblot techn ique. F igure  6.2A shows a typ ica l 
po lypeptide p a tte rn , on SDS-PAGE o f cytosol from contro l ra t liv e r and 
ra t HN, and p u rif ie d  GST-P. F igure  6.2B shows the au to rad iography 
a fte r tra n s fe rr in g  e lec tropho re tica lly  from SDS-PAGE on n itroce llu lose  
paper and reacting w ith  the an tibody to GST-P and 125I-labe lled  p ro te in
A. The b lo t on SDS-PAGE showed a single intense band on 
n itroce llu lose  w ith  HN cytosol a t the position o f GST-P an tigen ; no such 
band was observed w ith  con tro l ra t liv e r cy toso l. S im ilar resu lts  were 
obtained using antibodies prepared against P-26 (re su lts  not show n). 
The reaction to th is  an tibody prepara tion  w ith  GST-P was c le a rly  
ev ide n t. Thus the GST-P and P-26 as monitored by SDS-PAGE, and 
th e ir  re a c tiv ity  to antibodies prepared against each p u rif ie d  p re p a ra tio n , 
are ind is tingu ishab le  from one another.
Rat GST-P was fu r th e r  characterized using D r. Sato's a n t i- ra t  
placental GST-P ra b b it an tibody . Using the an tibody to G ST-P, it  was 
found th a t P-26 was present in a) pe rs is ten t nodules and hepatoce llu la r 
cancer induced by the RH model (F ig . 6 .3 ) ,  in male and female ra ts  o f 
several d if fe re n t s tra in s , b) ra t liv e r nodules generated by DENA 
in itia tio n  and fo u r d if fe re n t promoters (F ig . 6 .4 ) , c) transp lan ted  
nodules grow ing in spleen o f normal syngeneic ra t (F ig .6 .5 ) , and d) 
liv e r  cancer g row ing as pulmonary metastases.
Nodules produced by feeding the hypolip idem ic agen t, c ip ro f ib ra te , 
were GST-P and y -G T  negative. However, on w ithdraw al o f the
Figure 6
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Western blot  o f  SDS-PAGE (12.5% po lyacry lamide)  
o f  cytosol ic po lypep t ides o f  l i ve r  and hepatocyte 
nodule o f  ra t .  Approx im a te ly  25 yg o f  p ro te in  o f  
each cytoso l ic f rac t ion  was subjected to 
e lec trophores is .  One gel was stained d i r e c t l y  
w i th  Coomassie blue B ( A ) . The p ro te ins  in the 
o ther  gel (B)  were t ra n s fe r re d  e lec t rophore t ica l l y  
onto ni t rocel lu lose paper  and then t rea ted  w i th  
an t i -p lacenta l  GST (GST-P)  and w ith p ro te in  A 
label led w i th  125I .  1. Contro l  ra t  l i ve r  cytosol
(25 p g ) ;  2. Hepatocyte nodule cytosol  (25 p g ) ;  
3. Pure GST-P (5 pig).
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F igure  6.3 Analyses o f  cytoso ls f rom hepatocytes fo r  GST-P 
d u r in g  l i ve r  carcinogenesis  by  res is tan t  hepato­
cyte model. Centra l  well contained an t i -G S T -P  
( A b ) ,  wells 1-4 contained l i ve r  cytosol  f rom rats 
at  1 , 2 ,3 ,4  weeks a f te r  in i t ia t ion  in RH model; 
well 5 pe rs is tan t  HN; and well 6 contained cytosol  
f rom hepatoce l lu lar  carcinoma. Immunod if fus ion 
was done us ing 1.5% agar.
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Figure  6.4 Immunodif fusion  ana lysis o f  cytosols o f  hepatocyte 
nodules generated in f ive  models us ing d i f f e re n t  
in i t ia t in g -p rom o t in g  reg imens. Central  well 
a n t i -C S T -P  ( A b ) ;  well 1 cont ro l  ra t  l i v e r ,  well 2 
Pi tot 's  model -nodule;  well 3 Peraino model-  
nodule ;  well 4 o ro t ic  acid mode l-nodule;  well 5 
chol ine-methionine de f ic ien t -nodu le  and well 6 
res is tan t  hepatocyte nodule.
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Figure  6.5 Immunod if fus ion analyses o f  ra t  hepatocyte nodule 
(H N ) ,  HN grown in spleen o f  un t rea ted  ra t  and 
pure  GST-P.  Well 1 an t i -G S T -P  ( A b ) ; well 2 ra t  
HN; well 3 pure  GST-P and well 4 HN grown in 
spleen o f  un t rea ted  ra ts .  1 .5% agar  was used fo r  
immunod if fus ion.
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c ip ro fib ra te  d ie t, the nodules became GST-P pos itive , b u t were s til l 
y -G T  negative . RH nodules exposed to CF fo r 8 weeks were also GST-P 
positive  b u t y -G T  negative ( fo r  deta ils see Chapter 3 ).
The e ffec t o f adm in is tra tion  o f various xenobiotics on the 
e lec trophore tic  pa tte rn  o f the cytoso lic  po lypeptides o f live r were 
inves tiga ted . Typ ica l resu lts  obtained w ith  PB, 3-MC and Cobalt-heme 
are shown in F igure 9.6 o f Chapter 9. The amount o f P-26 was not 
a ffec ted . I t  was also found th a t no o ther xenob io tic adm in istra tion  
(DENA, 2 -A A F, 3'-Me DAB and 1,2-DMH) affected the amount o f P-26 in 
l iv e r  (data not show n). The e ffe c t o f p a rtia l hepatecomy (PH) on the 
po lypeptide o f live r was also examined, b u t d id  not apprec iab ly  a ffe c t 
the amount o f P-26 at 12, 24, 48, 82 or 130 hours (data not shown) 
a fte r s u rg e ry .
In an attem pt to understand the s ign ificance o f the induction  o f 
GST-P in ra t HN, experim ents were undertaken to determ ine w hether 
GST-P is unique to HN o r is p resent also in the live r o f o the r species 
(Roomi et a L , 1985c, 1986c). The resu lts  presented in Table 6.1 c lea rly  
indicate th a t o f the various species tes ted , on ly  mouse, horse and dog 
exh ib ited  a po lypeptide in the liv e r  cytosol which cross-reacted  w ith  
an ti-G S T -P . The observation th a t con tro l mouse live r cytosol gave a 
v e ry  s trong  p re c ip itin  band by double d iffu s ion  prompted a detailed 
s tudy  o f i t .  F igures 6.6A and 6.6B show the double d iffu s io n  ca rried  
ou t in agar according to O uchterlony w ith  an ti-G S T-P  an tibody against 
cytosols o f various s tra in s  o f male and female mice. Rat HN cytosol was 
also included in th is  as a positive  co n tro l. F igure 6.6A  shows the 
p re c ip itin  lines formed by in te raction  o f an ti-G S T -P  against liv e r cytosol 
o f th ree  d if fe re n t s tra ins  o f male mice, Swiss, C57 BL/6 and C 3H /B i.
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Table 6.1
O ccurrence o f GST-P in hepatic cytosol o f 
various species
GST-P present o r absent 
(O uch te rlony technique)
+++
++
Species
Rainbow tro u t 
Frog
17-day old chicken embryo
Chicken
Rabbit
Guinea pig
Rat
Mouse
Hamster
Cat
Dog
Monkey
Pig
Ox
Horse
Human
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Figure 6.6 Immunod if fus ion analys is  o f  cytoso ls o f  l i ve r  f rom 
var ious  s t ra ins  o f  male and female mice and ra t  
hepatocyte nodules (HN)  fo r  GST-P.  A.  Centra l  
well an t i -G ST-P  ( A b ) ;  wells 1 and 4 Swiss; 
wells 2 and 5 C57 BL /6  and wells 3 and 6 C3W/Bi 
male mice. B. Centra l  well contained a n t i -G S T-P  
( A b ) ; well 1 C3H/Bi  female; well 2 nude female, 
well 3 C57 BL /6  female; well 4 C57 BL /6  male 
mice, well 5 male ra t  HN and well 6 Swiss female 
l i v e r  cy tosols .  1.5% agar was used fo r  immuno­
d i f fus ion  .
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They all formed s ing le  p re c ip itin  line and all the lines were merged to 
form a hexagon w ith  an apparent line o f id e n tity . S im ilar resu lts  were 
obtained w ith  th ree  o ther s tra ins  o f male mice, namely, Nude, DBA and 
C D -I (re su lts  not show n). F igure  6.6B shows the p re c ip itin  lines 
formed by in te rac tion  o f an ti-G S T-P  against live r cytosols o f d if fe re n t 
s tra in s  o f female mice, Swiss, C 3H /B i, Nude and C57 BL/6 and male 
mouse, C57 B L /6 . A ll the female mice showed a fa in t p re c ip itin  band 
while the male mouse and HN showed th ic k  bands, b u t ra t HN cytosol 
showed a spur w ith  both male and female mice. Th is sp u r was observed 
w ith  d if fe re n t s tra ins  o f male and female mice.
F igure 6.7A shows a typ ica l po lypeptide pa tte rn  on SDS-PAGE o f 
con tro l ra t l iv e r ,  ra t HN, and normal male and female mice. As reported 
in th is  chapter ra t HN showed a series o f d iffe rences bu t the most 
prom inent one was the marked increase in the amount o f po lypeptide  o f 
26 kD . Slots 3 and 4 show the p ro te in  p ro file  o f male and female Swiss 
mice. The p ro te in  p ro file  is almost the same in liv e r cytosol o f both 
sexes except fo r  the large increase in po lypeptide  o f 26 kD in male 
mouse. Th is po lypeptide  band in male mouse corresponded to  P-26 o f 
ra t HN, which suggests th a t these two pro te ins ( ra t HN P-26 and mouse 
cytosol P-26) are closely re la ted . The na tu re  o f th is  band was fu r th e r  
characterized using the Western b lo t technique on n itroce llu lose  paper. 
F igure  6.7B shows the au to rad iography a fte r  tra n s fe rr in g  e le c tropho re - 
tic a lly  from SDS-PAGE onto n itroce llu lose  paper and reacting  w ith  
an ti-G S T-P  and 125I-labe lled  p ro te in  A . The b lo t showed a s ing le  band 
w ith  ra t HN, pure ra t HN P-26, male mouse liv e r cytosol and a fa in t 
band w ith  female mouse. No such band was observed w ith  con tro l ra t.
F igure 6.8 shows the p ro file  o f live r cytoso lic  p ro te ins o f th ree  o th e r
Figure  6 .7A Analyses by  SDS-PAGE (12.5% po lyacry lamide)  o f  
cytosol  po lypep t ides o f  male r a t ,  male ra t  
hepatocyte (HN) and male and female mice. 1 . 
pu re  GST-P.  2. marke r  p ro te ins ;  3. male Swiss 
mouse; 4. female Swiss mouse; 5. res is tan t  HN; 
6. Contro l  male r a t .  A pp rox im a te ly  25 yg o f  
p ro te in  o f  each cytoso l ic f rac t ion  was subjec ted to 
e lec t rophores is .  The gel was stained w ith 
Coomassie blue B. The molecular we igh t  m arke rs  
used were phosphory lase B (94 ,000) ,  bovine 
serum albumin (67 ,000) ,  ova lbumin (47 ,000) ,  
carbon ic  anhydrase (30 ,000) ,  t r y p s i n  i n h ib i t o r  
(21 ,000) and lysozyme (14 ,000) ;
1 2 3 4 5
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Figure 6.7B A u to ra d io g ra p h y  o f  Western b lo t .  1. Pure CST-P 
(5 y g ) ;  2. male Swiss mouse (50 yg o f  each) ;  3. 
female Swiss mouse; 4. res is tan t  hepatocy te 
nodule (H N ) ;  5. Control  male ra t .  The gel from 
the exper iments  descr ibed in F igure  6 .7A was 
used fo r  Western b lo t t in g .
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Figure 6 Analyses by  SDS-PAGE (12.5%) po lyacry lamide)  o f  
cytoso ls po lypep t ide  o f  male and female mice o f  
d i f f e re n t  s t ra ins .  1. C57 BL/6  female mouse; 2. 
C57 BL/6 male mouse; 3. C3H/B i female mouse; 4. 
C 3H / B i male mouse; 5. nude female mouse; 6. 
nude male mouse and 7,  pu re  GST-P.  
Approx im ate ly  30 yg o f  p ro te in  o f  each cy toso l ic  
f rac t ions  were subjected to e lec trophores is  and 
the gel was stained w i th  Coomassie blue B.
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male and female s tra ins  o f mice C57 B L /6 , C3H/B i and Nude. A ll the 
male mice showed a large increase in 26 kD po lypeptide  while the female 
mice showed a fa in t band.
The im m unoelectrophoretic pa tte rns  o f con tro l ra t, ra t HN, male and 
female mice against an ti-G S T-P  are shown in F igure 6.9 A -C . Rat HN 
cytosol showed a single arch a t the o rig in  bu t no such arch was 
observed w ith  contro l ra t liv e r  (F ig . 6 .9 A ). F igure  6.9B showed the 
arch formed by both ra t HN and male mouse live r cy toso l. F igure  6.9C 
showed on ly a lig h t arch w ith  con tro l female mouse and no arch formation 
w ith  con tro l female ra t. Horse and dog GST-P appeared to be d if fe re n t 
from  th a t o f ra t HN and mouse as spurs were observed w ith  each o ther 
(data not show n).
Comparisons w ith  o ther Studies on GST-P
The amino acid composition o f mouse GST-P and ra t HN GST-P are 
v e ry  s im ila r, according to studies o f D r. K.Sato (Table 2 ). Both mouse 
GST-P and ra t HN GST-P lack ca rbohydra te  moieties (K .S a to , personal 
com m unication). However, the isoe lectric  po in t (p i)  o f mouse GST-P 
d if fe rs  from ra t HN GST-P fo r both subun its  (mouse) 7.4 and 7.0 
compared to ra t 6.7 and 6.3 (8 .9  versus 7.0 fo r dimer re sp e c tive ly ; 
data from K. Sato). V e ry  s im ilar sequences have been recorded fo r 
mouse GST-P and ra t HN GST-P a t the NH2-te rm ina l region e .g . PPY(T) 
IVYFPV ( ra t)  and PPYT IVYFPU (mouse) as repeated by D r. M annerv ik 
and co -w orke r (1985) and Rushmore e t a l. (1987).
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F igure  6.9 Immunoelectrophoresis o f  con tro l male and female 
ra ts , male ra t hepatocyte nodule, male and female 
mouse liv e r cytosols against a n t i- ra t GST-P 
an tibody . A . Well 1, con tro l male ra t (MR) and 
well 2, male ra t hepatocyte nodule (RHN) cytoso l;
B. well 1, res is tan t hepatocyte nodule and well 2, 
male Swiss mouse (MM); C. well 1, con tro l female 
ra t (FR) and well 2, Swiss female mouse (FM ).
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Table 6.2
Amino acid composition o f  placental g lu ta th ione 
S -transfe rase  from mouse and ra t HN 
(K .S . Sato, personal communication)
Amino acid Mouse Rat (HN)
Asx 23.1 25.8
T h r 7.7 8.2
Ser 10.4 11.7
Glx 21 .3 18.9
Pro 12.3 12.2
Gly 19.3 19.4
Ala 12.6 14.8
Cys n .d . 4.0
Val 12.2 12.3
Met 1.6 1.8
lie 7.7 7.3
Leu 27.2 28.8
T y r 12.0 11.4
Phe 6.9 7.0
His 5.0 4.2
Lys 13.2 13.7
A rg 9.9 9.5
Values are amino acid residues per s u b u n it. Cysteine was determ ined as 
cyste ic acid a fte r  perform ic acid ox ida tion , n .d . ,  not determ ined.
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Discussion
A polypeptide o f mol w t 26 kD which cross-reacts  w ith  an ti-G S T -P  
is g re a tly  increased in nodules d u rin g  carcinogenesis suggesting th a t it  
may have some association w ith  hepatocarcinogenesis. A band fo r  GST-P 
is almost neg lig ib le  in contro l ra t l iv e r .
Sato and colleagues (1985) are o f the opin ion th a t the GST-P is the  
best available m arker fo r  "p reneop lastic" cells in ra t chemical hepato­
carcinogenesis and E riksson , Farber and colleagues (1983, 1984d) have 
considerable evidence to ind icate th a t po lypeptide m o l.w t. 26,000 is by 
fa r the best m arker fo r  the hepatocyte nodule. The evidence presented 
in th is  chapter s tro n g ly  indicates th a t GST-P and P-26 from nodules are 
ve ry  s im ila r. A s im ilar ten ta tive  conclusion was also reached by Jensson 
e t a l. (1985), these au thors designated GST-P as GST-77, a GST which 
is p resent a t a v e ry  low level in ra t live r b u t re la tive ly  h igh levels in 
k idney  and lung . A g lu ta th ione -S -trans fe rase  (GST-77) resembling 
GST-P has been p u rif ie d  from ra t p rim ary  hepatomas (Meyer e t a l . , 
1985).
Since GSTs are phase I I  components o f the d rug-m etabo liz ing  
system , it  is lik e ly  th a t the increased GSTs in HN con fe r the resistance 
p ro p e rty  towards those several xenobiotics which re su lt in the form ation 
o f activated e lectroph iles (Roomi et j d . , 1985a; Farber and Sarma,
1987). I t  is however, not ye t clear what role the increased GST-P plays 
in the newly acquired resistance p ro p e rty  o f HN.
Since HN have a cha rac te ris tic  biochemical phenotype th a t con fers 
unusual resistance to many xenobiotics it  is a ttra c tive  to  consider GST-P 
as another component o f th is  resistance spectrum .
In te re s tin g ly , th is  po lypeptide not on ly  is p resent in mouse HN b u t 
also present in con tro l mouse liv e r . P-26 is p resent in two d if fe re n t
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species, i.e . ra t and mouse; p roducing  the enzyme d u rin g  hepatocarcino- 
genesis ( ra t)  and the o the r having it as a normal cons tituen t (mouse). 
I t  was the re fo re  o f in te re s t to compare P-26 o f ra t HN and con tro l mouse 
liv e r . Th is po lypeptide is p resent in large amounts in male mouse liv e r 
compared to female liv e r .  On SDS-PAGE and Western b lo t ana lys is , 
mouse live r and ra t HN GST-P and the pure p ro te ins have the same 
m ob ility  ind ica ting  th a t the two polypeptides are closely re lated (Roomi 
and F a rbe r, 1986c). They both have v e ry  s im ila r amino acid 
com position, and NH2-te rm ina l amino acid sequences (M annervik et a L , 
1985; Suguoka e t ajl. ,  1985; Rushmore e t a L , 1987) and both lack 
carbohydra te  moieties. However, on O uchterlony they showed a spu r 
suggesting th a t they  are not to ta lly  identica l (Roomi and F a rbe r, 1986c). 
They also have d if fe re n t isoe lectric  po in ts . As the mouse P-26 o r GST-P 
seem to show marked sex d iffe rences in the normal liv e r cytosol 
con ten ts , th is  would c lea rly  d is tin g u ish  between the sexes. The ve ry  
low levels o f GST-P in the female mouse live r hepatocyte would enable 
th is  to be used as a m arker fo r  a lte red , in itia ted  o r preneoplastic 
hepatocytes d u rin g  carcinogenesis, in a s im ilar fashion to the use o f 
GST-P in the ra t. Analyzable models fo r  s tu d y ing  the e a rly  stages o f 
carcinogenesis are c u rre n t ly  being developed using various genetic  
s tra in s  o f female mice, and m arkers such as GST-P w ill be c r it ic a l to 
such s tud ies .
CHAPTER 7
EXPRESSION OF HEPATIC AND SERUM y-G LUTAM YL TRANSFERASE (y -G T ) 
A C TIV IT IES  DURING CARCINOGENIC PROCESS IN RESISTANT 
HEPATOCYTE (RH) MODEL IN RAT
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CHAPTER 7
EXPRESSION OF HEPATIC AND SERUM y-GLUTAM YL TRANSFERASE (y-G T) 
A C TIV IT IE S  DURING CARCINOGENIC PROCESS IN RESISTANT 
HEPATOCYTE (RH) MODEL IN RAT
In tro d u c tio n
y-G lu tam yl transferase (y -G T , EC 2 .3 .2 .2 ) an enzyme th a t catalyzes 
the tra n s fe r o f a y-g lu tam yl g roup  from y-g lu tam yl peptides such as 
g lu ta th ione to amino ac id , peptides and water (Hanes e t a L , 1950;
Meister and Tate , 1976), is h igh in fe ta l and neonatal ra t l iv e r ,  bu t 
ve ry  low in the adu lt organ (Fiala e t a L , 1972; Meister and Ta te , 
1976). I t  is rem arkably increased d u rin g  hepatocarcinogenesis (Fiala et 
a l . , 1972, 1973, 1976; Tan iguch i e t a l . , 1974; Kalengayi e t a L , 1975; 
Harada et a ll., 1976; Cameron et a L , 1978; Cheng et a L , 1978). In 
con tras t to human the basal level o f serum y -C T  in ra t is v e ry  low 
(Caisey and K ing , 1980). A lthough  it  is p resent in various tissues , it  
does not appear in serum except under ce rta in  pathological conditions 
(G o ldberg , 1980). C lin ica l stud ies indicate th a t the y -G T  a c tiv ity  o f 
serum is increased in human subjects rece iv ing microsomal d rug-m etabo­
liz ing  enzym e-inducing d rugs  (R osa lk i, 1975, 1976; Goldberg and
M artin , 1975). Th is increase in y -G T  a c tiv ity  has been proposed as an 
conventional index o f induction  o f hepatic microsomal enzyme in man 
(H un te r and Chasseaud, 1978; G oldberg, 1979, 1980). S upport fo r  th is  
view has come from experim ents dem onstrating increased y -G T  a c t iv ity  in 
live r homogenate and microsomes o f animals tha t are exposed to 
microsomal drug-m etabo liz ing  enzyme inducing  d rugs (B a rte ls  e t a L , 
1975a, 1975b; Ivanove e t a l . ,  1976; Teschke e t a l. ,  1977; Ish ii e t a l . ,
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1978). The use o f y -G T  has recen tly  been in troduced  in to  c lin ica l 
chem istry  fo r  the s tu d y  o f hepatic function  and b ilia ry  d iso rd e rs . High 
serum or plasma y-G T a c tiv ity  is usua lly  found in cases o f  live r disease, 
especia lly when cholestasis occurs (K ryszew sk i, 1973; Ad jarove e t a [ . , 
1976), in case o f excessive alcohol intake (Rosalki e t £h  , 1972; A d ja rov  
and Ivanov, 1973) o r a fte r the adm in is tra tion  o f d rugs  p a rtic u la r ly  those 
o f phenobarb ita l g roup  (Rosalki e t a L , 1971; H ildebrand t e t aL , 1975).
y -G T  shows low a c tiv ity  in ra t liv e r and almost neg lig ib le  a c t iv ity  in 
serum. However, its  a c tiv ity  increases d u rin g  hepatocarcinogenesis. 
Since y -G T  has some s im ila rities  w ith  phase I I  d rug  m etabolizing enzymes 
such as g lu ta th ione -S -trans fe rases  (GST) and g lu ta th ione  (GSH) 
(F a rb e r, 1984a, 1984b), its  expression was followed in serum and
hepatocyte nodule (HN) d u rin g  carcinogenic process in re s is ta n t 
hepatocyte model.
Materials and Methods
Hepatocyte nodule and hepatocellu lar carcinomas were induced in 
male F ischer ra ts  344 according to the re s is tan t hepatocyte (RH) model. 
The deta ils o f the protocol are shown in F igure  7.1 and have been 
described in Chapter 2.
Determ ination o f  y -G T  A c tiv ity
y-G T  a c tiv ity  was determ ined in serum and hepatocyte nodule 
according to the method o f Szasz (1969) using y -g lu ta m y l-p -n itro a n ilid e  
as substra te  and g lycy lg lyc in e  as acceptor.
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Solubilization o f HN
Since y-G T  is a membrane bound enzyme (Ratanasavanh e t a l . ,
1979), its  a c tiv ity  was determ ined, a fte r so lub iliza tion  w ith  sodium 
deoxycholate (DOC) and T rito n  X-100 and compared w ith  un treated  
samples (Tazi et a L , 1980). DOC o r T r ito n  X-100 in fina l concentration 
rang ing  from 0.1-2% (w /v )  was incubated w ith  homogenate and microsomal 
prepara tions fo r  10 min at room tem perature . The h ighest y -G T  a c tiv ity  
occurred in the presence o f 1% DOC o r 1% T rito n  X-100.
Results
F igure 7.2 shows the y-G T  a c tiv ity  in serum and hepatocyte nodules 
analyzed sequentia lly  in the RH model. The a c tiv ity  is v e ry  low in 
contro l ra t serum, bu t the serum showed a marked increase in y -G T  
a c tiv ity  d u rin g  the second m onth, a fte r cessation o f the 2-acetylam ino- 
fluorene (2-AAF) treatm ent in the carcinogenic regimen. An increased 
level was maintained fo r about 8 months and then showed a gradual 
increase over the period o f 8 to 12 months a fte r in it ia tio n , and increased 
again in the hepatocellu lar cancer sta te . y -G T  a c tiv ity  is also low in 
normal a du lt ra t liv e r . However, d u rin g  carcinogenesis i t  showed a 
s ig n ifica n t increase. y -G T  appeared v e ry  ea rly  in HN around 4-6 weeks 
a fte r in itia tio n  d u rin g  the hepatocarcinogenic process. Once i t  
appeared, the increased a c tiv ity  was maintained.
Since y-G T is a membrane bound enzyme, its  a c tiv ity  was measured 
a fte r  treatm ent w ith  DOC o r T r ito n  X-100. F igure  7.3 shows the 
sequential analysis o f y-G T a c tiv ity  in the RH model before and a fte r  
treatm ent w ith  DOC or T rito n  X-100 trea tm ent. I t  is obvious th a t the 
to ta l a c tiv ity  a fte r DOC or T r ito n  X-100 treatm ent in the nodules is
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g re a te r than the to ta l a c tiv ity  in the contro l l iv e r . Th is  shows th a t the 
increase is not due to  any expression o f la tent a c tiv ity .
F igure  7.4 (A -C ) shows the in tra ce llu la r d is tr ib u tio n  o f y -G T  in the 
pe rs is ten t hepatocyte nodule, the su rrou nd in g  live r and the contro l 
l iv e r ,  and the e ffe c t o f DOC and T rito n  X-100 on its  release. Persistent 
hepatocyte nodules showed a s ig n ifica n t increase in y -G T  a c tiv ity  over 
c o n tro l, in the to ta l homogenate (F ig . 7 .4 A ). A fte r  treatm ent w ith  DOC 
o r T r ito n  X-100, to ta l y -G T  a c tiv ity  was released and showed a 
s ig n ifica n t increase over the un treated  samples in c o n tro l, HN and 
su rrou nd ing  tissue. y -G T  a c tiv ity  is h ighest in the microsomal fra c tio n  
(see F ig .7 .4 B ) and much h ighe r a c tiv ity  was found in the HN than in 
su rrou nd ing  tissue o r co n tro l. On DOC o r T r ito n  X-100 trea tm ent the 
to ta l y -G T  a c tiv ity  released showed a s ig n ifica n t increase. y -G T  a c tiv ity  
in the tissue cytosols was low, and showed a s lig h t b u t s ig n ifica n t 
increase in the HN and su rrou n d in g  tissue (F ig . 7 .4 C ), compared w ith  
contro l liv e r cytoso l.
Serum y-G T  was also increased in ra ts bearing HN generated using 
various in itia tio n  and promotion pro toco ls , deta ils o f which are g iven in 
Chapter 2 o f th is  thes is .
Discussion
I t  is ev iden t from th is  s tu dy  th a t y -G T  a c tiv ity  in serum and HN is 
s ig n ific a n tly  increased d u rin g  the carcinogenic process in the RH model 
in ra t. The serum levels are elevated considerably d u rin g  the whole 
carcinogenesis process, w ith  some fluc tua tions  d u rin g  precancerous steps 
and a large increase when cancer appears around 12 months. S im ila rly , 
HN also showed a large increase, b u t the specific  a c tiv ity  remained
Figure 7.2 Sequential analysis o f y -G T  a c tiv ity  in 
serum and hepatocyte nodule in res is tan t 
hepatocyte model. Each po in t is an 
average o f 4 determ inations ± S .D .
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Figure 7.3 Sequential analysis o f y -G T  a c tiv ity  in 
hepatocyte nodule homogenate in un­
treated (U) and a fte r treatm ent w ith  
sodium deoxycholate (D) and w ith  T r ito n  
X-100 (T ) .  Average o f 4 determ inations 
± S .D .
171
h
o  o  o  o  o  o
O  00  CD CM
uiejojd 6tu . pjuj
U
D
T 
UD
 
UD
 
UD
 
U
D
T 
U
D
T 
UD
T 
U
D
T
C
on
tro
l 
1.5 
2.0
 
2.5
 
3 
5 
10 
12 
M
on
th
s
Figure 7.4 In tra ce llu la r d is tr ib u tio n  o f  y -G T  in 
con tro l l iv e r ,  hepatocyte nodule and the 
su rround ing  live r in to ta l homogenate 
(A ) ,  microsomal (B ) and cytosolic (C) 
frac tio ns . In  homogenate (A ) and in 
microsome the a c tiv ity  was determ ined in 
untreated (U) and a fte r sodium deoxy- 
cholate (D) and T rito n  X-100 (T ) tre a t­
ment. Values are average o f fo u r 
determ inations ± S .D .
Figure 7.4
Intracellular Distribution of yGT in Control Liver, Persistant Hepatocyte Nodule 
and the Surrounding Liver, and the Effect of DOC and Triton x-100 on its Release
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unchanged u n til the development o f hepatocellu lar carcinoma. y -G T  was 
m arkedly increased both in microsomal and cytoso lic fra c tio n s . Since the 
enzyme is membrane bound (Ratanasavanh e t a [ . , 1979), it  showed a 
large increase in a c tiv ity  a fte r DOC and T rito n  X-100 treatm ent (Tazi et 
a l. ,  1980).
An increase in serum y-G T  was seen not on ly  in the RH model b u t 
also in o the r models using d if fe re n t in it ia to rs  and promoters (Roomi et 
a L , 1985a). Thus serum y-G T could be used as a usefu l m arker to 
m onitor the carcinogenic process in l iv e r . In te re s tin g ly , HN generated 
by feeding the hypolip idem ic agent, c ip ro fib ra te  d id  not e x h ib it any 
increased y -G T  a c tiv ity  e ith e r in serum (Roomi et a L , 1987) o r in HN 
(fo r deta ils see Chapter 3 o f th is  th e s is ). These nodules were also 
placental g lu ta th ione -S -trans fe rase  (GST-P) (Roomi et a l. ,  1987; Rao et 
a ] . , 1986)negative in con tras t to the RH nodule, thus ind ica ting  th a t 
both y -G T  and GST-P have a close association. D uring  the carcinogenic 
process, using in itia tio n  and promotion pro toco ls , these two enzymes are 
induced s im ultaneously, whereas in hypolip idem ic nodules they  both 
remain repressed.
In  con tras t to  y -G T  and GST-P, the a c tiv ity  o f g ly c y lp ro lin e  
d ip e p tid y l aminopeptidase (GPDA) showed a s ig n ifica n t increase in the 
serum o f ra ts  in both types o f models, namely, those em ploying 
DNA-damaging in itia to rs  and prom oters, and those using hypolip idem ic 
d rugs which do not apparen tly  damage DNA (see C hapter 3 ). The 
usefulness o f GPDA as a m arker d u rin g  hepatocarcinogenesis needs 
fu r th e r  s tu d y .
CHAPTER 8
LEAD NITRATE INDUCES CERTAIN BIOCHEMICAL PROPERTIES 
CHARACTERISTIC OF HEPATOCYTE NODULES IN RAT
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CHAPTER 8
LEAD NITRATE INDUCES CERTAIN BIOCHEMICAL PROPERTIES 
CHARACTERISTIC OF HEPATOCYTE NODULES IN RAT
In tro d u c tio n
Hepatocyte nodules generated by d if fe re n t models using in itia tio n  
and promotion protocols as described in Chapter 2 e x h ib it a pa tte rn  o f 
enzymes characterized by a decrease in microsomal cytochromes P-450 
and cytochrome b5 and in several m ixed-function  oxygenase a c tiv itie s  
(phase I components) and by an increase in phase II  components such as 
g lu ta th io n e , cytosolic g lu ta th ione -S -trans fe rase  and D T-d iaphorase 
(Cravela e t a L , 1975; Cameron e t a l . , 1976; Okita e t a L , 1976; Feo 
e t c iL , 1978; Kaneko et a L , 1980; Bock et a L , 1982; Astrom  et a L , 
1983; Ericksson e t a L , 1983), which are known to p lay an im portan t 
ro le in the de tox ifica tion  o f several xenobiotics and free  radicals (Parke 
and Ioannides, 1984). Th is biochemical pa tte rn  is seen in hepatocyte 
nodules (HN) o f fou r d if fe re n t models o f liv e r  carcinogenesis, and has 
been considered to be responsible fo r the resistance o f the hepatocyte 
nodules towards several xenobiotics (Fiala et <a[., 1976; Schor e t a L , 
1978; Demi and O esterle , 1980; F a rbe r, 1984d; Sato e t a l . , 1984).
The present s tu d y  was designed to determ ine w hether th is  
biochemical pa tte rn  is unique fo r hepatocyte nodules o r is a p ro p e rty  o f 
the normal liv e r ce ll, expressed on ly  when the liv e r  is p e rtu rb e d . To 
understand the phenomenon at biochemical and molecular levels we 
attempted to reproduce the process by adm in iste ring  non-carc inogen ic
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chemicals. D uring  th is  attem pt we found th a t adm in is tra tion  o f lead 
n itra te  induces a biochemical pa tte rn  sim ilar to th a t seen in HN.
The model chemical chosen fo r  th is  s tudy  consisted o f adm in is tra tion  
o f acute dose o f lead n itra te  w h ich , as shown p re v io u s ly , is able to 
stim ulate live r cell p ro life ra tion  in ra ts  (Columbano e t a h , 1983, 1984). 
The observation  th a t lead n itra te  is an inducer o f liv e r  cell p ro life ra tio n  
despite its  p ro p e rty  o f im pairing the m ixed-function  oxygenase system 
(A lva res et a l. , 1972; Scoppa et aL , 1973), since most o f the inducers 
o f liv e r g row th  are also inducers o f  the m ixed-function  oxygenase system 
(Schulte-H erm ann, 1979), led to investiga te  w hether the acute 
adm in istra tion  o f th is  chemical could also stim ulate the phase I I  enzymes, 
thus re su ltin g  in a biochemical p a tte rn  s im ilar to th a t observed in liv e r 
nodules.
The resu lts  indicate th a t adm in is tra tion  o f lead n itra te  a t doses o f 5 
and 10 pmole/100 g body w t, had an in h ib ito ry  e ffe c t on phase I 
components, such as cytochromes P-450 and am inopyrine N-demethylase 
a c t iv ity ,  while it  increased phase I I  components such as g lu ta th ione  and 
the a c tiv itie s  o f g lu ta th ione -S -trans fe rases  (GST) inc lud ing  the placental 
GST (GST-P) (Roomi et a l . , 1986a).
Materials and Methods
In most o f the experim ents male Wistar ra ts  (Charles R iver B reeding 
Laboratories, W ilm ington, MA) weighing 150 g were used. Male F ischer 
344 ra ts  (Charles R iver Breeding Laboratories, S t. C onstant, Quebec, 
Canada) were used fo r the generation o f hepatic nodules. The ra ts  were 
maintained on Purina rodent labora to ry  chow d ie t (No. 5001 ) and d a ily  
cycles o f a lte rna ting  12 hours period o f lig h t and darkness. A ll ra ts
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were g iven food and water ac[ lib itum  and were acclimatized to th e ir  
environm ent fo r at least 1 week before use in the experim ent. D-glucose 
6-phosphate (disodium s a lt) ,  NADP+ + NADPH+ , glucose 6-phosphate 
dehydrogenase 600 u n its /m l) , n icotinam ide, cytochrome c , L -y -g lu ta m y l- 
p -n itro a n ilid e , g ly c y lg ly c in e , g lu ta th ione (reduced fo rm ), 1 -ch lo ro - 
2 ,4 -d in itrobenzene , 5 ,5 '-0 -d ith io b is  2 -n itrobenzo ic  acid and bovine serum 
album in, were obtained from Sigma Chemical C o ., S t. Louis, MO. 
Sodium d ith io n ite  and am inopyrine were from A ld rich  Chemical C o ., 
Milwaukee, WI. A ll o ther chemicals were o f the h ighest reagent grade.
Hepatic nodules were generated in ra ts  in itia te d  w ith  d ie th y ln it ro -  
samine (200 m g/kg  i . p . ,  A ld rich  Chemicals, M ilwaukee, WI) and promoted 
using the res is tan t-hepa tocyte  (RH) model (see Chapter 2 fo r d e ta ils ). 
S ix months a fte r in it ia tio n , the ra ts  were k illed  and the g ra y ish -w h ite  
nodules o f 0 .5-2 cm w ith  sharp demarcation from the su rrou n d in g  
redd ish -b row n  liv e r ,  were scooped ou t and the cytosol fra c tio n  was 
prepared as described e a rlie r.
Lead n itra te  (F isher S c ien tific  C o ., Canada) was dissolved in 
d is tille d  water p r io r  to use, and in jected th ro ugh  the femoral ve in  a t the 
doses ind ica ted , under lig h t e thy l e ther anesthesia. C ontro l ra ts  
received an equ iva len t volume o f d is tille d  w ater.
T h ir ty  s ix  hours a fte r the adm in istra tion  o f lead n itra te , the ra ts  
were bled under e ther anesthesia, the live rs  were taken ou t q u ic k ly  and 
subjected to subce llu la r frac tion a tio n . Details o f the determ ination o f 
cytochromes P-450, cytochrome b5 , to ta l microsomal heme and U D P -g lucu- 
rony l transferase in the microsomal fra c tio n , am inopyrine-N -dem ethylase 
a c tiv ity  (EC 1 .14 .14 .1) in the postm itochondria l fra c tio n , g lu ta th io n e - 
S -transferase (GST) (EC 2 .4 .1 .18 ) and DT-diaphorase a c tiv it ie s  in the
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cytosolic fra c tio n , g lu ta th ione  and y-g lu tam yl transferase (y -G T ) in to ta l 
liv e r  homogenate and o f p ro te in  (Low ry et a L , 1951; M ille r, 1959) and 
DNA by B u rton 's  method (1956) were described e a rlie r. The microsomal 
dea lky la tion  o f e tho xyreso ru fin  (EROD) and p en toxyreso ru fin  (PROD) as 
substra tes were ca rried  out by the method o f Burke e t a l. (1977, 1985). 
Ide n tifica tion  o f placental g lu ta th ione -S -trans fe rase  (GST-P) in the 
cytosolic frac tion  o f live r and nodules was done using a n t i- ra t  GST-P 
(Roomi e t a L , 1985c; Roomi and F arbe r, 1986c) and the O uch te rlony 
technique (1958). SDS-PAGE was ca rried  out according to Laemmli 
(1970).
Results
E arlie r find ings  (Columbano e t a L , 1983, 1984) have shown th a t a 
s ing le adm in istra tion  o f lead n itra te  at a dose o f 2 .5 , 5 and 10 ymol/100 
g body w t, stim ulates live r cell p ro life ra tio n  which peaks a t 30-36 hours 
a fte r  trea tm ent. F igure  8.1 shows a typ ica l liv e r trea ted  w ith  10 
pmol/lOO body w t. For comparative purpose a contro l liv e r is also 
shown.
The resu lts  presented in Table 8.1 reveal th a t the live r w e igh t (p e r 
100 g body w t) was increased by the adm in istra tion  o f lead n itra te  at 
doses o f 5 and 10 pmol b u t not 2.5 ymol/100 g body w t. S im ila r ly , a t 
the two h ighe r doses o f lead n itra te  used, the p ro te in  concentra tion  o f 
the whole live r and o f the cytosolic and microsomal frac tions  was also 
increased b u t on ly when expresed per whole liv e r and not when 
expressed per gram o f liv e r . These data are consistent w ith  the e a rlie r 
observation th a t lead n itra te  treatm ent resu lts  in hyperp lasia  (Columbano 
et a l. ,  1983, 1984).
Figure  8.1 A.  Control  ra t  l i ve r
B. Rat l i ver  t rea ted  w i th  lead n i t r a te ,  36 
hours  later .
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In Table 8.2 the e ffects o f d if fe re n t doses o f lead n itra te  on some 
hepatic phase I and phase I I  components o f the d rug-m etabo liz ing  system 
are presented. A s ign ifica n t decrease in cytochrome P-450 content and 
am inopyrine-N -dem ethylase a c tiv ity  was observed in ra ts  exposed to lead 
n itra te  a t doses o f 5 o r 10 ymol/100 g body w t. Cytochrome b5 and to ta l 
microsomal heme were s ig n ific a n tly  decreased at 10 ymol/100 g body wt 
and dealky la tion  a c tiv ity  w ith  the two d if fe re n t su bs tra tes , 
e th o xy reso ru fin  and p e n to xy re so ru fin , was undetectab le. However, no 
such decrease was observed when a low dose (2.5 pmol/100 g body w t) 
o f lead n itra te  was employed. Th is  low dose d id  not e lic it any e ffec t on 
hepatic DNA (Columbano e t a L , 1984) and p ro te in  content (Table 8 .1 ) .
In  con tras t to its  in h ib ito ry  e ffec t on phase I components, lead 
n itra te  treatm ent resu lted in a s tr ik in g  increase in levels o f hepatic 
g lu ta th io n e , and in the a c tiv itie s  o f g lu ta th ion e -S -trans fe ra se  and 
D T-d iaphorase. As was observed before, on ly  5 and 10 bu t not 2.5 
limol/100 g body w t lead n itra te  exh ib ited  th is  stim u la ting  e ffe c t. Lead 
n itra te  a t 10 vimol/100 g body w t also caused a s ig n ifica n t increase in 
U D P -g lucuronyl transfe rase  and y -G T  a c tiv it ie s .
The resu lts  presented (Table 8.3) so fa r  c lea rly  indicate th a t lead 
n itra te  induces a pa tte rn  o f biochemical changes which in some respects 
is sim ilar to th a t p resent in hepatic nodules (Roomi e t a L , 1985a,
1986a). Hepatic nodules also e x h ib it an increased level o f a 
g lu ta th ione -S -trans fe rase  th a t c ross-reacts  w ith  the placental type  o f 
GST (GST-P) (Roomi et a L , 1985a). I t  was o f in te res t the re fo re  to 
determ ine w hether lead n itra te  treatm ent also induces GST-P. The 
resu lts  presented in F igure  8.2A c lea rly  revealed th a t the liv e r  cytosol 
o f ra ts  treated w ith  lead n itra te  contains a p ro te in  which c ross-reac ts
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Table 8.3
Commonalities in ra t HN and lead n itra te  
Exposed Rat L ive r
Biochemical parameters Rat
HN
Rat L ive r
Exposed to Lead N itra te
Phase I Component
i
Cytochromes P-450 
Cytochrome b 5 
Total microsomal heme 
Am inopyrine N-demethylase 
Dealkylations 
(E th o xy - and P entoxy- 
reso ru fin )
- Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Phase I I  Component
GST
UDP-G lucuronyl T ransferase
G lutathione
y-G T
DT-diaphorase
A
A
A
X
A
A
A
A
A
A
Others
P-26 (GST-P)
P-14 (heme b ind ing  p ro te in ) 
Epoxide hydrolase
A
Y-
A
!
A
Y
A
-------------------:__ l_____________
Figure  8.2A Demonstrat ion o f  the id e n t i t y  o f  the po ly ­
pep t ide  as placental  g lu ta th ione -S - t ra ns fe ras e  
(GST-P) us ing immunod if fus ion techn ique .  
Centra l  well conta ined a n t i - r a t  GST-P 
a n t ib ody ;  wells 1,3 and 5 were loaded w i th  
l i v e r  cytosol  f rom ra ts  t rea ted  w i th  lead 
n i t ra te  (10 pmoles/lOO g) and wells 2,4 and 6 
had cytosol  from hepatocyte nodules.
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1
Figure 8 .2B .  E f fec t  o f  d i f f e r e n t  doses o f  lead n i t ra te  on
the induc t ion  o f  a po lypep t ide  tha t  c ross -  
reacts w i th  a n t i - r a t  GST-P a n t ib o d y .  
Centra l  well contained a n t i - r a t  GST-P 
an t ib o d y ;  wells 2 and 3 were loaded w i th  
l i ve r  cytosol  o f  ra ts  t rea ted  w i th  2.5 
l imoles/100 g o f  lead n i t r a te ;  wells 5 and 6 
had l i ve r  cytosol  f rom ra ts t rea ted  w i th  5 
pmoles/100 g o f  lead n i t r a te ,  and wells 1 and 
4 contained l i ve r  cytosol f rom ra ts t rea ted  
w i th  10 jjmoles/100 g o f  lead n i t r a te .
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w ith  GST-P an tibody and was immunologically c ross -reac tive  w ith  a 
cytoso lic  p ro te in  from hepatic nodules. The resu lts  presented in F igure 
8.2B indicate th a t the increased GST-P was seen in liv e r cytosols o f ra ts  
trea ted  w ith  5 and 10 pmol bu t not w ith  2.5 pmol/100 g body w t o f  lead 
n itra te . In  add ition , immunohistochemical analysis using the p e rox i­
dase-anti-perox idase (PAP) technique revealed the presence o f GST-P in 
most o f  the hepatocytes o f the ra ts  trea ted  w ith  10 ymol/100 g body w t 
o f  lead n itra te  and k illed  72 hours la te r (data not p resen ted ).
Th is was fu r th e r  supported by SDS-PAGE analys is. Lead n itra te  
trea ted  cytoso lic  frac tion  showed an increase in po lypeptide  o f  mol w t 26 
kD which appeared at the same position as GST-P ( P—26) o f  ra t HN (F ig . 
9 .6 ) . F igure 9.7A and B shows the SDS-PAGE o f p ro te in  pa tte rn  o f the 
liv e r microsomal frac tion  from lead n itra te  trea ted  ra ts . The po lypeptide  
pa tte rn  showed a decrease in cytochrome P-450 reg ion , and an increase 
in epoxide hydrolase reg ion .
S im ilar to HN, a po lypeptide o f mol w t 14 kD (P-14) is decreased in 
the cytoso lic frac tion  o f ra ts  trea ted  w ith  lead n itra te . Th is  po lypeptide  
bands sim ilar to th a t o f heme b ind ing  p ro te in  (F ig . 9 .6 ) (V incen t and 
E berha rd , 1985).
Discussion
The resu lts  obtained in th is  s tudy  (Tables 8.2 and 8 .3 ) c le a rly  
ind icate th a t lead n itra te  treatm ent e lic its  a biochemical response, v e ry  
sim ilar in ce rta in  respects to th a t seen in hepatic nodules in the ra t 
(Roomi et a L , 1985a, 1986a).
Rat live r nodules, as a general popu la tion , are one p re cu rso r lesion 
from which cancer arises (Fa rbe r and Cameron, 1980). They e x h ib it
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several unique biochemical p roperties  one o f which is the development o f 
an enzymic pa tte rn  con fe rrin g  resistance to the cy to to x ic  e ffects  o f 
certa in  xenobiotics (H u lte re r e t aL , 1969; Farber e t a j . , 1976; F a rbe r, 
1984d; Roomi et a t . , 1985a), which include cytochromes P-450, and 
am inopyrine N-demethylase, benzo [a ]pyrene  hyd roxy lase , e th o xy re so ru fin  
O -de-ethylase and ethoxycoum arin O -de-e thylase a c tiv itie s  (Gravela et 
a ] . ,  1975; Cameron e t a l . , 1976; Okita e t a l . , 1976; Feo e t aL , 1978; 
Kaneko et a L , 1980; Bock et aL , 1982; Astrom  et aL , 1983;
Ericksson e t a l . , 1983). In  add ition , th ey  e x h ib it an increase in
g lu ta th ione -S -trans fe rases  and DT-diaphorase ac tiv itie s  ( Fiala et a L , 
1976; Schor e t a l . , 1978; Demi and O esterle, 1980; Astrom  e t a L ,
1983; Roomi et a L , 1985a) to mention a few , which are invo lved  in the 
conjugation and de tox ifica tion  o f ce rta in  types o f xenobiotics and oxygen 
radicals (Parke and Ioannides, 1984). Appearance in th is  type  o f 
biochemical pa tte rn  is unique to the hepatic nodule. The live r cell does 
not appear to e xh ib it th is  type  o f expression e ith e r in response to 
several agents th a t induce drug-m etabo liz ing  enzymes, d u rin g  its  
development o r d u rin g  liv e r cell regeneration (S tou t and Becker, 1987). 
Inducers o f d rug-m etabo liz ing  enzymes, such as phenobarb ita l, induce 
both phase I and phase I I  components, whereas fetal l iv e r ,  fo r example, 
is low in cytochromes P-450 bu t is also low in g lu ta th ione  and 
g lu ta th ione -S -trans fe rases . However, lead n itra te  adm in is tra tion  w ith in  
36 hours e lic its  a response in the hepatocyte which is ve ry  s im ilar to  
th a t seen in the hepatocyte o f the nodule. In te re s tin g ly  lead n itra te  
treatm ent also resu lts  in an increased expression o f GST-P, an enzyme 
th a t is present in la rg e r concentrations in the nodules (E ricksson , 1983; 
Sato, 1984; Satoh, 1985; Roomi e t a l. ,  1985c). I t  is o f in te re s t to
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note th a t in addition  to lead n itra te , bu ty la ted  hyd roxy to luene  and 
bu ty la ted  hydroxyan iso le  also induce biochemical changes sim ilar in 
ce rta in  respects to those seen in the hepatic nodule in the ra t (Cha and 
Bueding, 1979; Cha and Heine, 1982). In  HN th is  p ro p e rty  is 
co n s titu tive  whereas in lead n itra te -tre a te d  ra ts  i t  is tra n s ie n t and 
re ve rts  back to the normal enzyme pa tte rn  ind ica ting  th a t some o the r 
additional mechanism must be opera ting  d u rin g  the carcinogenic process. 
Agents such as lead n itra te  may thus be o f help in uncovering  the 
mechanism by which hepatocytes express th is  d iffe re n tia te d  func tion  seen 
in hepatic nodules. The advantage o f  such model compounds is the 
ra p id ity  w ith  which they can induce the d iffe re n tia te d  fu n c tio n , and 
because o f th is  ra p id ity , systems using model compounds can also be 
subjected to fu r th e r  biochemical m anipulation.
CHAPTER 9
EFFECT OF INDUCERS AND INHIBITORS OF CYTOCHROME P-450
ON HEPATIC NODULES
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CHAPTER 9
EFFECT OF INDUCERS AND INHIBITORS OF CYTOCHROME P-450
ON HEPATIC NODULES
In tro d u ction
I t  is clear from preceding Chapters th a t hepatocyte nodules (HN) 
have a decreased level o f phase I components inc lud ing  cytochromes 
P-450.
Th is p ro p e rty  appears to be co n s titu tive  in HN and does not seem 
to re fle c t a response to any p a rticu la r in it ia tin g  or prom oting chemical 
(Cameron e t a L , 1978; Feo e t a [ . , 1978; Astrom e t a L , 1983;
Ericksson e t a l. ,  1983; Roomi et a l. ,  1985a). However, what is not ye t 
established is w hether HN s t il l  reta ined the capacity to respond to 
inducers and in h ib ito rs  o f cytochromes P-450 in p a rticu la r and phase I 
components in genera l.
In  th is  s tudy  the e ffects o f two induce rs , phenobarb ita l (PB) and 
3-m ethylcholanthrene (3-MC) (C onney, 1967) and two in h ib ito rs , lead 
n itra te  (A lvares and Kappas, 1979) and cobalt heme (Drummond and 
Kappas, 1982) on the levels o f phase I components inc lud ing  cytochromes 
P-450, in ra t live r HN have been examined. In  addition  the e ffec ts  o f 
these agents on the levels o f phase II  components in HN have also been 
s tud ied .
M aterials and Methods
Experimental conditions were s im ilar to those described in e a rlie r 
Chapters 2,3 and 7. Male F ischer 344 ra ts  (Charles R iver Breeding 
Laboratories, S t. C onstant, Quebec, Canada) were used. HN were
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induced by the RH model and used s ix  months a fte r in itia tio n  (So lt and 
F a rbe r, 1976). HN are also induced by o ro tic  acid (OA) model 
(Columbano e t a l . , 1982; Laurie r e t a L , 1984). Rats were maintained 
on Purina chow and da ily  cycles o f a lte rna tin g  12 hour periods o f lig h t 
and darkness. A ll ra ts  were g iven food and water ad lib itum  and were 
acclimatized to th e ir  environm ent fo r  a t least 1 week before the 
experim ent.
Phenobarbital d issolved in 0.15 M NaCI was injected in tra p e rito n e a lly  
a t a dose o f 100 m g /kg /d a y  fo r 5 days. 3-M ethylcho lanthrene dissolved 
in corn oil was g iven by stomach tube a t 40 m g /kg /d a y  fo r  3 days.
Cobalt heme was injected subcutaneously a t a sing le  dose o f 100 
ym o l/kg . Solutions o f cobalt-heme were prepared by d isso lv ing  the 
compound in 0.1 M NaOH, ad jus ting  to pH 7.4 w ith  1 M HCI and making 
up to fina l volume w ith  0.9% NaCI. The cobalt-heme solutions were 
adm inistered (0.5 ml/100 g body w t) w ith in  10 min o f prepara tion  
(Drummond and Kappas, 1982) and animals were k illed  3 days a fte r ­
w ards. Control ra ts were g iven e ith e r saline or corn o il. Cobalt-heme 
was supplied by p o rp h y rin  p roducts  (Logan U T ).
Lead n itra te  (Columbano et a | . , 1983) dissolved in d is tille d  water 
was g iven via the femoral vein (10 pmol per 100 g body w e ig h t). 
C orresponding contro l ra ts  received an equ iva len t volume o f 0.9% NaCI. 
Rats in these two groups were k illed  36 hours a fte r  lead n itra te  
trea tm ent. A ll o ther chemicals used were supplied by e ith e r Sigma 
Chemical Company o r Fischer S c ien tific  Co.
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Serum and Tissue P reparation
For ha rvesting  o f nodules, the animals were anesthetized w ith  e th y l 
e th e r, blood was drawn by cardiac punctu re  and the live rs  were ra p id ly  
removed, ch illed  and weighed. The nodules from each animal were 
pooled, and each pool was considered as a single specimen. C a re fu lly  
d issected HN, con tro l and trea ted  live rs  were rinsed tw ice in ice cold 
0.9% NaCI, weighed and homogenized in 3 volumes o f HEPES b u ffe r  pH 
7.0 conta in ing 0.2 M sucrose and 1 mM EDTA. Details o f p repara tion  o f 
va rious  subce llu la r frac tions  are g iven in Chapter 2.
Determ ination o f cytochromes P-450, cytochrome b5 , to ta l microsomal 
heme, e thoxy reso ru fin  (EROD) and pen toxyre so ru fin  (PROD) dea lky la tion  
and U D P -g lucuronyl transferase in the microsomal fra c tio n , am inopyrine 
N-demethylase in the post-m itochondria l fra c tio n , g lu ta th ione  
S -transfe rase  (GST) and D T-diaphorase a c tiv itie s  in the cy toso lic  
fra c tio n s , y -g lu tam y l transferase  (y -G T ) and g lu ta th ione  in to ta l liv e r  
homogenate and p ro te in  were described in Chapters 2, 3 and 5.
SDS-PAGE was perform ed by the method described by Laemmli 1970).
Results
Typ ica l gross live rs  w ith  nodules and a fte r treatm ent toge the r w ith  
l iv e r  section showing HN are shown in F igures 9 .1 -9 .5 . They all have 
v is ib le  lesions rang ing  from 1-2 cm in diam eter. Acute trea tm ent w ith  
PB, 3-MC, cobalt-heme or lead n itra te  d id  not appear to induce any 
gross changes in the nodules.
Phase I Components
The contents o f cytochromes P-450, cytochrome b 5, to ta l microsomal 
heme, a c tiv itie s  o f am inopyrine N-dem ethylation and e th o x y - and
F igure  9.1 A L ive r  showing hepatocyte nodule (HN) genera ted  by  
re s is ta n t  hepatocyte  (RH) model.
F igure  9.1 B L ive r  sections showing HN.
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CENTIMETRES
INCHES/POUCES
F igure  9 .2A  L ive r  showing hepatocyte  nodule (HN) genera ted  by  
re s is ta n t  hepatocyte  (RH) model and exposed to 
p h e n o b a rb i ta l . (Experim en ta l details are g iven  in the
F ig. 9 .2B L ive r sections show ing HN exposed to p h e n o b a rb i ta l .
Note they  do not show any gross change.
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Figure  9 .3A  L ive r  showing hepatocyte  nodules generated by  re s is ta n t  
hepatocyte  model and exposed to 3 -m e thy lcho lan th rene  
(3 -M C ). (Experim en ta l de ta ils  are g iven  in the t e x t ) .
A
sTrmnr; i  t w o  i :// Fisher Scientific Co., Limited 1926-19
F igu re  9.3B L ive r  sections showing hepatocyte  nodules exposed to 
3-MC. Note the nodules do not show any gross change.
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F igure  9 .4A  L ive r  showing hepatocyte nodule genera ted  by re s is ta n t  
hepatocyte  (RH) model and exposed to coba lt-hem e. 
(Experim enta l de ta ils  are g iven  in the t e x t ) .
F igu re  9.4B L ive r  section showing hepatocyte  nodule exposed to 
cobalt-heme. Note the nodules do not show any g ross 
change.
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F igure  9.5 L ive r showing hepatocyte  p roduced by re s is ta n t
hepatocyte (RH) model and exposed to lead n i t ra te .  
(Experim enta l de ta ils  are g iven  in the t e x t ) .
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p e n to xy -re so ru fin  dealkyla tion  in contro l and HN exposed to PB, 3-MC
cobalt-heme and lead n itra te  are summarized in Table 9 .1 .
The levels o f cytochromes P-450, cytochrome b 5 and to ta l microsomal 
heme were m arkedly increased in PB-treated HN (O kita  et c iL , 1976;
Feo e t a l . , 1978; Keneko e t a l . , 1980). Am inopyrine N-demethylase 
a c tiv ity  was also increased (4 -fo ld ) whereas e thoxy reso ru fin  was only 
s lig h tly  increased. V e ry  marked increases in p e n toxyre so ru fin  was 
observed in PB-treated nodules. S im ilar changes were seen in 
non-nodular con tro l ra t live r exposed to PB.
3-M ethylcholanthrene treated nodules showed large increases in 
cytochrome-448 and to ta l microsomal heme and moderate increases in 
cytochrome b5 conten t. S tr ik in g  increases in e tho xy reso ru fin  and no 
s ig n ifica n t increases in pen toxyreso ru fin  were noted in 3-MC trea ted
nodules whereas am inopyrine N-demethylase a c tiv ity  was unchanged. 
C ontrol ra t liv e r not treated w ith  any carcinogen also responded to  3-MC 
s im ila rly .
Cobalt-heme treated nodules showed a fu r th e r  s ig n ifica n t decrease 
in cytochromes P-450, cytochrome b5 and to ta l microsomal heme. A 
s ig n ifica n t decrease was also seen in am inopyrine demethylase a c tiv ity  
whereas e thoxyreso ru fin  a c tiv ity  was to ta lly  undetectab le .
The e ffe c t o f lead n itra te  on phase I components in HN generated 
by RH and o ro tic  acid models are shown in Table 9 .3 . Lead n itra te  d id  
not e xe rt any noticeable e ffec t on phase I components o f HN. In 
con tra s t, as shown e a rlie r, such a treatm ent resu lted in decreased levels 
o f phase I components in su rround ing  non-nodu lar areas as well as in 
contro l ra t live r not exposed to any carcinogen (Table 9 .3 ) .
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Phase I I  Components
A c tiv itie s  o f enzymes associated w ith  phase I I  reactions such as 
g lu ta th ione  S -trans fe rase , U D P -g lucuronyl tra n s fe rase , D T-d iaphorase, 
y-G T and g lu ta th ione  contents are shown in Table 9 .2 . GST, 
U D P -g lucuronyl transfe rase  and y-G T  a c tiv itie s  were s ig n ific a n tly  
increased in PB-treated nodules whereas D T-diaphorase a c tiv ity  and 
g lu ta th ione  content were unchanged. In  co n tra s t, con tro l ra t live rs  not 
treated w ith  any carcinogen showed an increase in all the param eters. 
When exposed to 3-MC, nodules showed a s ig n ifica n t increase in 
D T-d iaphorase, U D P -g lucuronyl transferase and GST a c t iv ity ,  whereas 
y -G T  a c tiv ity  and g lu ta th ione  levels were unchanged. Control ra t liv e r  
treated w ith  3-MC showed sim ilar changes. Cobalt-hem e-treated nodules 
showed a decrease in g lu ta th ione  content and no changes in the level o f 
GST, U D P -g lucuronyl trans fe rase , D T-diaphorase and y-G T  a c tiv it ie s . 
C ontrol ra ts  not trea ted  w ith  any carcinogen showed a tre n d  in the same 
d irec tion  as nodules except th a t GST showed a decrease in a c t iv ity  on 
exposure to cobalt-hem e. Lead n itra te  however, caused no change in 
phase I I  components o f HN (Table 9 .4 ) .
F igures 9.6 and 9.7A show the SDS-PAGE o f cytoso lic  and 
microsomal p ro te in  pa tte rn  o f hepatocyte nodules trea ted  w ith  PB, 3-MC, 
cobalt-heme and lead n itra te . For comparison cytoso lic and microsomal 
frac tions  o f con tro l ra ts  trea ted  w ith  the above xenobiotics are also 
shown. The levels o f cytoso lic  po lypeptide  o f m ol.w t 26 which has been 
iden tifie d  as placental g lu ta th ione -S -trans fe rase  (E ricksson et a L , 1983; 
Sato e t a L , 1984; Roomi e t a L , 1985b; Satoh e t a [ . , 1985) and the 14 
kD po lypeptide which has been te n ta tive ly  iden tified  as heme b ind ing  
pro te in  (V incent and E berhard , 1985) were unchanged (F ig . 9 .6 ) except
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F igure  9 .6 .
=  *
SDS-PAGE (15% po lyacry lam ide ) cy toso ls  from l iv e r  and 
hepatic  nodule o f  ra ts  trea ted  w ith  PB, 3-MC, co b a lt -  
heme and lead n i t r a te .  1. M a rke rs ;  2. C on tro l (C o n ) ;  
3. H epatocyte -nodu le  (H N ) ;  4. C on-P B ; 5. H N -P B ; 6.
Con-3-M C; 7. HN-3MC; 8. Con-lead n i t r a te ;  9. HN-lead 
n i t r a te ;  10. Con-coba lt  heme; 11. HN -coba lt-haem . 
A pp rox im a te ly  30 yg p ro te in  o f  cy toso lic  f ra c t io n  
analyzed was sub jected to e lec trop ho res is .  The gel was 
stained w ith  Coomassie b lue B. M arke r p ro te in s  were 
the same as used in F igu re  6 .1 .
SDS-PAGE (12.5% p o lyac ry lam id e ) .  Microsomes o f  l iv e r  
and hepatic nodules o f  ra t  t rea ted  w ith  PB, 3-MC, 
cobalt-heme and lead n i t ra te .  1. C on tro l (C o n ) ;  2. 
Hepatocyte nodule (H N ) ;  3. Con-lead n i t r a te ;  4.
HN-lead n i t ra te ;  5. Con-coba lt-hem e; 6. H N -co ba lt-  
heme; 7. M a rke rs ;  8. Con-PB; 9. HN -PB; 10. C on-3 - 
MC; 11. HN-3-M C; 12. M arke rs . The gel was s ta ined 
w ith  Coomassie blue B. The m arke r p ro te in s  were the 
same as used in F igure  6 .1 .
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F igure  9.7B Same gel as in F igu re  9 .7A . The cytochrom e P-450 
po iypep tide  region has been expanded.
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in lead n itra te  trea ted  ra ts (see Chapter 8 ). The microsomal po lypeptide 
pa tte rn  o f nodules trea ted  w ith  xenobiotics is shown in F igure 9.7A and 
B. The po lypeptide pa tte rn  showed an induction  in the po lypeptide 
region o f cytochromes P-450 fo llow ing PB and 3-MC exposure . 
Cobalt-heme showed a decrease, however lead n itra te  showed no change 
in the po lypeptide  pa tte rn  in th is  region in HN.
Discussion
The resu lts  (Tables 9.1 and 9 .2) ind icate th a t HN re ta in  th e ir  
capacity  to respond to a v a r ie ty  o f inducers and in h ib ito rs  o f 
cytochromes P-450 (Conney, 1967). Both PB (O kita  e t a L , 1976; Feo 
e t a L , 1978; Kenoko et a L , 1980) and 3-MC induced the approp ria te  
cytochrom es. However, the induced levels in HN are s t i l l  lower than the 
induced levels in su rround ing  or contro l ra t l iv e r . The response o f the 
phase I I  components in HN to these inducers is d if fe re n t. For example,
both PB and 3-MC d iffe re d  in th e ir  a b ility  to induce phase I I  components
in HN as compared w ith  con tro l ra t l iv e r .
Hepatic nodules responded d if fe re n t ly  to d if fe re n t in h ib ito rs  o f 
cytochrome P-450. For example cobalt heme (Drummond and Kappas, 
1982) could fu r th e r  decrease the levels o f cytochrome P-450 as well as
o ther phase I components in HN. However, lead n itra te  an agent th a t
decreases the phase I components in con tro l non-nodu la r liv e r  (A lvares 
et a L , 1972; Scoppa e t a L , 1973), d id  not decrease the phase I
components in HN. With respect to phase II  components the response o f 
HN d iffe rs  from con tro l ra t live r toward cobalt heme. Lead n itra te  
however, d id  not induce any change in phase I I  components o f the HN. 
This is in con tras t to its e ffects on the con tro l ra t liv e r .
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The present s tu d y  shows th a t HN exh ib its  in a co n s titu tive  fashion 
a decreased level o f phase I components and have reta ined the capacity 
to respond to inducers and in h ib ito rs  o f the microsomal cytochromes. 
However, the magnitude o f response d if fe rs  w ith  d if fe re n t agents.
CHAPTER 10 
GENERAL DISCUSSION
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CHAPTER 10 
GENERAL DISCUSSION
The overa ll aim o f th is  s tu dy  was to characterize  the re s is ta n t 
phenotype exh ib ited  by nodule population th a t develop d u rin g  chemical 
carcinogenesis in ra t liv e r . I t  has long been known th a t cancer cells 
are res is tan t to several xenobiotics inc lud ing  carcinogens (Haddow, 
1938). I t  was reasoned i f  the resistance p ro p e rty  is acquired  d u rin g  the 
in itia tio n  phase o f the carcinogenic process then th is  res is tan t phenotype 
can be se lective ly  stim ulated to grow  in response to a p ro life ra tiv e  
stim ulus in the presence o f a m ito - in h ib ito ry  environm ent. A cco rd in g ly , 
Farber and his associates developed the res is tan t-hepa tocyte  model (RH 
model) where in the in itia ted  hepatocytes were se lective ly  stim ulated to 
grow to form hepatic foc i/nodu les in response to a p ro life ra tiv e  stim u lus 
in an otherw ise m ito in h ib ito ry  environm ent. In  th is  p a rtic u la r design the 
m ito in h ib ito ry  environm ent was created by exposing the in itia te d  ra ts  to 
a d ie t conta in ing 2-acetylam inofluorene (2 -A A F) and the p ro life ra tiv e  
stim ulus was e ith e r 2/3 pa rtia l hepatectomy o r a necrogenic dose o f CCI4 
(Solt and F a rbe r, 1976). Th is concept was la te r extended by Ito  and 
his co -w orkers (1980) who employed several live r carcinogens to  create 
m ito in h ib ito ry  environm ent and se lective ly  stim ulated the g row th  o f 
in itia ted  hepatocytes to form hepatic nodules ( Ito  e t a L , 1980). The 
hepatic nodules so formed could serve as one p recu rso r population fo r  
hepatocellu lar carcinoma. The rationale fo r  the present s tu dy  stems from  
the rea lization th a t hepatocytes e xh ib itin g  the res is tan t phenotype is one 
o f the early  a lte red cell populations th a t can be monitored and is one
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p re cu rso r fo r  the development o f liv e r cell cancer. Since xenobiotics 
were employed to create m ito in h ib ito ry  environm ent, the present s tud y  
was designed to characterize  one aspect o f resistance phenomenon, 
namely the activa tion  and de tox ifica tion  o f xenob io tics. One o f the 
routes o f elim ination o f xenobiotics is mediated by microsomal d rug  
metabolizing system. The in itia l step (phase I)  is an ox ida tive  process 
mediated by cytochromes P-448 and P-450. The la tte r one appears to 
mediate the de tox ifica tion  pathway while the form er seems to mediate the 
generation o f an active  metabolite th a t e xh ib its  the carcinogenic potentia l 
(Parke and Ioannides, 1984). In  most instances phase I I  components 
such as g lu ta th ione , g lu ta th ione -S -trans fe rases  (G S T ), D T-d iaphorase, 
y -g lu tam yl transfe rase  (y -G T ) mediate the second stage in the 
de tox ifica tion  process. A cco rd ing ly  in the present s tu d y  phase I and 
phase II  components were monitored in hepatic nodules.
In itia te d  Hepatocyte -  A Resistant Phenotype
Hepatic nodules generated by the res is tan t hepatocyte model 
exh ib ited  a decreased phase I and an increased phase I I  components, a 
biochemical m achinery th a t co n tribu tes  to th e ir  resistance to  the 
cy to to x ic  e ffec t o f several hepatotoxic agents crea ting  the resistance 
phenotype (C hapter 2 ). The next obvious question was to determ ine 
w hether the resistance p ro p e rty  is cha rac te ris tic  o f the res is tance- 
hepatocyte model, because the in itia ted  hepatocytes were se lec tive ly  
stim ulated to grow in a m ito in h ib ito ry  environm ent o r is it  an expression 
o f hepatic nodule irresp ec tive  o f how the nodule is generated. Results 
presented in Chapter 2 c lea rly  indicated th a t ra t liv e r  nodules generated
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by fo u r o ther in itia tion -p rom o tion  protocols also exh ib ited  the same 
unique biochemical m achinery, i.e .  a decrease in cytochromes P-450, 
cytochrome b5 and several dealkylases and an increase in g lu ta th ione  
trans fe rase , D T-diaphorase and y g lu ta m y l trans fe rase . In  a d d itio n , 
hepatic nodules generated by Ponceaux (P arke r and G ray, 1977) also 
exh ib ited  a decreased cytochromes P-450. Th is suggested th a t the 
acqu is ition  o f the resistance phenotype is not in response to a p a rtic u la r 
in it ia to r  or a promotion protocol used bu t perhaps is an in tr in s ic  
p ro p e rty  o f the hepatic nodule.
Experiments were then designed to determ ine w hether the acqu ired  
resistance phenomenon pers is ts  in the nodule hepatocytes even when 
they are subsequently allowed to develop in the absence o f xenob io tic  
used fo r th e ir  selection. Hepatic nodules were transp lan ted  in to  the 
spleen o f ra ts  not exposed to any carcinogen. A fte r  72 weeks o f g ro w th  
the hepatic nodules s til l exh ib ited  a decrease in phase I components and
an increase in phase II  components. These resu lts  s tro n g ly  favou r the
contention th a t the acquired resistance p ro p e rty  has become c o n s titu tiv e .
Even though the res is tan t hepatocyte model was developed on the 
premise th a t in itia te d  hepatocytes are res is tan t to the m ito in h ib ito ry  
e ffects o f liv e r carcinogens (Solt and F arbe r, 1976; Ito  e t a l . , 1980) the 
resistance o f hepatic nodules is not re s tr ic te d  to on ly  the m ito in h ib ito ry  
e ffects o f live r carcinogens. Th is concept o f a " re s is ta n t phenotype" 
can be b e tte r appreciated when we consider th a t ca rc inogen-a lte red  cells 
p ro life ra te  to grow and become nodules in an otherw ise m ito in h ib ito ry  
environm ent o f 2-AAF or tox ic  environm ent o f choline d e fic ie n t d ie t, 
o ro tic  acid o r lasiocarpine. The nodules appear to be res is ta n t to  a
v a rie ty  o f e ffects induced by a broad spectrum  o f agents. For
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example, hepatic nodules generated in the re s is tan t hepatocyte model are 
re s is ta n t to the m ito in h ib ito ry  e ffects o f 2-AAF and to some other 
chemical carcinogens used in the development o f nodules (S o lt and 
F a rbe r, 1976; Ito  e t a L , 1980). The nodules grown in the choline 
de fic ien t model are res is tan t to fa t accumulation due to choline d e fic ien t 
d ie t (Sells et aL , 1979); the nodules generated in o ro tic  acid model are 
resisant to the imbalances o f nucleotide pools created by o ro tic  acid 
(Laconi and Sarma, personal com m unication), nodules generated in the 
lasiocarpine model are res is ta n t to the megalocytic e ffec t o f th is  Senecio 
a lka lo id  (Hayes et a [ . , 1985) and nodules generated by polybrom inated 
b iphenyls are res is tan t to fa t accumulation w ith  th is  agent (Jensen et 
a [ . , 1983). In  phenobarb ita l model, however, it  is not clear ye t to  what 
p ro p e rty  o f phenobarb ita l the nodules are re s is tan t. Could it  be th a t 
the nodules are res is tan t to the m ito in h ib ito ry  e ffects  o f ch ron ic  
exposure to phenobarbita l? Perhaps o f g rea te r s ign ificance is the 
cross-res is tance  exh ib ited  by the nodules to a wide v a r ie ty  o f tox ic  
agents and environm ents. For example, the nodules generated in choline 
de fic ien t model (Columbano and Sarma, personal communication) and in 
the phenobarb ita l model (Schulte-Herm ann e t a_[., 1981) are re s is ta n t to 
the m ito in h ib ito ry  e ffects o f 2 -A A F ; the nodules generated in the 
res is tan t hepatocyte model are res is tan t to the fa t accumulation by 
choline de fic ien t d ie t (Ghoshal and A h luw a lia , personal com m unication). 
S im ila rly , the nodules generated by ch ron ic  exposure to 2 -AAF are 
re s is tan t to  the tox ic  e ffects o f Phallo id in (M itaka, 1985) and necrogenic 
e ffects o f CC\k and d im ethyln itrosam ine (F a rbe r e t a l . , 1976; H a rris  e t 
a j . , 1987). Thus the spectrum  o f agents to which the nodules are 
res is ta n t is so broad th a t no known boundaries can be defined as ye t.
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M ulti-R esistance Phenotype in L ive r and M u lti-D ru g  Resistance in Human 
Cancer
A new fin d in g  o f some sign ificance is the s im ila r ity  between the 
resistance phenomenon in the in itia ted  hepatocytes and the m u lti-d ru g  
resistance th a t is exh ib ited  by o r encountered by cancer cells d u rin g  
chem otherapy. T h us , the ra t hepatocyte nodules e x h ib it an increased 
expression o f gp 170, a g lycopro te in  un ique ly  expressed in some 
m u lti-d ru g  res is tan t cells (F a irch ild  et a [ . , 1987; Thorge irsson  et a L , 
1987). Resistance is also associated w ith  decreased tox in  accum ulation. 
In  add ition  the m u lti-d ru g  resistance in human breast and colon cancer 
cells appears to be s im ilar to the resistance phenomenon seen in hepatic 
nodules in th a t both these phenotypes exh ib ited  a decrease in phase I 
and an increase in phase II  components o f the d rug-m etabo liz ing  systems 
( B a tis t et a [ . , 1987).
A ll o f the above find ings  would seem to imply th a t acqu is ition  o f 
th is  type  o f resistance confers some advantage on the in itia te d  cell in its  
a b ility  to expand in a hostile  environm ent and la ter in the process a 
su rv iva l value as well.
In con tras t to  the hepatocyte nodules generated by the 
in itia tion -p rom o tion  protocols in several models, the hepatic nodules and 
hepatocellu lar carcinomas generated by hypolip idem ic agents exh ib ite d  
on ly  a decrease in the phase I components o f d rug  metabolizing system 
and not a generalized increase in phase I I  components (C hap te r 3 ). 
A lso , the mouse liv e r  nodules generated spontaneously (Sout and 
Becker, 1986) o r by chemicals (C hapter 4) exh ib ited  the decrease in the 
phase I components and an increase in some b u t not all phase II 
components. Human hepatocellu lar carcinomas resembled the nodules
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developed by hypolip idem ic agents in ra ts in th a t they exh ib ited  a 
decrease in phase I and not a generalized increase in phase I I  
components (Mouelhi et a l . , 1987). However, i t  should be pointed ou t 
th a t the phenotype o f malignant hepatocyte neoplasms in humans and 
hepatocellu lar carcinomas in ra ts  is qu ite  d if fe re n t from the phenotype o f 
the precancerous hepatocyte nodules. The marked d iv e rs ity  and 
heterogene ity  o f m alignant neoplasms is to be contrasted w ith  the 
remarkable commonality and homogeneity seen in p recu rso r lesions d u rin g  
carcinogenesis (F a rb e r, 1984b).
These observations raised at least two im portan t questions: 1)
w hether nodules generated by hypolip idem ic agent in ra ts  and those 
generated in mice e x h ib it the same resistance phenomenon seen in the 
hepatocyte nodules o f the ra t and 2) w hether a decrease in phase I 
components o f the drug-m etabo liz ing  system is more re levan t to  the 
development o f nodules (and resistance phenomenon?) than a generalized 
increase in the phase II  components. I t  would be im portan t th e re fo re  to 
s tu d y  the resistance phenomenon in the hypolip idem ic nodules. For 
example one can determ ine i f  these nodule cells are res is tan t to the 
m ito in h ib ito ry  e ffec t o f 2-AAF and respond to cell p ro life ra tiv e  stim uli in 
a manner s im ilar to th a t seen in the hepatocyte nodules generated by the 
d if fe re n t in itia tion -p rom o tion  pro tocols. I t  is also conceivable th a t phase
I components are im portant fo r  some types o f resistance while the phase
I I  components are requ ired  fo r o ther aspects o f resistance. An indepth  
investiga tion  in to  the acqu is ition  and regula tion  o f the resistance 
phenotype seems even more w arran ted  in view o f the tra n s ie n t induction  
o f th is  pa tte rn  in hepatocytes by some agents as discussed below.
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T ra n s ie n t Induction  o f the Resistant Phenotype in Rat Hepatocytes by 
Non-Carcinogen
One o f the questions raised by the above find in g s  was w hether the 
pa tte rn  o f changes in the d rug-m etabo liz ing  enzymes seen in the 
precancerous hepatic nodules occurred  ve ry  ea rly  in the process a fte r 
trea tm ent w ith  carcinogens or w hether it  can be e lic ited  by o ther 
non-carcinogenic xenob io tics. A ttem pts to answer th is  question revealed 
th a t adm in is tra tion  o f a sing le  dose o f lead n itra te  resu lted  in a decrease 
o f phase I components and an increase in phase I I  components o f 
d rug-m etabo liz ing  system w ith in  30 hours . In  a d d itio n , i t  also induced 
the placental form o f g lu ta th ione -S -trans fe rase  (C hapter 8) which is 
presen t v e ry  l it t le  in normal hepatocytes bu t is p resent in large 
quan tities  in the nodule (Sato e t a [ . , 1984; Roomi e t a L , 1985b).
S im ilar pa tte rn  o f induction  was observed using an in te rfe ro n  (Wolf et 
a L , 1986), bu ty la ted  hydroxyan iso le  (Cha and B ueding , 1979) and
bu ty la ted  hydroxyto luene  (Cha and Heine, 1982). However, un like  in 
the nodules, the biochemical p a tte rn  induced by these agents is 
re ve rs ib le . C onceivably, fu r th e r  stud ies w ith  these agents may generate 
new ins igh ts  in to  how th is  unique biochemical machinery is regu la ted . 
These observations make one wonder w hether carcinogen treatm ent 
somehow helps to f ix  th is  acquired pa tte rn  in the nodule cells so th a t i t  
now becomes co n s titu tive .
Mechanism o f Carcinogenesis
There are two major mechanisms invo lved in malignancy a) genotoxic 
mechanism -  invo lv ing  damage to nuclear (Rajalakshmi e t a l . ,  1982) and 
m itochondria l DNA (W ilkie and Even, 1982) and b) nongenotoxic
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(ep igenetic) mechanisms -  invo lv ing  o ther mechanisms and o ther 
subce llu la r organe lles, inc lud ing  the endoplasmic re ticu lum , the site o f 
detoxication o r activa tion  o f potentia l carcinogens. A t the presen t time 
there  is no unequivocal evidence fo r  im plicating e ith e r one alone. 
N everthe less, most o f the known causative agents fo r cancer, fo r 
example ion izing and u ltra v io le t ra d ia tio n , chemical carcinogens and 
v iruses  are known to damage the DNA and in some cases cause mutation 
as w ell. The association o f genetic defect o r a lte ra tion  in DNA w ith  
some types o f cancer e .g . Bloom's syndrom e, Fanconis anemia, xeroderma 
pigmentosum, retinoblastomas and lymphomas have len t fu r th e r  su p po rt 
to th is  idea. However in experim ental model systems developed fo r  a 
s tudy  o f chemical carcinogens a t least, i t  has been shown th a t rep lica tion  
o f the damaged DNA p r io r  to repa ir o f the induced damage is a key 
p re requ is ite  fo r  the in itia tio n  o f the carcinogenic process. One can 
the re fo re  conceptualize th a t carcinogens can act not on ly  the DNA 
causing a lesion b u t can also in te rfe re  w ith  the subsequent processes. 
For example they can in te rfe re  w ith  the rep lica tive  m achinery by 
decreasing the s tr in g en cy  o f the enzymes invo lved in rep lica tion  
re su ltin g  in possible m utations, a lte r DNA pro te in  in te rac tions s lich  th a t 
phenotyp ic expressions are a lte red . The in te rac tion  o f non-carc inogen ic  
agents o r o ther xenobiotics may a lte r fo r  example cell surface recep to rs , 
components o f the endoplasmic re ticu lum  which includes the m achinery 
fo r  metabolizing xenobio tics. An approp ria te  combination o f in itia l 
damage to DNA and a lte ra tions in the epigenetic elements in some cells 
would then possib ly confer on these cells advantages o f g ro w th , 
resistance to hostile  environm ent and su rv iva l value so th a t they develop 
in to  preneoplastic lesions and u ltim a te ly  cancer.
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In th is  s tudy  some aspects o f resistance phenomenon as it  is 
exh ib ited  in the hepatocyte nodules which represent one p recu rso r 
population fo r  cancer development has been s tud ied . To evaluate its  fu ll 
relevance in the development o f cancer, a lo t o f questions remain to be 
answered. Fu ture  studies w ith  the hypolipidem ics and w ith  the model 
compounds which tra n s ie n tly  induce th is  phenomenon should help us gain 
new in s ig h t into the mechanisms th a t regulate the expression o f th is  
phenomenon and the ro le , i f  any o f carcinogens in th is  process.
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